Inflammation is a crucial part of our body’s defense system, but it can also play a villainous role in both aging and cancer.Acute, short-term inflammation helps heal wounds and fight infections. Chronic inflammation, however, lingers and disrupts healthy cellular processes. This disarray creates an environment ripe for cellular mutations, a key driver of cancer development.

Furthermore, chronic inflammation fuels the growth and spread of existing cancers. Inflammatory cells release molecules that promote tumor cell proliferation, blood vessel formation for tumors to thrive, and even metastasis, the ability of cancer to travel to other parts of the body. This complex interplay between inflammation and cancer highlights their critical influence on our health and lifespan.

1. 042P Prospective Study Evaluating White Adipose Tissue Inflammation And Clinicopathologic Features In Endometrial Cancer
2. 109 The Wolf In Sheep’S Clothing: The Role Of Interleukin-6 In Immunity, Inflammation And Cancer 120 Airway Epithelial Control Of Pseudomonas Aeruginosa Infection In …
3. 113Pcould A Systemic Inflammation Response Index (Siri) Predict Overall Survival (Os) In Metastatic Pancreatic Cancer (Pc)?
4. 12.1 Enhanced Proatherogenic Inflammation After Recombinant Human Tsh Administration In Patients Monitored For Thyroid Cancer Remnant
5. 127P A Model Based On A New Inflammation–Nutrition Score And Tnm Stage For Predicting Overall Survival Of Patients With Colorectal Cancer
6. 128. The Relationship Between Inflammation And Fatigue Development In Patients With Head And Neck Cancer Receiving Imrt
7. 133P Sarcopenia And Inflammation Predicts Survival In Advanced Stage Cancer Patients (Pts) Treated With Immunotherapy (Io)
8. 139: Hck Drives Pulmonary Inflammation Via Il-6 And Promotes Alternative Activation Of Macrophages And Cancer Progression
9. 139P Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
10. 140Pmetabolic Syndrome And Inflammation In Castration Resistant Prostate Cancer (Crpc) Patients (Pts) Treated With Abiraterone (Abi) And Enzalutamide (Enza)
11. 143P A Systemic Inflammation Response Index (Siri) Correlates With Survival And Could Be A Predictive Factor For Mfolfirinox In Metastatic Pancreatic Cancer (Pc)
12. 151. Redirected T-Cells For Adoptive Immunotherapy Of Cancer And Autoimmune Inflammation: Lessons From Transgenesis
13. 1565Passociation Between Systemic Inflammation And Symptoms In Advanced Cancer Patients
14. 180P A Novel Prognostic Score Based On Inflammation And Nutrition In Colorectal Cancer Patients
15. 18Fdg Pet/Ct & Arterial Inflammation: Predicting Cardiovascular Events In Lung Cancer
16. 18F-Pbr06 Pet/Ct Imaging Of Inflammation And Differentiation Of Lung Cancer In Mice
17. 18Α-Glycyrrhetinic Acid Targets Prostate Cancer Cells By Down-Regulating Inflammation-Related Genes
18. 1908. Normocytic Anaemia Is Associated With Systemic Inflammation And Poorer Survival In Patients With Colorectal Cancer Treated With Curative Intent
19. 193P Prognostic Implication Of Inflammation-Based Scores In Patients With Metastatic Pancreatic Cancer (Mpc) Treated With First-Line Nab-Paclitaxel Plus Gemcitabine …
20. 198: Inflammation And Nitric Oxide Synthase 2 In Driving Poor Prognosis In Era (-) Breast Cancer
21. 19F Mri Tracking Of Inflammation For Earlier Prediction Of Colitis-Associated Cancer
22. 2153 The Relation Between Systemic Inflammation And Incident Cancer In Patients With Stable Cardiovascular Disease; A Cohort Study
23. 3, 5-Disubstituted Isoxazole Derivatives: Potential Inhibitors Of Inflammation And Cancer
24. 31 Loss Of P53 Drives Systemic Neutrophilic Inflammation In Breast Cancer
25. 339Phypoxia, Inflammation And Redox Status As Determinants Of Malignant Progression Of Cancer Stem Cells
26. 3B, A Novel Photosensitizer, Inhibits Glycolysis And Inflammation Via Mir-155-5P And Breaks The Jak/Stat3/Socs1 Feedback Loop In Human Breast Cancer Cells
27. 3-Like 1 Induces Survival And Proliferation Of Intestinal Epithelial Cells During Chronic Inflammation And Colitis-Associated Cancer By Regulating S100A9
28. 459P Advanced Lung Cancer Inflammation Index As A Predictor Of Response Rate In First-Line Chemotherapy For Metastatic Non-Small Cell Lung Carcinoma Patients
29. 46 Indoleamine 2, 3-Dioxygenase And Cancerous Inhibitor Of Pp2A Expression And Inflammation In Lingual Hyperplasia And Tongue Cancer
30. 4-Methylumbelliferone Treatment And Hyaluronan Inhibition As A Therapeutic Strategy In Inflammation, Autoimmunity, And Cancer
31. 504P Association Of Systemic And Local Inflammation With Prognosis In Rectal Cancer Treated With Neoadjuvant Radiotherapy
32. 504P Association Of Systemic Inflammation With Survival In Egfr Wild-Type Lung Cancer
33. 5-Bromo-3-(3-Hydroxyprop-1-Ynyl)-2H-Pyran-2-One Targets Prostate Cancer Cells By Down-Regulating Inflammation-Related Genes
34. 61P Mir-125B Plays A Tumor Suppressor Role In Inflammation-Related Non-Small Cell Lung Cancer Via Repressing Igf-1 Signal Pathway
35. 634P Prognostic Impact Of Inflammation-Based Scores In Esophageal Cancer Patients Achieving Pathologic Complete Response After Neoadjuvant Chemoradiotherapy …
36. 6-Phenylimidazo (4, 5-B) Pyridine (Phip) Induces Gene Expression Changes In Jak/Stat And Mapk Pathways Related To Inflammation, Diabetes And Cancer
37. 729P Prognostic Implication Of Inflammation-Based Scores In Patients With Metastatic Pancreatic Cancer (Mpc) Treated With First-Line Nab-Paclitaxel Plus Gemcitabine …
38. 771: Polymorphisms In Inflammation Genes And Bladder Cancer: From Initiation To Recurrence, Progression, And Survival
39. 88. Psychological Resilience Is Associated With Markers Of Inflammation And Angiogenesis In Pre-Surgical Ovarian Cancer Patients
40. 8-Nitroguanine As A Potential Biomarker For Progression Of Malignant Fibrous Histiocytoma, A Model Of Inflammation-Related Cancer
41. 947: Serum Psa Level Correlates With The Needle Biopsy Extent Of Atrophy And Chronic Inflammation, But Not With High Grade Pin And Prostate Cancer
42. A Case Of Early Colon Cancer Discovered By Granulomatous Inflammation Of The Ileum Caused By Fish Bone
43. A Case Of Granulomatous Inflammation Of The Sigmoid Colon Caused By A Fish Bone That Resembled Cancer.
44. A Challenging Picture Of Cancer-And Inflammation-Related Changes
45. A Clinical Perspective On The Role Of Chronic Inflammation In Gastrointestinal Cancer
46. A Combination Of Hydroxytyrosol, Omega-3 Fatty Acids And Curcumin Improves Pain And Inflammation Among Early Stage Breast Cancer Patients Receiving Adjuvant …
47. A Commentary On “Ptx3 Is An Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation In Cancer”
48. A Common Repertoire Of Autoantibodies Is Shared By Cancer And Autoimmune Disease Patients: Inflammation In Their Induction And Impact On Tumor Growth
49. A Comparative Approach Of Tumor-Associated Inflammation In Mammary Cancer Between Humans And Dogs
50. A Comparison Of Inflammation-Based Prognostic Scores In Patients With Cancer. A Glasgow Inflammation Outcome Study
51. A Comparison Of The Prognostic Value Of Preoperative Inflammation-Based Scores And Tnm Stage In Patients With Gastric Cancer
52. A Comprehensive Association Study For Genes In Inflammation Pathway Provides Support For Their Roles In Prostate Cancer Risk In The Caps Study
53. A Cytokine-Mediated Link Between Innate Immunity, Inflammation, And Cancer
54. A Dual Role For The Immune Response In A Mouse Model Of Inflammation-Associated Lung Cancer
55. A Folate Receptor-Α–Specific Ligand That Targets Cancer Tissue And Not Sites Of Inflammation
56. A Functional Module-Based Exploration Between Inflammation And Cancer In Esophagus
57. A Grape Powder Attenuates Colonic Inflammation, Inhibits Colitis-Associated Colorectal Cancer Development And Causes Favorable Changes Of Gut Microbiota In …
58. A Holistic Approach To Study The Effects Of Natural Antioxidants On Inflammation And Liver Cancer
59. A Ketogenic Formula Prevents Tumor Progression And Cancer Cachexia By Attenuating Systemic Inflammation In Colon 26 Tumor-Bearing Mice
60. A Long History As Analgesics In Inflammation, Head-Ache Or Trauma. If Adequately Used, They Are Effective For The Management Of Late Post-Operative And Early Cancer …
61. A Metabolically Stable Leucine Mimic Identifies Cancer From Inflammation With Positron Emission Tomography
62. A Mir-34A-Numb Feedforward Loop Triggered By Inflammation Regulates Asymmetric Stem Cell Division In Intestine And Colon Cancer
63. A Model For Cancer-Suppressive Inflammation
64. A Modest Change In Regulation Of Nod1 Expression Has A Major Impact On Inflammation And Gastric Cancer
65. A Mouse Model Of Chronic Prostatic Inflammation Using A Human Prostate Cancer‐Derived Isolate Of Propionibacterium Acnes
66. A Mouse Model Of The Δ133P53 Isoform: Roles In Cancer Progression And Inflammation
67. A Neutraceutical By Design: The Clinical Application Of Curcumin In Colonic Inflammation And Cancer
68. A New Link Between Cancer And Inflammation?
69. A New Mouse Model Of Inflammation And Gastric Cancer
70. A New Perspective On Cancer-Related Fatigue: Negative Affectivity, Depression, And Inflammation Leading To Increased Effort Expenditure
71. A Nomogram Integrated With Inflammation-Based Factors To Predict The Prognosis Of Gastric Cancer Patients
72. A Nomogram To Predict Overall Survival In Colorectal Cancer Patients Based On New Inflammation-Nutrition Score And Tnm Stage.
73. A Novel Link Between Inflammation And Cancer
74. A Novel Link Between Inflammation And Cancer.
75. A Novel Murine Model Of Inflammatory Bowel Disease And Inflammation-Associated Colon Cancer With Ulcerative Colitis-Like Features
76. A Novel Nomogram Integrated With Inflammation-Based Factors To Predict The Prognosis Of Gastric Cancer Patients
77. A Novel Pak1/Notch-1 Axis Contributes To Intestinal Inflammation And Cancer
78. A Novel Pathway Linking Oxidative Stress And Inflammation: Prevention Of Cancer, Sepsis, Asthma, Diabetes And Uveitis By Aldose Reductase Inhibition.
79. A Novel Player In Inflammation And Cancer: The Deubiquitinase Cyld Controls Hcc Development
80. A Novel Prognostic Inflammation Score Predicts Outcomes In Patients With Ovarian Cancer
81. A Novel Shogaol Analog Suppresses Cancer Cell Invasion And Inflammation, And Displays Cytoprotective Effects Through Modulation Of Nf-Κb And Nrf2-Keap1 Signaling …
82. A Novel Systematic Inflammation Related Index Is Prognostic In Curatively Resected Non-Metastatic Colorectal Cancer
83. A Novel Systemic Inflammation Response Index (Siri) For Predicting The Survival Of Patients With Pancreatic Cancer After Chemotherapy
84. A Pilot Randomised Controlled Trial To Reduce Colorectal Cancer Risk Markers Associated With B-Vitamin Deficiency, Insulin Resistance And Colonic Inflammation
85. A Pilot Study On Acute Inflammation And Cancer: A New Balance Between Ifn-Γ And Tgf-Β In Melanoma
86. A Postoperative Systemic Inflammation Score Predicts Short-And Long-Term Outcomes In Patients Undergoing Surgery For Colorectal Cancer
87. A Prognostic Factor Based On Inflammation, Nutrition, And Immune Status For Fstage Ii/Iii Colorectal Cancer
88. A Prospective Longitudinal Study Of Performance Status, An Inflammation-Based Score (Gps) And Survival In Patients With Inoperable Non-Small-Cell Lung Cancer
89. A Prospective Study Of Chronic Inflammation In Benign Prostate Tissue And Risk Of Prostate Cancer: Linked Pcpt And Select Cohorts
90. A Prospective Study Of Immune And Inflammation Markers And Risk Of Lung Cancer Among Female Never Smokers In Shanghai
91. A Prospective Study Of Inflammation Markers And Endometrial Cancer Risk In Postmenopausal Hormone Nonusers
92. A Prospective Study Of Intraprostatic Inflammation, Focal Atrophy, And Progression To Lethal Prostate Cancer
93. A Prospective Study Of The Role Of Inflammation In Bladder Cancer
94. A Putative Link Among The Triad: Inflammation, Reprogramming, And Cancer
95. A Red Meat-Derived Glycan Promotes Inflammation And Cancer Progression
96. A Self-Illuminating Nanoparticle For Inflammation Imaging And Cancer Therapy
97. A Standardized Herbal Extract Mitigates Tumor Inflammation And Augments Chemotherapy Effect Of Docetaxel In Prostate Cancer
98. A Study Of Inflammation-Based Predictors Of Tumor Response To Neoadjuvant Chemoradiotherapy For Locally Advanced Rectal Cancer
99. A Study On Changes And Clinical Significance Of Blood Glucose, Blood Lipid And Inflammation In Patients With Ovarian Cancer
100. A Survey Of Attitudes Towards The Clinical Application Of Systemic Inflammation Based Prognostic Scores In Cancer
101. A Systemic Inflammation Response Index (Siri) Correlates With Survival And Predicts Oncological Outcome For Mfolfirinox Therapy In Metastatic Pancreatic Cancer
102. A Systemic Inflammation-Based Prognostic Scores (Mgps) Predicts Overall Survival Of Patients With Small-Cell Lung Cancer
103. A Systemic Inflammation-Based Prognostic Scores (Mgps) To Predict Overall Survival Of Patients With Small Cell Lung Cancer.
104. A Task Force Against Local Inflammation And Cancer: Lymphocyte Trafficking To And Within The Skin.
105. A Translational Study To Investigate The Association Between Smoking-Induced Lung Inflammation And Lung Metastases (Lm) From Breast Cancer (Bc).
106. A Tumor Microenvironment‐Responsive Biodegradable Mesoporous Nanosystem For Anti‐Inflammation And Cancer Theranostics
107. A Two-Photon Fluorophore Labeled Multi-Functional Drug Carrier For Targeting Cancer Therapy, Inflammation Restraint And Aie Active Bioimaging
108. A20 Prevents Chronic Liver Inflammation And Cancer By Protecting Hepatocytes From Death
109. A3 Adenosine Receptor Ligands In The Treatment Of Inflammation And Cancer
110. A61 Lung Fibrosis: Animal Models Ii: Pulmonary Inflammation And Cancer Cachexia In Krasg12D Induced Lung Adenocarcinoma
111. Abo Phenotypes And Inflammation-Related Predictors Of Lung Cancer Mortality: The Copenhagen Male Study–A 16-Year Follow-Up
112. Abstract B266: Systemic Inflammation And Tissue Atrophy In Cancer Cachexia Is Mediated By Cytokine‐Dependent Protease Activation: Physiological And Functional …
113. Accelerated Aging In The Tumor Microenvironment: Connecting Aging, Inflammation And Cancer Metabolism With Personalized Medicine
114. Actions Of Vitamin D Are Mediated By The Tlr4 Pathway In Inflammation-Induced Colon Cancer
115. Activation Of Mucosal Mast Cells Promotes Inflammation-Related Colon Cancer Development Through Recruiting And Modulating Inflammatory Cd11B+ Gr1+ Cells
116. Activation Of Nf-Κb: Bridging The Gap Between Inflammation And Cancer In Colitis-Mediated Colon Carcinogenesis
117. Activation Of Polycyclic Aromatic Hydrocarbons By Phorbol Ester-Stimulated Human Polymorphonuclear Leukocytes: Possible Link Between Inflammation And Cancer
118. Activation-Induced Cytidine Deaminase (Aid) Linking Immunity, Chronic Inflammation, And Cancer
119. Activation‐Induced Cytidine Deaminase: An Intrinsic Genome Modulator In Inflammation‐Associated Cancer Development
120. Acute Inflammation And Micrometastasis Proliferation: A Fissure In The Uniformitarian Facade Of Cancer
121. Acute Local Inflammation Causing Generalized Increased Ground Substance Viscosity: Guttate Psoriasis, Reiter’S Syndrome, Adjuvant Disease, Cancer Regression
122. Adam10 As A Therapeutic Target For Cancer And Inflammation
123. Adam17 Activity And Il-6 Trans-Signaling In Inflammation And Cancer
124. Adenopathies Following Tumor Resection Could Help To Better Define The Nature Of The Association Between Granulomatous Inflammation And Cancer In This Case.
125. Adenovirus Serotype 11 Causes Less Long-Term Intraperitoneal Inflammation Than Serotype 5: Implications For Ovarian Cancer Therapy
126. Adipocytokines, Inflammation, And Breast Cancer Risk In Postmenopausal Women: A Prospective Study
127. Adipokines And Systemic Inflammation In Weight-Losing Lung Cancer Patients
128. Adiponectin And Selenium Rich Diet Can Act As A Complimentary Medicine In The Treatment Of Intestinal And Chronic Inflammation Induced Colon Cancer
129. Adiponectin And Selenium: Role In Chronic Inflammation Induced Colon Cancer: P-220.
130. Adiponectin Deficiency: Role In Chronic Inflammation Induced Colon Cancer
131. Adipose Tissue Inflammation And Cancer Cachexia: Possible Role Of Nuclear Transcription Factors
132. Adipose Tissue Inflammation And Cancer Cachexia: The Role Of Steroid Hormones
133. Adipose Tissue Inflammation And Vdr Expression And Methylation In Colorectal Cancer
134. Adipose Tissue Inflammation In Breast Cancer Survivors: Effects Of A 16-Week Combined Aerobic And Resistance Exercise Training Intervention
135. Adipose Tissue Macrophages In Obesity, Inflammation, And Cancer
136. Adiposity Results In Metabolic And Inflammation Differences In Premenopausal And Postmenopausal Women Consistent With The Difference In Breast Cancer Risk
137. Adiposity, Inflammation, Genetic Variants And Risk Of Post-Menopausal Breast Cancer Findings From A Prospective-Specimen-Collection, Retrospective-Blinded …
138. Adolescent Obesity And Inflammation In Relation To Colorectal Cancer Risk: Recent Findings And Future Implications
139. Adrenal Cortex Stimulated By Acth To Produce Cortisol. Cortisol Decreases Inflammation And Immune Responses And …
140. Advanced Lung Cancer Inflammation Index (Ali) Is A Feasible Prognostic Marker In Patients With Heart Failure
141. Advanced Lung Cancer Inflammation Index (Ali): A New Pronostic Score In Patients With Non Small Cell Lung Cancer
142. Advanced Lung Cancer Inflammation Index Predicts Outcomes Of Patients With Pathological Stage Ia Lung Adenocarcinoma Following Surgical Resection
143. Advanced Lung Cancer Inflammation Index, A New Prognostic Score, Predicts Outcome In Patients With Small-Cell Lung Cancer
144. Advanced Lung Cancer Inflammation Index: A Prognostic Score In Patients With Metastatic Non-Small Cell Lung Cancer.
145. Advanced Prostate Cancer: Reinforcing The Strings Between Inflammation And The Metastatic Behavior
146. Advances In Research On The Interaction Between Inflammation And Cancer
147. Aetiology Of Systemic Inflammation And Its Link With Prognosis In Gastro-Oesophageal Cancer
148. Ageing: From Inflammation To Cancer
149. Age-Promoted Creation Of A Pro-Cancer Microenvironment By Inflammation: Pathogenesis Of Dyscoordinated Feedback Control
150. Aging And Cancer/Inflammation
151. Aging And Inflammation: Etiological Culprits Of Cancer
152. Aging, Inflammation And Cancer
153. Aim2 Inflammasome In Infection, Cancer, And Autoimmunity: Role In Dna Sensing, Inflammation, And Innate Immunity
154. Alkylation Of The Tumor Suppressor Pten Activates Akt And Β-Catenin Signaling: A Mechanism Linking Inflammation And Oxidative Stress With Cancer
155. Allergic Pulmonary Inflammation Accelerates Breast Cancer Metastasis Via Increase Of Myeloid Cells In The Lung Microenvironment (Tum6P. 1005)
156. Allergies In Other Diseases: 255 Chronic Obstructive Pulmonary Disease And Lung Cancer Share Inflammation Pathways
157. Alleviating Promotion Of Inflammation And Cancer Induced By Nonsteroidal Anti-Inflammatory Drugs
158. Alox15 As A Suppressor Of Inflammation And Cancer: Lost In The Link
159. Alterations In Serum Amino-Acid Profile In The Progression Of Colorectal Cancer: Associations With Systemic Inflammation, Tumour Stage And Patient Survival
160. Altered Cytochrome 2E1 And 3A P450‐Dependent Drug Metabolism In Advanced Ovarian Cancer Correlates To Tumour‐Associated Inflammation
161. Altered Expression Of Butyrophilin (Btn) And Btn‐Like (Btnl) Genes In Intestinal Inflammation And Colon Cancer
162. Altered Iron Metabolism, Inflammation, Transferrin Receptors, And Ferritin Expression In Non-Small-Cell Lung Cancer
163. Aluminium, Carbonyls And Cytokines In Human Nipple Aspirate Fluids: Possible Relationship Between Inflammation, Oxidative Stress And Breast Cancer Microenvironment
164. Ambient Pm2. 5 Exposure Promotes Angiogenesis And Inflammation Of Lung Cancer Mediated By Macrophage
165. American Ginseng Suppresses Western Diet-Promoted Tumorigenesis In Model Of Inflammation-Associated Colon Cancer: Role Of Egfr
166. Amifostin Reduces The Rate Of Acute Mucosa Inflammation Among Patients Reached By An Inoperable Cancer Of The Ear Nose Throat Sphere Treated By The Association Of …
167. Ampullary Xanthogranulomatous Inflammation Mimicking Periampullary Cancer: Report Of A Case.
168. An 8 Year-Review Of Granulomatous Inflammation In Ebus Samples-Common In Sarcoidosis, Rare But Identified In The Setting Of Cancer Where Fdg Uptake Can Be …
169. An Apple Oligogalactan Prevents Against Inflammation And Carcinogenesis By Targeting Lps/Tlr4/Nf-Κb Pathway In A Mouse Model Of Colitis-Associated Colon Cancer
170. An Epidemiological Analysis Of Potential Associations Between C-Reactive Protein, Inflammation, And Prostate Cancer In The Male Us Population Using The 2009 …
171. An Epigenetic Switch Involving A Positive Feedback Loop Linking Inflammation To Cancer Effected By Myc And Mirna-17-92 Microrna Cluster
172. An Epigenetic Switch Leads To Emt Memory In Chronic Inflammation In Non-Small Cell Lung Cancer
173. An Epigenetic Switch Linking Inflammation To Cancer And The Use Of Metformin As An Anti-Cancer Drug
174. An Essential Role For T Helper 17 (Th17) Immune Response In Lung Cancer Promotion By Inflammation
175. An Experimental Study On Differential Diagnosis Of Cancer From Inflammation Using 11Cl-Methionine
176. An Immune-Modulating Diet In Combination With Chemotherapy Prevents Cancer Cachexia By Attenuating Systemic Inflammation In Colon 26 Tumor-Bearing Mice
177. An Inflammation Based Score Can Optimize The Selection Of Patients With Advanced Cancer Considered For Early Phase Clinical Trials
178. An Inflammation-Based Prognostic Score (Mgps) Predicts Cancer Survival Independent Of Tumour Site: A Glasgow Inflammation Outcome Study
179. An Innately Dangerous Balancing Act: Intestinal Homeostasis, Inflammation, And Colitis-Associated Cancer
180. An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model Of Hepatocellular Cancer Arising In The Setting Of Hepatic Inflammation And Fibrosis.
181. An Up-Date Of Olive Oil Phenols In Inflammation And Cancer: Molecular Mechanisms And Clinical Implications
182. An Update On Curcuma As A Functional Food In The Control Of Cancer And Inflammation
183. An Update On The Mechanisms Of Action Of The Peroxisome Proliferator-Activated Receptors (Ppars) And Their Roles In Inflammation And Cancer
184. Analysis Of Local Chronic Inflammatory Cell Infiltrate Combined With Systemic Inflammation Improves Prognostication In Stage Ii Colon Cancer Independent Of Standard …
185. Analysis Of Repeated 24-Core Saturation Prostate Biopsy: Inverse Association Between Asymptomatic Histological Inflammation And Prostate Cancer Detection
186. Analysis Of The Intricate Relationship Between Chronic Inflammation And Cancer
187. And Diabetes Affect The Incidence Of False-Negative 18F-Fdg Pet/Ct Studies In Patients Evaluated For Infection Or Inflammation And Cancer? A Comparative Analysis
188. And Identification Of H2O-Soluble And Low Toxic Hexacyclic Camptothecin Derivatives With Improved Efficacy In Cancer And Lethal Inflammation Models In Vivo
189. And Older With Localized Prostate Cancer In Japan Re: Diagnostic Performance Of Ct For Diagnosis Of Fat-Poor Angiomyolipoma Infection And Inflammation Of …
190. And Other Biomarkers Of Inflammation For Total Death, Incident Cardiovascular Events, Noncardiovascular And NonCancer Inflammatory-Related Events, And Total Cancer …
191. And Progesterone Action, Inflammation And Differentiation According To Demographic, Histopathological And Clinical Characteristics Of Endometrial Cancer …
192. Androgen Receptor And Immune Inflammation In Benign Prostatic Hyperplasia And Prostate Cancer
193. Andrographolide And Its Analogues: Versatile Bioactive Molecules For Combating Inflammation And Cancer
194. Anemia Of Aging: The Role Of Chronic Inflammation And Cancer
195. Angiogenesis And Lymphangiogenesis In Inflammation And Cancer
196. Angiogenesis And Lymphangiogenesis: New Molecular Targets For The Treatment Of Cancer And Inflammation
197. Angiogenesis As An Immunopharmacologic Target In Inflammation And Cancer
198. Angiogenesis Links Chronic Inflammation With Cancer
199. Angiogenesis: Potentials For Pharmacologic Intervention In The Treatment Of Cancer, Cardiovascular Diseases, And Chronic Inflammation
200. Angiopoietin-Like Protein 2 Is A Useful Biomarker For Pancreatic Cancer That Is Associated With Type 2 Diabetes Mellitus And Inflammation
201. Angiopoietin-Like Proteins In Angiogenesis, Inflammation And Cancer
202. Animal Models Of Gastrointestinal Inflammation And Cancer
203. Annexin A1 In Inflammation And Breast Cancer: A New Axis In The Tumor Microenvironment
204. Anthropometry And Ovarian Cancer: The Inflammation Connection
205. Antibody-Cytokine Fusion Proteins: A Novel Class Of Biopharmaceuticals For The Therapy Of Cancer And Of Chronic Inflammation
206. Anticopper Therapy Against Cancer And Diseases Of Inflammation And Fibrosis
207. Anticopper Therapy With Tetrathiomolybdate For Wilson’S Disease, Cancer, And Diseases Of Inflammation And Fibrosis
208. Antigen Levels In Men With Benign Prostatic Hyperplasia And Lower Urinary Tract Symptoms And Helps Differentiate Chronic Inflammation From Prostate Cancer
209. Anti–Il-20 Monoclonal Antibody Alleviates Inflammation In Oral Cancer And Suppresses Tumor Growth
210. Anti-Inflammation And Anti-Cancer Activity Of Ethanol Extract Of Antarctic Freshwater Microalga, Micractinium Sp.
211. Anti‐Inflammatory And Anti‐Tumor Effects Of Α-L-Guluronic Acid (G2013) On Cancer-Related Inflammation In A Murine Breast Cancer Model
212. Anti‐Inflammatory Mechanism Of Metformin And Its Effects In Intestinal Inflammation And Colitis‐Associated Colon Cancer
213. Antimicrobial Peptides In Intestinal Inflammation, Infection And Cancer.
214. Antitumor Potential Of Herbomineral Formulation Against Breast Cancer: Involvement Of Inflammation And Oxidative Stress
215. Anxiety Levels Parallel Changes In Inflammation Over Time In Ovarian Cancer Patients
216. Apolipoprotein Ai (Apoa-I), Immunity, Inflammation And Cancer
217. Apoptosis, Angiogenesis, Inflammation, And Oxidative Stress: Basic Interactions In Patients With Early And Metastatic Breast Cancer
218. Apoptotic And Inflammation Markers In Oral Mucositis In Head And Neck Cancer Patients Receiving Radiotherapy: Preliminary Report
219. Apoptotic Responses Common To Cancer And Inflammation
220. Application Of Chemokine Receptor Antagonist With Stents Reduces Local Inflammation And Suppresses Cancer Growth
221. Are Associated With Inflammation And Matrix Metalloproteinase-9 Activity At Incision Sites In A Murine Model Of Peritoneal Dissemination Of Colorectal Cancer
222. Are Genital Infections And Inflammation Cofactors In The Pathogenesis Of Invasive Cervical Cancer?
223. Are Markers Of Systemic Inflammation Good Prognostic Indicators In Colorectal Cancer?
224. Are Peripheral Blood Derived Inflammation Markers Prognostic Indicators In Breast Cancer?
225. Are The Survival Benefits Associated With Primary Resection In De Novo Metastatic Colorectal Cancer (Mcrc) Mediated By Reversal Of Systemic Inflammation?
226. Art. X. Case Of Cancer In The Throat, Operation And Recovery. Death From Peritoneal Inflammation. Remarkable Transposition Of All The Organs.
227. Artesunate Suppresses Inflammation And Oxidative Stress In A Rat Model Of Colorectal Cancer
228. Asbestos‐Induced Chronic Inflammation And Cancer
229. Assessment Of Some Biomarkers Of Inflammation In Breast Cancer Patients In Benin City, Nigeria
230. Assessment Of Systemic And Metastatic Neutrophilic Inflammation In Synchronously Resected Colorectal Cancer And Liver Metastases.
231. Assessment Of The Impact Of Acute Inflammation On The Anti-Cancer Responses In A Mouse Model
232. Association Among Metabolic Syndrome, Inflammation, And Survival In Prostate Cancer
233. Association And Prognostic Value Of Serum Inflammation Markers In Patients With Leukoplakia And Oral Cavity Cancer
234. Association Between Dietary Inflammation Index And The Risk Of Colorectal Cancer: A Meta-Analysis
235. Association Between Diet-Related Inflammation, All-Cause, All-Cancer, And Cardiovascular Disease Mortality, With Special Focus On Prediabetics: Findings From Nhanes …
236. Association Between Inflammation And Cancer Stem Cell Phenotype In Breast Cancer
237. Association Between Local Inflammation And Breast Tissue Age-Related Lobular Involution Among Premenopausal And Postmenopausal Breast Cancer Patients
238. Association Between Low-Grade Inflammation And Breast Cancer And B-Cell Myeloma And Non-Hodgkin Lymphoma: Findings From Two Prospective Cohorts
239. Association Between Low-Grade Inflammation Markers And Body Mass Index In Children With Cancer Undergoing Chemotherapy
240. Association Between Lysyl Oxidase And Fibrotic Focus In Relation With Inflammation In Breast Cancer
241. Association Between Obesity And Biomarkers Of Inflammation And Metabolism With Cancer Mortality In A Prospective Cohort Study
242. Association Between Prayer Activity, Inflammation, And Survival In Advanced Cancer Patients (Acps): A Preliminary Study.
243. Association Between Prediagnostic Biomarkers Of Inflammation And Endothelial Function And Cancer Risk: A Nested Case-Control Study
244. Association Between Regular Aspirin Use And Circulating Markers Of Inflammation: A Study Within The Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial
245. Association Between Variants In Inflammation And Cancer‐Associated Genes And Risk And Survival Of Cholangiocarcinoma
246. Association Of Adiposity, Dysmetabolisms, And Inflammation With Aggressive Breast Cancer Subtypes: A Cross-Sectional Study
247. Association Of Biomarkers Of Insulin Resistance And Inflammation With Pet Ct Suv Values In Stage Iv Non-Small Cell Lung Cancer (Nsclc).
248. Association Of Biomarkers Of Insulin Resistance And Inflammation With Skeletal Muscle Index (Smi) In Stage Iv Non-Small Cell Lung Cancer (Nsclc).
249. Association Of Body Mass Index And Systemic Inflammation Index With Survival In Patients With Renal Cell Cancer Treated With Nivolumab.
250. Association Of Childhood Trauma With Fatigue, Depression, Stress, And Inflammation In Breast Cancer Patients Undergoing Radiotherapy
251. Association Of Chronic Baseline Prostate Inflammation With Lower Tumor Grade In Men With Prostate Cancer On Repeat Biopsy.
252. Association Of Chronic Inflammation With Carcinogenesis: Implications Of Anti-Inflammatory Strategies For Cancer Prevention
253. Association Of Circulating Inflammatory Biomarkers And Dietary Inflammation Potential With Postmenopausal Breast Cancer Prognosis.
254. Association Of Human Papillomavirus Infection And Inflammation In Cervical Cancer
255. Association Of Markers Of Systemic And Local Inflammation With Prognosis Of Patients With Rectal Cancer Who Received Neoadjuvant Radiotherapy
256. Association Of Physical Activity And Inflammation With All-Cause, Cardiovascular-Related, And Cancer-Related Mortality
257. Association Of Sugar Intake And Inflammation In Newly Diagnosed Colorectal Cancer Patients
258. Association Of Systemic Inflammation And Sarcopenia With Survival In Nonmetastatic Colorectal Cancer: Results From The C Scans Study
259. Association Of The Age-Adjusted Charlson Comorbidity Index And Systemic Inflammation With Survival In Gastric Cancer Patients After Radical Gastrectomy
260. Association Of The Innate Immunity And Inflammation Pathway With Advanced Prostate Cancer Risk
261. Associations Among Hpv, Inflammation, And Fatigue In Head And Neck Cancer Patients
262. Associations Among Human Papillomavirus, Inflammation, And Fatigue In Patients With Head And Neck Cancer
263. Associations Between Dietary Acid Load And Biomarkers Of Inflammation And Hyperglycemia In Breast Cancer Survivors
264. Associations Between Single Nucleotide Polymorphisms (Snps) In Inflammation-Related Genes And Quality Of Life After Radiation Therapy (Rt) For Prostate Cancer.
265. Associations Of Chronic Inflammation, Insulin Resistance, And Severe Obesity With Mortality, Myocardial Infarction, Cancer, And Chronic Pulmonary Disease
266. Associations Of Inflammation With Frailty In Patients With Breast Cancer Aged 50 And Over Receiving Chemotherapy
267. Associations Of Inflammation-Related Single Nucleotide Polymorphisms And High Fructose Corn Syrup Intake With Prostate Cancer Susceptibility And Survival
268. Associations Of Transitional Zone Volume With Intraprostatic Chronic Inflammation And Prostate Cancer Risk In Patients Undergoing A First Random Biopsy Set
269. Astaxanthin At An Early Stage Inhibits N-Nitrosomethylbenzylamine–Induced Esophageal Cancer Oxidative Stress And Inflammation Via Downregulation Of …
270. At The Crossroads Of Cancer And Inflammation: Ras Rewires An Hif-Driven Il-1 Autocrine Loop
271. At The Crossroads Of Inflammation And Cancer
272. At The Intersection Of Diabetes And Cancer: The Role Of Angiogenesis And Inflammation
273. Attenuation Of Diethylnitrosamine Induced Hepatic Cancer In Wistar Albino Rats By Madhuca Longifolia Extract Via Knockdown Oxidative Stress And Inflammation
274. Atx-Lpa Receptor Axis In Inflammation And Cancer
275. Author Correction: Inflammation-Induced Iga. Sup.+ Cells Dismantle Anti-Liver Cancer Immunity
276. Author Correction: Inflammation-Induced Iga+ Cells Dismantle Anti-Liver Cancer Immunity.
277. Autophagy And Crohn’S Disease: At The Crossroads Of Infection, Inflammation, Immunity, And Cancer
278. Autophagy In Inflammation, Infection, Neurodegeneration And Cancer
279. Autophagy, Inflammation, And Breast Cancer Risk
280. Autophagy, Inflammation, And Immunity: A Troika Governing Cancer And Its Treatment
281. Autophagy: A Janus-Faced Role In Inflammation And Cancer
282. Autotaxin, A Secreted Lysophospholipase D, As A Promising Therapeutic Target In Chronic Inflammation And Cancer
283. Autotaxin-Lysophosphatidic Acid: From Inflammation To Cancer Development
284. Axl And Mer Receptor Tyrosine Kinases: Distinct And Nonoverlapping Roles In Inflammation And Cancer?
285. B10 Cells And Regulatory B Cells Balance Immune Responses During Inflammation, Autoimmunity, And Cancer
286. B30 Molecular And Immunological Aspects Of Lung Cancer: Il-17-Mediated Inflammation Promotes Cigarette Smoke-Induced Genomic Instability
287. Bacteria, Inflammation And Cancer
288. Bacteria, Inflammation And Colon Cancer. Tale From The Intestine
289. Bacteria, Inflammation, And Colon Cancer
290. Bacterial Infection Of Smad3/Rag2 Double-Null Mice With Transforming Growth Factor-Β Dysregulation As A Model For Studying Inflammation-Associated Colon Cancer
291. Bacterial Infections As Seen From The Eukaryotic Genome: Dna Double Strand Breaks, Inflammation And Cancer
292. Bacterial Signaling At The Intestinal Epithelial Interface In Inflammation And Cancer
293. Baicalein, An Enteric Microbial Metabolite, Suppresses Gut Inflammation And Cancer Progression In Apcmin/+ Mice
294. Baseline Insulin-Like Growth Factor-I Plasma Levels, Systemic Inflammation, Weight Loss And Clinical Outcome In Metastatic Non-Small Cell Lung Cancer Patients
295. Baseline Prostate Inflammation Is Associated With A Reduced Risk Of Prostate Cancer In Men Undergoing Repeat Prostate Biopsy: Results From The Reduce Study
296. Baseline Prostate Inflammation Is Associated With Reduced Risk Of Prostate Cancer In Men Undergoing Repeat Prostate Biopsy: Results From The Reduce Study
297. Basis For The Role Of Nf-Kb In Inflammation & Cancer
298. Bdnf Met Allele As A Risk Factor For Inflammation-Induced Depression In Breast Cancer Survivors
299. Beneficial Role Of Insect-Derived Bioactive Components Against Inflammation And Its Associated Complications (Colitis And Arthritis) And Cancer
300. Benefits Of Exercise Training On Breast Cancer Progression And Inflammation In C3 (1) Sv40Tag Mice
301. Bet Bromodomain Proteins And Epigenetic Regulation Of Inflammation: Implications For Type 2 Diabetes And Breast Cancer
302. Bet Domain Co-Regulators In Obesity, Inflammation And Cancer
303. Bet Family Protein Brd4: An Emerging Actor In Nfκb Signaling In Inflammation And Cancer
304. Bet Proteins In Abnormal Metabolism, Inflammation, And The Breast Cancer Microenvironment
305. Beta-Glucans And Cancer: The Influence Of Inflammation And Gut Peptide
306. Betaine Suppresses Cell Proliferation By Increasing Oxidative Stress–Mediated Apoptosis And Inflammation In Du-145 Human Prostate Cancer Cell Line
307. Between Adherence To The World Cancer Research Fund/American Institute For Cancer Research Cancer Prevention Recommendations And Biomarkers Of Inflammation …
308. Between The Presence And Site Of Cancer, An Inflammation-Based Prognostic Score And Biochemical Parameters. Initial Results Of The Glasgow Inflammation …
309. Bevacizumab Induces Inflammation In Mda-Mb-231 Breast Cancer Cell Line And In A Mouse Model
310. Bilateral Orbital Inflammation Following Intravesical Bacille Calmette–Guérin Immunotherapy For Bladder Cancer
311. Bile Acid Metabolism And Signaling In Cholestasis, Inflammation, And Cancer
312. Bilirubin: Physiological Role In Cancer And Inflammation
313. Bindarit Attenuates Pain And Cancer-Related Inflammation By Influencing Myeloid Cells In A Model Of Bone Cancer
314. Binding Sites For The Regulatory Small Vault Rnas On Messenger Rnas Of Selected Genes Relating To Cancer, Multi-Drug Resistance, And Inflammation: An Honors Thesis …
315. Bioactive Components Of Tea: Cancer, Inflammation And Behavior
316. Bioactive Compounds Isolated From Microalgae In Chronic Inflammation And Cancer
317. Bioactive Lipids In Cancer, Inflammation And Related Diseases
318. Bioactive Sphingolipids In Inflammation And Cancer
319. Biochemical And Genetic Markers In Aggressiveness And Recurrence Of Prostate Cancer: Race-Specific Links To Inflammation And Insulin Resistance
320. Biochemical And Molecular Mechanisms For The Association Between Obesity, Chronic Inflammation, And Breast Cancer
321. Biochemical Mechanism Of Inflammation In Colorectal Cancer
322. Biological Activity Studies On Marine Natural Products As Therapeutic Strategies In In Vitro Models Of Inflammation And Colon Cancer
323. Biological Ageing And Colorectal Cancer: Fetuin A, Sirtuins And Telomeres At The Interface Between Inflammation, Metabolism And Cancer
324. Biological Properties Of Citrus Flavonoids Pertaining To Cancer And Inflammation
325. Biological Role Of The Tumor Suppressor Protein, Rassf1A In Inflammation And Cancer
326. Biomarkers For Evaluating The Inflammation Status In Patients With Cancer
327. Biomarkers Of Inflammation And Breast Cancer Risk: A Case-Control Study Nested In The Epic-Varese Cohort
328. Biomarkers Of Inflammation And Immune Function And Risk Of Colorectal Cancer
329. Biomarkers Of Inflammation Are Associated With Colorectal Cancer Risk In Women But Are Not Suitable As Early Detection Markers
330. Biomarkers Of Oxidative Stress, Proliferation, Inflammation And Invasivity In Saliva From Oral Cancer Patients
331. Biomarkers Of Systemic Inflammation And Risk Of Incident, Symptomatic Benign Prostatic Hyperplasia: Results From The Prostate Cancer Prevention Trial
332. Biomarkers, Inflammation And Cancer: Where To Go?
333. Biomolecular Basis Related To Inflammation In The Pathogenesis Of Endometrial Cancer
334. Biophysical And Biochemical Characterization Of Selectin-Ligand Interactions Pertinent To Cancer Metastasis And Inflammation.
335. Biophysics Of Selectin–Ligand Interactions In Inflammation And Cancer
336. Bitter Melon As A Therapy For Diabetes, Inflammation, And Cancer: A Panacea?
337. Bitter Melon: A Panacea For Inflammation And Cancer
338. Black-White Disparity In Physical Performance Among Older Women With Breast Cancer: The Role Of Physical Activity And Inflammation.
339. Blockade Of Fas Signaling In Breast Cancer Cells Suppresses Tumor Growth And Metastasis Via Disruption Of Fas Signaling-Initiated Cancer-Related Inflammation
340. Blockade Of Mk 2 Is Protective In Inflammation‐Associated Colorectal Cancer Development
341. Blockade Of Tnf-Α Decreases Both Inflammation And Efficacy Of Intrapulmonary Ad. Ifnβ Immunotherapy In An Orthotopic Model Of Bronchogenic Lung Cancer
342. Blocking Inflammation To Improve Immunotherapy Of Advanced Cancer
343. Blood And Tumor Inflammation Markers In Non-Small Cell Lung Cancer (Nsclc): Blood Leukocytosis As An Independent Risk Factor In Early Stage.
344. Blood Cellular Markers Of Inflammation In Breast Cancer And Response To Neoadjuvant Chemotherapy
345. Blood Gene Expression Profiling In Patients Undergoing Colon Cancer Surgery Identifies Differential Expression Of Genes Involved In Immune Surveillance, Inflammation …
346. Bmx And Its Role In Inflammation, Cardiovascular Disease, And Cancer
347. Body Composition, Serum Biomarkers Of Inflammation And Quality Of Life In Clinically Stable Women With Estrogen Receptor Positive Metastatic Breast Cancer
348. Body Fatness And Adipose Tissue Subtypes Are Associated With Circulating Biomarkers Of Inflammation And Angiogenesis In Colorectal Cancer Patients: The Colocare …
349. Body Fatness, Adipose Tissue Compartments, And Biomarkers Of Inflammation And Angiogenesis In Colorectal Cancer: The Colocare Study
350. Both Acute And Chronic Inflammation Are Associated With Less Perineural Invasion In Men With Prostate Cancer On Repeat Biopsy
351. Bovine Lactoferrin Inhibits Lung Cancer Growth Through Suppression Of Both Inflammation And Expression Of Vascular Endothelial Growth Factor
352. Bowel Inflammation As Measured By Fecal Calprotectin: A Link Between Lifestyle Factors And Colorectal Cancer Risk
353. Bradykinin-Related Compounds As New Drugs For Cancer And Inflammation
354. Brain Cancer: Failure Of Resolution Of Inflammation?
355. Brain-Resident Microglia And Blood-Borne Macrophages Orchestrate Central Nervous System Inflammation In Neurodegenerative Disorders And Brain Cancer
356. Breaking The Obesity-Breast Cancer Link: The Roles Of Inflammation And Epigenetic Reprogramming
357. Breast Cancer Survivors, Common Markers Of Inflammation, And Exercise: A Narrative Review
358. Breast Cancer, Inflammation And Proliferation
359. Breast Implant (Pip), Chronic Inflammation And Cancer: Is There A Connection?
360. Breast Implant (Pip), Chronic Inflammation And Cancer: Is There A Connection? Case Report.
361. Breast Inflammation Mimicking Breast Cancer On Multimodality Breast Imaging
362. Bridging Hypoxia, Inflammation And Estrogen Receptors In Thyroid Cancer Progression
363. Bridging The Gap: A Regulator Of Nf-Κb Linking Inflammation And Cancer
364. Bromodomain Coactivators In Cancer, Obesity, Type 2 Diabetes, And Inflammation
365. C1. Inflammation And Cancer: Intracellular Signaling And Beyond Lectures L1.
366. C44Role Of Inflammation Parameters In Locally Advanced Breast Cancer: The Debate Is Still Open
367. Cachexia And Malnutrition In Cancer Patients: Inflammation Indexes Evaluation And Nutritional Intervention
368. Calcium-Sensing Receptor In Colorectal Inflammation And Cancer: Current Insights And Future Perspectives
369. Call For Papers: Adenosine In Inflammation And Cancer
370. Caloric Restriction Counteracts Chemotherapy-Induced Inflammation And Increases Response To Therapy In A Triple Negative Breast Cancer Model
371. Calprotectin (S100A8/S100A9): A Key Protein Between Inflammation And Cancer
372. Can A Modified Mediterranean Diet Reduce Inflammation In Men With Prostate Cancer?
373. Can Systemic Inflammation At Diagnosis Predict Benefit From Primary Resection In Metastatic Colorectal Cancer (Mcrc)?
374. Can Tissue Factor, A Multifactorial Molecule Of The Hemostasis, Be Used As A Biomarker For Thrombosis, Inflammation And Cancer?
375. Can We Hiit Cancer If We Attack Inflammation?
376. Cancer And Cancer-Related Fatigue And The Interrelationships With Depression, Stress, And Inflammation
377. Cancer And Inflammation
378. Cancer And Inflammation Mechanisms
379. Cancer And Inflammation Studies Using Zebrafish Cell Lines
380. Cancer And Inflammation. Differentiation By Uspio-Enhanced Mr Imaging; Tumor Oder Entzuendung. Differenzierung Mittels Uspio-Verstaerkter …
381. Cancer And Inflammation: An Aspirin A Day Keeps The Cancer At Bay
382. Cancer And Inflammation: An Old Intuition With Rapidly Evolving New Concepts
383. Cancer And Inflammation: Beyond The Malignant Cell
384. Cancer And Inflammation: Differentiation By Uspio‐Enhanced Mr Imaging
385. Cancer And Inflammation: Implications For Pharmacology And Therapeutics
386. Cancer And Inflammation: Promise For Biological Therapy
387. Cancer And Inflammation: Review On How Inflammation Furthers Tumour Development
388. Cancer And Inflammation: Role Of Macrophages And Monocytes
389. Cancer And Systemic Inflammation: Stage The Tumour And Stage The Host
390. Cancer And Systemic Inflammation: Treat The Tumour And Treat The Host
391. Cancer Anorexia: Hypothalamic Activity And Its Association With Inflammation And Appetite‐Regulating Peptides In Lung Cancer
392. Cancer Associated With Prostate Imaging Reporting And Data System Category 3 (Equivocal) Lesions Identified Infection And Inflammation Of The Genitourinary Tract …
393. Cancer Cachexia And Targeting Chronic Inflammation: A Unified Approach To Cancer Treatment And Palliative/Supportive Care
394. Cancer Cachexia: Malignant Inflammation, Tumorkines, And Metabolic Mayhem
395. Cancer Cell-Derived Transforming Growth Factor (Tgf)-Β And Myeloid Cell-Derived Interleukin (Il)-1Β Synergize To Promote Type 2 Inflammation And Breast Cancer …
396. Cancer Chemoprevention By Dietary Polyphenols: Role For Epigenetics And Inflammation
397. Cancer Due To Prolonged Inflammation
398. Cancer Evolution-Development: Novel Theory Based On Studies Of Inflammation–Cancer Transformation
399. Cancer Immunology, Inflammation, And Tolerance: An Introduction
400. Cancer Immunosurveillance, Immunoediting And Inflammation: Independent Or Interdependent Processes?
401. Cancer Immunotherapy And Inflammation: Reciprocity Of Antigen Specific And Antigen Non-Specific Bystander T Cell Responses
402. Cancer Induced Anti‐Inflammation And Its Potentiation By Tumor Excision And Rechallenge
403. Cancer Induces Inflammation And Depressive-Like Behavior In The Mouse: Modulation By Social Housing
404. Cancer Inflammation And Cytokines
405. Cancer Inflammation And Regulatory T Cells
406. Cancer Issue: Why Cancer And Inflammation?
407. Cancer Metastasis In The Temporal Bone Simulating Acute Inflammation In The Middle Ear
408. Cancer Microenvironment And Inflammation: Role Of Hyaluronan
409. Cancer Microenvironment, Inflammation And Cancer Stem Cells: A Hypothesis For A Paradigm Change And New Targets In Cancer Control
410. Cancer Of The Ovary. Comparative Value Of Serum Ca-125, Immunochemistry And Biological Tests Of Inflammation
411. Cancer Pain And Its Relationship To Systemic Inflammation: An Exploratory Study
412. Cancer Patients Under Maintenance Hemodialysis: Relationship Between Quality Of Life, Depression, Sleep Quality And Malnutrition-Inflammation Score
413. Cancer Preventive Effect Of Recombinant Trail By Ablation Of Oncogenic Inflammation In Colitis-Associated Cancer Rather Than AntiCancer Effect
414. Cancer Related Inflammation: The Macrophage Connection
415. Cancer Secretome And Inflammation: The Bright And The Dark Sides Of Nf-Κb
416. Cancer Surgery Induces Inflammation, Immunosuppression And Neo-Angiogenesis, But Is It Influenced By Analgesics?
417. Cancer Therapy: Transforming Weakness Into Strength: Photothermal‐Therapy‐Induced Inflammation Enhanced Cytopharmaceutical Chemotherapy As A …
418. Cancer, Immunity And Inflammation. Report From The Cdd Cambridge Conferences 2018 And 2019
419. Cancer, Inflammation, And Insights From Ayurveda
420. Cancer, Inflammation, And Therapy: Effects On Cytochrome P450–Mediated Drug Metabolism And Implications For Novel Immunotherapeutic Agents
421. Cancer: Il-22: Linking Inflammation And Cancer
422. Cancer: Inflammation By Remote Control
423. Cancer: Inflammation Lights The Way To Metastasis
424. Cancer-Associated Fibroblasts Are Activated In Incipient Neoplasia To Orchestrate Tumor-Promoting Inflammation In An Nf-Κb-Dependent Manner
425. Cancer-Associated Fibroblasts Influence Production Of Cancer Stem Cell Markers And Inflammation-Associated Cell Surface Molecules, In Liver Cancer …
426. Cancer-Derived Exosomes As Effectors Of Key Inflammation-Related Players
427. Cancer-Induced Inflammation
428. Cancer-Induced Inflammation And Inflammation-Induced Cancer In Colon: A Role For S1P Lyase
429. Cancer-Promoting Effect Of Capsaicin On Dmba/Tpa-Induced Skin Tumorigenesis By Modulating Inflammation, Erk And P38 In Mice
430. Cancer-Related Fatigue, Inflammation And Thyrotropin-Releasing Hormone
431. Cancer-Related Fatigue: Links With Inflammation In Cancer Patients And Survivors
432. Cancer-Related Inflammation
433. Cancer-Related Inflammation And Barrett’S Carcinogenesis: Interleukin-6 And Stat3 Mediate Apoptotic Resistance In Transformed Barrett’S Cells
434. Cancer-Related Inflammation And Treatment Effectiveness
435. Cancer-Related Inflammation As Predicting Tool For Treatment Outcome In Locally Advanced And Metastatic Non-Small Cell Lung Cancer
436. Cancer-Related Inflammation, The Seventh Hallmark Of Cancer: Links To Genetic Instability
437. Cancer‐Related Inflammation: An Emerging Prognostic Domain In Metastatic Castration‐Resistant Prostate Carcinoma
438. Cancer-Related Inflammation: Common Themes And Therapeutic Opportunities
439. Cancer‐Related Systemic Inflammation: The Challenges And Therapeutic Opportunities For Personalized Medicine
440. Candidates In Bladder Cancer Reveals Negative Correlation Between Antigen-Specific Immunoreactivity And Inflammation
441. Cannabimimetic Eicosanoids In Cancer And Inflammation: An Update
442. Cannabimimetic Fatty Acid Derivatives In Cancer And Inflammation
443. Cannabinoids In Intestinal Inflammation And Cancer
444. Cannabis Sativa L. And Nonpsychoactive Cannabinoids: Their Chemistry And Role Against Oxidative Stress, Inflammation, And Cancer
445. Carbohydrate Sulfotransferases: Novel Therapeutic Targets For Inflammation, Viral Infection And Cancer
446. Carcinogen Induced Inflammation And Pancreatic Cancer
447. Cardio-Oncology: Low-Grade Inflammation As A Common Pathway Of Cancer And Cardiovascular Disease
448. Caspases–A New Target In Inflammation And Cancer Therapy?
449. Catalpol Suppressed Proliferation, Growth And Invasion Of Ct26 Colon Cancer By Inhibiting Inflammation And Tumor Angiogenesis
450. Cathelicidin A Potential Therapeutic Peptide For Gastrointestinal Inflammation And Cancer
451. Catherine Pasquier Memorial Award Lecture (Shared): Critical Role Of Oxidative And Nitrosative Stress In Pathophysiology: Inflammation, Cell Injury And Cancer
452. Ccr2 Mediated Inflammation And Gut Microbiota In Promoting Intestinal Cancer (Ccr5P. 214)
453. Cd14 Knockdown Reduces Lipopolysaccharide-Induced Cell Viability And Expression Of Inflammation-Associated Genes In Gastric Cancer Cells In Vitro And In …
454. Cd19Locd27Hi Plasmablasts Suppress Harmful Th17 Inflammation Through Interleukin 10 Pathway In Colorectal Cancer
455. Cd90+ Stromal Cells Are The Major Source Of Il‐6, Which Supports Cancer Stem‐Like Cells And Inflammation In Colorectal Cancer
456. Cd98 Expression Modulates Intestinal Homeostasis, Inflammation, And Colitis-Associated Cancer In Mice
457. Cell Death, Inflammation, Tumor Burden, And Proliferation Blood Biomarkers Predict Lung Cancer Radiotherapy Response And Correlate With Tumor Volume And …
458. Cell Intrinsic Deregulated ß-Catenin Signaling Promotes Expansion Of Bone Marrow Derived Connective Tissue Type Mast Cells, Systemic Inflammation, And Colon Cancer.
459. Cell Membrane Biomimetic Nanoparticles For Inflammation And Cancer Targeting In Drug Delivery
460. Cell-Cell Interactions In Inflammation And Cancer Metastasis
461. Cell-Free Chromatin From Dying Cancer Cells Integrate Into Genomes Of Bystander Healthy Cells To Induce Dna Damage And Inflammation
462. Cell-Type-Specific Responses To Interleukin-1 Control Microbial Invasion And Tumor-Elicited Inflammation In Colorectal Cancer
463. Cellular And Molecular Pathways Linking Inflammation And Cancer
464. Cellular Basis Of Hepatic Fibrosis And Its Role In Inflammation And Cancer
465. Cellular Determinants And Therapeutic Implications Of Inflammation In Pancreatic Cancer
466. Cellular Expression Of Cyclooxygenase, Aromatase, Adipokines, Inflammation And Cell Proliferation Markers In Breast Cancer Specimen
467. Cellular Senescence As A Novel Mechanism Of Chronic Inflammation And Cancer Progression
468. Cellullar Plasticity And Dedifferentiation: A Link Between Cancer Stem Cells, Hypoxia, Cell Injury, And Inflammation
469. Central Nervous System And Innate Immune Mechanisms For Inflammation-And Cancer-Induced Anorexia
470. Cervical Cancer Systemic Inflammation Score: A Novel Predictor Of Prognosis
471. Change In Systemic Inflammation Markers And Cea Levels As Predictive Marker For Chemotherapy Response And Prognosis In Metastatic Colorectal Cancer.
472. Changes In Biomarkers Of Inflammation And Angiogenesis During Androgen Deprivation Therapy For Prostate Cancer
473. Changes In Inflammation And Insulin Pathways Mediate The Association Between Resistance Training And Breast Cancer Survival
474. Characterisation Of The Role Of Fas In Intestinal Inflammation And Cancer
475. Characterization Of Genetic And Epigenetic Modifications In A Model Of Inflammation-Driven Cancer
476. Characterization Of Hyaluronan, Hyaluronidase Ph20, And Ha Synthase Has2 In Inflammation And Cancer
477. Characterization Of Lipid Metabolic Reprogramming And Loss Of Foxo3 In Inflammation-Promoted Colon Cancer
478. Characterization Of The Biological Effects Of Natural Compounds Against Inflammation, Metabolic Syndrome And Cancer
479. Characterizing Dsrna-Induced Inflammation In Ovarian Cancer Cells
480. Checkpoints In Tnf-Induced Cell Death: Implications In Inflammation And Cancer
481. Chemerin As A Biomarker At The Intersection Of Inflammation, Chemotaxis, Coagulation, Fibrinolysis And Metabolism In Resectable Non-Small Cell Lung Cancer
482. Chemical Modulators For Epigenome Reader Domains As Emerging Epigenetic Therapies For Cancer And Inflammation
483. Chemical Proteomics For Characterization Of Small Molecule Kinase Inhibitors In Cancer And Inflammation
484. Chemoattractant Protein-1 Expression Delays Mammary Tumorigenesis And Reduces Localized Inflammation In The C3 (1)/Sv40Tag Triple Negative Breast Cancer Model
485. Chemokines And Chemokine Receptors: New Insights Into Cancer-Related Inflammation
486. Chemokines In Cancer Related Inflammation
487. Chemokines Sound The Alarmin: The Role Of Atypical Chemokine In Inflammation And Cancer
488. Chemoprevention Of Inflammation-Related Colorectal Cancer By Silymarin-, Acetyl-11-Keto-Beta-Boswellic Acid-, Curcumin-And Maltodextrin-Enriched Dietetic Formulation …
489. Chemoprevention Of Matrine And Oxymatrine On Prevention Of Inflammation Related Colorectal Cancer
490. Chemoprevention With Phytonutrients And Microalgae Products In Chronic Inflammation And Colon Cancer
491. Chemopreventive Activity On Prostate Cancer Cells And Anti-Inflammatory Effect On 12-O-Tetradecanoylphorbol-13-Acetate-Induced Mouse Ear Inflammation
492. Chemoradiation Abrogates Inflammation, Induces Sickness Behavior, Activates Hypoxia Signaling Pathways, And Causes Mitochondrial Dysfunction In A Syngeneic …
493. Chemoradiotherapy-Related Carotid Artery Inflammation In Head And Neck Cancer Patients Quantified By [18F] Fdg Pet/Ct
494. Chemoresistance And Cancer-Related Inflammation: Two Hallmarks Of Cancer Connected By An Atypical Link, Pkcζ
495. Chemoresistance In A Breast Cancer Animal Model: The Role Of Obesity And Inflammation
496. Chemotherapy Necessitates Increased Immune Control Of Hhvs: A Cause Of Persistent Inflammation Enabling Protracted Fatigue In Breast Cancer Survivors
497. Chemotherapy Reduces The Prevalence Of Asthma Symptoms In Children With Cancer: Implications For The Role Of Airway Inflammation In Asthma
498. Chemotherapy Treatment, Brain Gray Matter, And Markers Of Inflammation In Women With Breast Cancer: A Longitudinal Cohort Study
499. Chest Drainage System Reduce Pleural Inflammation And Volume Of Pleural Effusion After Major Lung Resections For Cancer? A …
500. Childhood Adversity And Inflammation In Breast Cancer Survivors
501. Chitinase-3 Like-Protein-1 (Chi3L1) Expression Associated With Pulmonary Inflammation Accelerates Breast Cancer Metastasis (Tum7P. 960)
502. Cholera-Toxin Suppresses Carcinogenesis In A Mouse Model Of Inflammation-Driven Sporadic Colon Cancer
503. Chromatin Dependencies In Cancer And Inflammation
504. Chromen-3-One As A Potential Inhibitor Of Nf-Κb: A Key Regulatory Molecule In Inflammation-Mediated Pathogenesis Of Diabetes, Alzheimer’S, And Cancer
505. Chronic Adventitial Inflammation, Vasa Vasorum Expansion, And 5-Lipoxygenase Up-Regulation In Irradiated Arteries From Cancer Survivors
506. Chronic Baseline Prostate Inflammation Is Associated With Lower Tumor Volume In Men With Prostate Cancer On Repeat Biopsy: Results From The Reduce Study
507. Chronic Immune Activation And Inflammation In The Pathogenesis Of Aids And Cancer
508. Chronic Infection, Inflammation, Andepithelial Ovarian Cancer
509. Chronic Inflammation And Bladder Cancer
510. Chronic Inflammation And Breast Cancer Recurrence
511. Chronic Inflammation And Cancer In Various Organ Systems
512. Chronic Inflammation And Cancer: Emerging Roles Of Triggering Receptors Expressed On Myeloid Cells
513. Chronic Inflammation And Cancer: Paradigm On Tumor Progression, Metastasis And Therapeutic Intervention.
514. Chronic Inflammation And Cancer: Potential Role Of Bcl-2 Gene Family Members As Regulators Of Cellular Antioxidant Status
515. Chronic Inflammation And Cancer: Suppressing The Suppressors
516. Chronic Inflammation And Colorectal Cancer: The Role Of Vascular Endothelial Growth Factor
517. Chronic Inflammation And Gallbladder Cancer
518. Chronic Inflammation And Gastric Cancer Development
519. Chronic Inflammation And Oxidative Stress As A Major Cause Of Age-Related Diseases And Cancer
520. Chronic Inflammation And Oxidative Stress In The Genesis And Perpetuation Of Cancer: Role Of Lipid Peroxidation, Dna Damage, And Repair
521. Chronic Inflammation And Oxidative Stress: The Smoking Gun For Helicobacter Pylori-Induced Gastric Cancer?
522. Chronic Inflammation And Pancreatic Cancer
523. Chronic Inflammation And Risk Of Lung Cancer In Older Adults In The Health, Aging And Body Composition Cohort Study
524. Chronic Inflammation And Smoke Induced Lung Cancer.
525. Chronic Inflammation As A Potential Predictive Factor Of Nivolumab Therapy In Non-Small Cell Lung Cancer
526. Chronic Inflammation As A Promotor Of Mutagenesis In Essential Thrombocythemia, Polycythemia Vera And Myelofibrosis. A Human Inflammation Model For Cancer …
527. Chronic Inflammation As Inductor Of Pro-Cancer Microenvironment: Pathogenesis Of Dysregulated Feedback Control
528. Chronic Inflammation Confers To The Metabolic Reprogramming Associated With Tumorigenesis Of Colorectal Cancer
529. Chronic Inflammation Does Not Alter Patterns Of Gene Expression In Carcinogeninitiated Lung Cancer
530. Chronic Inflammation In Benign Prostate Tissue Is Associated With High-Grade Prostate Cancer In The Placebo Arm Of The Prostate Cancer Prevention Trial
531. Chronic Inflammation In Cancer Development
532. Chronic Inflammation In Cancer: The Role Of Human Viruses
533. Chronic Inflammation In Chronic Obstructive Pulmonary Disease Induces Growth And Metastasis Of Lung Cancer Cells Via Il-6/Jak/Stat3/Nf-Κb Signaling Pathway
534. Chronic Inflammation In Endometriosis And Endometriosis-Associated Ovarian Cancer: New Roles For The “Old” Complement Pathway
535. Chronic Inflammation In Prostate Biopsy Cores Is An Independent Factor That Lowers The Risk Of Prostate Cancer Detection And Is Inversely Associated With The Number Of …
536. Chronic Inflammation In The Pathogenesis Of Copd And Lung Cancer
537. Chronic Inflammation In Urothelial Bladder Cancer
538. Chronic Inflammation Induced Immunosuppression Tumor Microenvironment Of Oral Cancer
539. Chronic Inflammation Initiates Multiple Forms Of K-Ras-Independent Mouse Pancreatic Cancer In The Absence Of Tp53
540. Chronic Inflammation Is A Major Cause Of Preventable Cancer
541. Chronic Inflammation Is Negatively Associated With Prostate Cancer And High‐Grade Prostatic Intraepithelial Neoplasia On Needle Biopsy
542. Chronic Inflammation Links Cancer And Parkinson’S Disease
543. Chronic Inflammation Markers Are Associated With Risk Of Pancreatic Cancer In The Swedish Amoris Cohort Study
544. Chronic Inflammation Of The Prostate Type Iv With Respect To Risk Of Prostate Cancer
545. Chronic Inflammation Predisposing To Cancer Metastasis: Lesson Learned From A Chronically Embedded Foreign Body In A Duodenal Diverticulum
546. Chronic Inflammation Promotes Skin Carcinogenesis In Cancer-Prone Discoid Lupus Erythematosus
547. Chronic Inflammation Promotes Tobacco Carcinogen Associated Tumors In Lung Cancer Susceptible (A/J) And Resistant (B6) Mice
548. Chronic Inflammation Toward Cancer Incidence: An Epidemiological Systematic Review
549. Chronic Inflammation, Cardiorespiratory Fitness, And Dietary Inflammatory Index In Cancer Survivors
550. Chronic Inflammation, Colorectal Cancer And Gene Polymorphisms
551. Chronic Inflammation, Nf-[Kappa] B, And Cancer
552. Chronic Inflammation: An Issue To Consider For Clinical Imaging In Cancer Care
553. Chronic Inflammation: Key Player And Biomarker-Set To Predict And Prevent Cancer Development And Progression Based On Individualized Patient Profiles
554. Chronic Inflammation: Synergistic Interactions Of Recruiting Macrophages (Tams) And Eosinophils (Eos) With Host Mast Cells (Mcs) And Tumorigenesis In Calts. M-Csf …
555. Chronic Inflammation‐Elicited Liver Progenitor Cell Conversion To Liver Cancer Stem Cell With Clinical Significance
556. Chronic Intestinal Inflammation: Inflammatory Bowel Disease And Colitis-Associated Colon Cancer
557. Chronic Low-Grade Inflammation In Obesity And Diabetes Associated Colorectal Cancer Development.
558. Chronic Obstructive Pulmonary Disease And Lung Cancer: Inflammation, The Missing Link
559. Chronic Periglandular Inflammation On Prostate Needle Biopsy Does Not Increase The Likelihood Of Cancer On Subsequent Biopsy
560. Chronic Prostatic Inflammation: A Confounding Factor In The Diagnosis Of Prostatic Cancer
561. Chronic Stress, Inflammation, And Colon Cancer: A Crh System-Driven Molecular Crosstalk
562. Chronic Subclinical Bowel Inflammation May Explain Increased Risk Of Colorectal Cancer In Obese People
563. Chrysobalanus Icaco L. Anthocyanins Reduced Cell Proliferation And Inflammation In Ht-29 Colon Cancer Cells
564. Cigarette Smoke Induces Cyclooxygenase-2 And Microsomal Prostaglandin E2 Synthase In Human Lung Fibroblasts: Implications For Lung Inflammation And Cancer
565. Cilostazol And Enzymatically Modified Isoquercitrin Attenuate Experimental Colitis And Colon Cancer In Mice By Inhibiting Cell Proliferation And Inflammation
566. Circadian Clock Disruption Promotes Th17 Inflammation And Colon Cancer
567. Circulating Endothelial Cells, Endothelial Progenitor Cells, Microparticles, And Markers Of Inflammation And Coagulation In Advanced Non-Small Cell Lung Cancer.
568. Circulating Galectin-3 Correlates With Angiogenetic Factors And Indicators Of Systemic Inflammation In Patients With Stage Iv Esophageal Cancer
569. Circulating Galectin-3 Correlates With Angiogenetic Factors, Indicators Of Nutritional Condition And Systemic Inflammation In Patients With Thyroid Cancer
570. Circulating Inflammation Markers And Prospective Risk For Lung Cancer
571. Circulating Inflammation Markers And Prostate Cancer
572. Circulating Inflammation Markers And Risk Of Epithelial Ovarian Cancer
573. Circulating Inflammation Markers, Risk Of Lung Cancer, And Utility For Risk Stratification
574. Circulating Inflammation Proteins Associated With Lung Cancer In African Americans
575. Circulating Inflammation Signature Predicts Overall Survival And Relapse-Free Survival In Metastatic Colorectal Cancer
576. Circulating Levels Of Coagulation And Inflammation Markers And Cancer Risks: Individual Participant Analysis Of Data From Three Long-Term Cohorts
577. Circulating Micrornas As Markers Of Liver Inflammation, Fibrosis And Cancer
578. Circulating Myeloid-Derived Suppressor Cells Are Increased And Correlate To Immune Suppression, Inflammation And Hypoproteinemia In Patients With Cancer
579. Cisplatin-Induced Immune Modulation In Ovarian Cancer Mouse Models With Distinct Inflammation Profiles
580. Cleavage Profiling Suggests A Distinct Function Of Bacteroides Fragilis Metalloproteinases (Fragilysin And Metalloproteinase Ii) At The Microbiome-Inflammation–Cancer …
581. Clinical Aspects Of Inflammation In Non-Small Cell Lung Cancer
582. Clinical Epidemiological Studies Of The Association Between Chronic Inflammation, Immune-Modulatory Therapies, And Cancer
583. Clinical Experience With Intravenous Administration Of Ascorbic Acid: Achievable Levels In Blood For Different States Of Inflammation And Disease In Cancer …
584. Clinical Implication Of Inflammation Markers For Identifying Radiotherapy Candidates In Inoperable Locally Advanced Pancreas Cancer
585. Clinical Implication Of Inflammation-Based Prognostic Score And Perioperative Nutrition Control In Pancreatic Cancer.
586. Clinical Implication Of Inflammation-Based Prognostic Score In Pancreatic Cancer: Glasgow Prognostic Score Is The Most Reliable Parameter
587. Clinical Implications Of Granulomatous Inflammation Detected By Endobronchial Ultrasound Transbronchial Needle Aspiration In Patients With Suspected Cancer …
588. Clinical Significance Of An Inflammation-Based Prognostic System For Gastric Cancer Patients With A Preoperative Normal Serum Level Of Carcinoembryonic Antigen
589. Clinical Utility Of Inflammation-Based Prognostic Systems In Patients With Colorectal Cancer
590. Clinical Value Of Selected Markers Of Angiogenesis, Inflammation, Insulin Resistance And Obesity In Type 1 Endometrial Cancer
591. Coagulation And Inflammation In Long‐Term Cancer Survivors: Results From The Adult Population
592. Coarse Particulate Matter (Pm 2.5–10) In Los Angeles Basin Air Induces Expression Of Inflammation And Cancer Biomarkers In Rat Brains
593. Coffee Intake With Liver Cancer Risk Is Mediated By Biomarkers Of Inflammation And Hepatocellular Injury: Data From The European Prospective Investigation Into Cancer …
594. Cognitive Behavioral Stress Management Effects On Social Well-Being, Negative Affect, And Inflammation After Surgery For Breast Cancer
595. Cold-Inducible Rna Binding Protein (Cirp) In Inflammation And Breast Cancer
596. Cold‐Inducible Rna Binding Protein In Cancer And Inflammation
597. Colon Cancer And Igg4-Related Disease With Orbital Inflammation And Bilateral Optic Perineuritis: A Case Report
598. Colon Cancer In Ibd: A Paradigm For The Role Of Inflammation In Neoplastic Development
599. Colon Cancer: Inflammation-Associated Cancer
600. Colon Cancer-Derived Factors Activate Nf-Κb In Myeloid Cells Via Tlr2 To Link Inflammation And Tumorigenesis
601. Colonic Epithelial Genes In The Transition From Chronic Inflammation To Carcinoma In Human Colitis-Associated Cancer: Focus On The Truncated Neurokinin-1 …
602. Colonic Inflammation And Cancer Are Driven By Elevated D-2-Hydroxyglutarate Levels In An Egln1-Dependent Mechanism
603. Colonic Macrophage Polarization In Homeostasis, Inflammation, And Cancer
604. Colorectal Cancer Diagnosis In 2012: A New Focus For Crc Prevention—More Serration, Less Inflammation
605. Colorectal Cancer Microenvironment: Among Nutrition, Gut Microbiota, Inflammation And Epigenetics
606. Colorectal Cancer Mouse Models: Integrating Inflammation And The Stroma
607. Colorectal Cancer, Systemic Inflammation, And Outcome
608. Colorectal Cancer—Driven By Inflammation And Gut Bacteria?
609. Combination Of Advanced Lung Cancer Inflammation Index And C-Reactive Protein Is A Prognostic Factor In Patients With Operable Non-Small Cell Lung Cancer
610. Combination Regimens Using Dietary Components For The Chemoprevention Of Colorectal Cancer And Inflammation
611. Combined Effect Of Cmv Seropositivity And Systemic Inflammation On Dementia Prevalence In Cancer Survivors
612. Combined Effect Of Sarcopenia And Systemic Inflammation On Survival In Patients With Advanced Stage Cancer Treated With Immunotherapy.
613. Commd1 Regulates Inflammation And Colitis-Associated Cancer Progression
614. Commensal Microbiota Activates An S100A7-Tlr4-Stat-3 Signaling To Induce Chronic Inflammation And Consequent Growth And Metastasis Of Breast Cancer
615. Commentary (Weitberg): Chronic Inflammation And Cancer
616. Commixed Index Of Inflammation, Immune Responses, Hemostasis, And Nutrition, For Predicting Metastatic Non-Small Cell Lung Cancer Prognosis And Metastases
617. Comorbidity And Systemic Inflammation Are Independent Prognostic Factors In Patients With Colorectal Cancer: A Scotscan Collaborative Study.
618. Comparison Of An Inflammation-Based Prognostic Score (Gps) With Performance Status (Ecog) In Patients Receiving Platinum-Based Chemotherapy For …
619. Comparison Of Inflammation Nutrition-Related Scores As Predictors In Patients With Unresectable Advanced Pancreatic Cancer
620. Comparison Of Inflammation-Based Prognostic Scores In A Cohort Of Patients With Resectable Esophageal Cancer
621. Comparison Of Inflammation-Based Prognostic Scores In Patients Undergoing Curative Resection For Non-Small Cell Lung Cancer
622. Comparison Of Interleukin 17 Family Protein Expression In Neutrophils Of Patients With Oral Inflammation And Patients With Cancer Disease Of The Same Location
623. Comparison Of Nanoparticle Uptake By Cancer Versus Sites Of Inflammation
624. Comparison Of Positive Lymph Node Ratio With An Inflammation‐Based Prognostic Score In Colorectal Cancer
625. Comparison Of Selected Inflammation-Based Prognostic Markers In Relapsed Or Refractory Metastatic Colorectal Cancer Patients
626. Comparison Of The Prognostic Impact And Combination Of Preoperative Inflammation-Based And/Or Nutritional Markers In Patients With Stage Ii Gastric Cancer
627. Comparison Of The Prognostic Value Of Longitudinal Measurements Of Systemic Inflammation In Patients Undergoing Curative Resection Of Colorectal Cancer
628. Comparison Of The Prognostic Value Of Preoperative Inflammation-Based Scores And Tnm Stage In Patients With Gastric Cancer
629. Comparison Of The Prognostic Value Of Systemic Inflammation Response Markers In Small Cell Lung Cancer Patients
630. Comparison Of The Prognostic Value Of Various Preoperative Inflammation-Based Factors In Patients With Stage Iii Gastric Cancer
631. Comparison Of The Prognostic Values Of Preoperative Inflammation-Based Parameters In Patients With Breast Cancer
632. Comparison Of The Prognostic Values Of Various Inflammation Based Factors In Patients With Pancreatic Cancer
633. Comparison Of The Tumor And Inflammation Uptake Of [18F]-Deoxy-1-Fluoro-Scyllo-Inositol And [18F]-Fdg In Athymic Mice Bearing Human Breast Cancer Xenografts
634. Comparison Of Tumour-Based (Petersen Index) And Inflammation-Based (Glasgow Prognostic Score) Scoring Systems In Patients Undergoing Curative Resection For Colon Cancer
635. Comparison Of Two Inflammation-Based Prognostic Scores In Patients With Thoracic Esophageal Cancer Undergoing Chemoradiotherapy
636. Comparison Of Two Inflammation-Based Prognostic Scores In Patients With Unresectable Advanced Gastric Cancer
637. Comparisons Of [18F]-1-Deoxy-1-Fluoro-Scyllo-Inositol With [18F]-Fdg For Pet Imaging Of Inflammation, Breast And Brain Cancer Xenografts In Athymic Mice
638. Comparisons Of Endothelial Dysfunction, Inflammation And Insulin Resistance In Differentiated Thyroid Cancer Patients According To Their Radioactive Iodine …
639. Complement Receptor Immunoglobulin: A Control Point In Infection And Immunity, Inflammation And Cancer
640. Compositions For Treatment Of Cancer And Inflammation
641. Comprehensive Genetic Characterization Of Intraprostatic Chronic Inflammation And Prostate Cancer In African American Men
642. Computational Models Accurately Predict Multi-Cell Biomarker Profiles In Inflammation And Cancer
643. Concurrent Chemo-Radiotherapy Potentiates Vascular Inflammation: Increased Fdg Uptake In Head And Neck Cancer Patients
644. Conditioned Medium Derived From Rat Amniotic Epithelial Cells Confers Protection Against Inflammation, Cancer, And Senescence
645. Conflicting Roles Of Connexin43 In Tumor-Induced Inflammation And Cancer Pathology
646. Conjugated Linoleic Acid Ameliorates Inflammation-Induced Colorectal Cancer In Mice Through Activation Of Pparγ
647. Connecting Pathway Errors In The Insulin Signaling Cascade: The Molecular Link To Inflammation, Obesity, Cancer, And Alzheimer’S Disease
648. Consensus Molecular Subtypes (Cms), Markers Of Systemic Inflammation (Si) And Clinicopathological Parameters In Colorectal Cancer (Crc).
649. Contribution Of Angiogenesis To Inflammation And Cancer
650. Contribution Of Genetic Polymorphisms Of Inflammation Response Genes On Sporadic Colorectal Cancer Predisposition Risk In Malaysian Patients–A Case …
651. Contributions Of Metabolic Dysregulation And Inflammation To Nonalcoholic Steatohepatitis, Hepatic Fibrosis, And Cancer
652. Control Of Breast Cancer Through The Resolution Of Inflammation
653. Control Of Cancer-Associated Inflammation And Survival: Results From A Prospective Randomized Phase Ii Trial In Gastric Cancer
654. Control Of Nf-Κb Activity, Inflammation And Stemness Properties In Cancer Cells By Copper Metabolism (Murr1) Domain-Containing 1
655. Controlled Trial Of The Effects Of Eicosapentaenoic Acid Supplementation On Muscle Inflammation And Physical Function In Patients Undergoing Colorectal Cancer …
656. Cooperation Of Loss Of Nkx3. 1 And Inflammation In Prostate Cancer Initiation
657. Copd And Squamous Cell Lung Cancer: Aberrant Inflammation And Immunity Is The Common Link
658. Copd‐Dependent Effects Of Genetic Variation In Key Inflammation Pathway Genes On Lung Cancer Risk
659. Copd-Type Lung Inflammation Promotes K-Ras Mutant Lung Cancer Through Epithelial Hif-1Α Mediated Tumor Angiogenesis And Proliferation
660. Copper Metabolism Domain-Containing 1 Represses Genes That Promote Inflammation And Protects Mice From Colitis And Colitis-Associated Cancer
661. Copper‐Lowering Therapy With Tetrathiomolybdate For Cancer And Diseases Of Fibrosis And Inflammation
662. Cordycepin Blocks Lung Injury-Associated Inflammation And Promotes Brca1-Deficient Breast Cancer Cell Killing By Effectively Inhibiting Parp
663. Correction: Usp17 Mediates Macrophage-Promoted Inflammation And Stemness In Lung Cancer Cells By Regulating Traf2/Traf3 Complex Formation
664. Correlation Between Hsd17B4 Expression In Rat Liver Cancer Tissues And Inflammation Or Proliferation
665. Correlation Between Preoperative Systemic Inflammation And Postoperative Infection In Patients With Gastrointestinal Cancer: A Multicenter Study
666. Correlation Of Histological Inflammation In Needle Biopsy Specimens With Serum Prostate-Specific Antigen Levels In Men With Negative Biopsy For Prostate Cancer
667. Correlation Of Inflammation In Frozen Sections With Site Of Nonmelanoma Skin Cancer
668. Correlation Of Systemic Immune-Inflammation Index And Neutrophil-To-Lymphocyte Ratio With Histopathological Findings In Patients With Tongue Cancer
669. Correlations Between Inflammation And Development Of Cancer, A Small Review
670. Correlations Of Gastrointestinal Hormones With Inflammation And Intestinal Flora In Patients With Gastric Cancer.
671. Correlations Of Recurrence After Radical Surgery For Esophageal Cancer With Glucose-Lipid Metabolism, Insulin Resistance, Inflammation, Stress And Serum P53 …
672. Corrigendum To “Metabolic Syndrome, Inflammation, And Cancer”
673. Corrigendum To” Chemokines Sound The Alarmin: The Role Of Atypical Chemokine Receptors In Inflammation And Cancer“[Semin. Immunol. 38 (2018) 63-71].
674. Counteracting Cancer Cachexia-Related Inflammation: It Takes Systemic Strategies To Treat A Systemic Syndrome.
675. Counteraction Of Skin Inflammation And Aging Or Cancer By Polyphenols And Flavonoids From Polypodium Leucotomos And Xanthohumol
676. C-Reactive Protein And Chronic Inflammation―Is It A Novel Therapeutic Target For Subsequent Cancer Death In Patients With Coronary Artery Disease?―
677. C-Reactive Protein, An Inflammation Marker, In Nipple Aspirate Fluid: Relation To Breast Cancer Risk, Body Mass Index, Lipids And Carotenoids
678. C-Reactive Protein/Albumin Ratio As A Novel Inflammation-Based Prognostic Index For Predicting Outcomes Of Patients With Colorectal Cancer
679. Critical Roles Of Balanced Innate Lymphoid Cell Subsets In Intestinal Homeostasis, Chronic Inflammation, And Cancer
680. Crocetin Treatment Inhibits Proliferation Of Colon Cancer Cells Through Down-Regulation Of Genes Involved In The Inflammation
681. Cross Cancer Genomic Investigation Of Inflammation Pathway For Five Common Cancers: Lung, Ovary, Prostate, Breast, And Colorectal Cancer
682. Cross Talk Between Lymph Node Lymphatic Endothelial Cells And T-Cells During Inflammation And Cancer
683. Crossroad Of Inflammation And Oxidative Stress In Cancer
684. Cross-Talk Within The Tumor Microenvironment Mediates Th2-Type Inflammation In Pancreatic Cancer
685. Cryptotanshinone Inhibits The Growth And Invasion Of Colon Cancer By Suppressing Inflammation And Tumor Angiogenesis Through Modulating Mmp/Timp System, Pi3K …
686. C‐Type Lectin Domain Group 14 Proteins In Vascular Biology, Cancer And Inflammation
687. Curcuma As A Functional Food In The Control Of Cancer And Inflammation
688. Curcumin Inhibits Copd-Like Airway Inflammation And Lung Cancer Progression In Mice
689. Curcumin Targets In Inflammation And Cancer
690. Current And Potential Inflammation Targeted Therapies In Head And Neck Cancer
691. Current Concepts On The Role Of Inflammation In Copd And Lung Cancer
692. Current Knowledge Of The Potential Links Between Inflammation And Prostate Cancer
693. Current Perspectives Of Molecular Pathways Involved In Chronic Inflammation-Mediated Breast Cancer
694. Current Therapy And Future Perspectives For Inflammation-Associated Cancer
695. Cutaneous Complications Of Intravesical Treatments For Bladder Cancer: Granulomatous Inflammation Of The Penis Following Bcg Therapy And Penile Gangrene Following …
696. Cxcl12/Cxcr4 Promotes Inflammation-Driven Colorectal Cancer Progression Through Activation Of Rhoa Signaling By Sponging Mir-133A-3P
697. Cxcl13 And Its Receptor Cxcr5 In Cancer: Inflammation, Immune Response, And Beyond
698. Cyp1B1, Oxidative Stress, And Inflammation In The Etiology Of Ovarian Epithelial Cancer Using An Avian Model Of Ovarian Carcinoma
699. Cysteinyl Leukotrienes And Their Receptors: Bridging Inflammation And Colorectal Cancer
700. Cytochrome P450 Vitamin D Hydroxylases In Inflammation And Cancer
701. Cytochrome P450 Ω-Hydroxylases In Inflammation And Cancer
702. Cytochrome P450-Cyp2 Family-Epoxygenase Role In Inflammation And Cancer
703. Cytokines And Proteases In Invasive Processes: Molecular Similarities Between Inflammation And Cancer
704. Cytokines As A Key Component Of Cancer-Related Inflammation
705. Cytokines, Inflammation And Colon Cancer
706. Cytokines, Nf-Κb, Microenvironment, Intestinal Inflammation And Cancer
707. Cytokines: From Gut Inflammation To Colorectal Cancer
708. Cytokines–Major Molecular Messengers Orchestrate Between Inflammation And Cancer
709. Cytological And Dna Characteristics Of Hyperplasia/Inflammation And Cancer Of The Prostate
710. Cytomegalovirus And Systemic Inflammation Is Associated With Worse Outcomes In Serous Ovarian Cancer Patients
711. Cytoplasmic Chromatin Triggers Inflammation In Senescence And Cancer
712. Cytoplasmic Gain-Of-Function Mutant P53 Contributes To Inflammation-Associated Cancer
713. Cytotoxicity Of Pomegranate Polyphenolics In Breast Cancer Cells In Vitro And Vivo: Potential Role Of Mirna-27A And Mirna-155 In Cell Survival And Inflammation
714. Dammann K, Khare V, Gasche C. Tracing Paks From Gi Inflammation To Cancer. Gut 2014; 63: 1173–84. This Article Is Now Open Access, Under Cc-By Nc License.
715. Dancing With The Devil: Cancer-Related Fatigue, From Inflammation To Treatment Options
716. Dangerous Liaisons Between Interleukin-6 Cytokine And Toll-Like Receptor Families: A Potent Combination In Inflammation And Cancer
717. Deacetylation By Sirt1 Reprograms Inflammation And Cancer
718. Death Receptor–Ligand Systems In Cancer, Cell Death, And Inflammation
719. Deciphering Key Cancer And Inflammation Signaling Pathways With A Novel Homogeneous Bioluminescent Cell Based Kinase Activity Assays
720. Deciphering The Complex Interplay Between Microbiota, Hpv, Inflammation And Cancer Through Cervicovaginal Metabolic Profiling
721. Decoding Immune Heterogeneity Of Triple Negative Breast Cancer And Its Association With Systemic Inflammation
722. Decreased Preoperative Serum 25-Hydroxyvitamin D Levels In Colorectal Cancer Are Associated With Systemic Inflammation And Serrated Morphology
723. Deficiencies Of Gm-Csf And Interferon Γ Link Inflammation And Cancer
724. Deficiency In Stat1 Signaling Predisposes Gut Inflammation And Prompts Colorectal Cancer Development
725. Deficient Import Of Acetyl-Coa Into The Er Lumen Causes Neurodegeneration And Propensity To Infections, Inflammation, And Cancer
726. Definition Of Cancer Cachexia: Effect Of Weight Loss, Reduced Food Intake, And Systemic Inflammation On Functional Status And Prognosis
727. Delayed Radiation-Induced Inflammation Accompanying A Marked Carbohydrate Antigen 19-9 Elevation In A Patient With Resected Pancreatic Cancer
728. Deletion Of P120-Catenin Results In A Tumor Microenvironment With Inflammation And Cancer That Establishes It As A Tumor Suppressor Gene
729. Deletion Of Tlr4 Attenuates Adipose Tissue Inflammation In Cancer Cachexia
730. Demonstration Of Inflammation-Induced Cancer And Cancer Immunoediting During Primary Tumorigenesis
731. Dendritic Cells, Inflammation And Breast Cancer
732. Dendrophthoe Pentandra (L.) Miq Extract Effectively Inhibits Inflammation, Proliferation And Induces P53 Expression On Colitis-Associated Colon Cancer
733. Department Of Surgery Graduate School In Inflammation, Immunity And Cancer
734. Depression And Inflammation Among Epidermal Growth Factor Receptor (Egfr) Mutant Nonsmall Cell Lung Cancer Patients
735. Depression And Inflammation In Male Ostomates, A Study Of Colorectal Cancer And Risk Factors
736. Depression, Inflammation, And Epidermal Growth Factor Receptor (Egfr) Status In Metastatic Non-Small Cell Lung Cancer: A Pilot Study
737. Derivatives To Image Pancreatic Cancer: A Comparative Study With [{Sup 18} F] Fluoro-2-Deoxy-D-Glucose In Human Pancreatic Carcinoma Xenografts And In Inflammation …
738. Derivatives To Image Pancreatic Cancer: A Comparative Study With [18F] Fluoro-2-Deoxy-D-Glucose In Human Pancreatic Carcinoma Xenografts And In Inflammation …
739. Derived Markers Of Tumour Metabolism And Systemic Inflammation In Patients With Recurrent Disease Following Surgery For Colorectal Cancer
740. Design And Optimization Of Dexamethasone Matrix Tablets For The Treatment Of Inflammation In Colon Cancer.
741. Design And Synthesis Of New 1, 3, 5‐Trisubstituted Triazines For The Treatment Of Cancer And Inflammation
742. Details Unfold: The Er Stress Response In Intestinal Inflammation And Cancer
743. Detection Of Braf Gene In Some Iraqi Bowel Inflammation And Colorectal Cancer Patients
744. Determinants Of Systemic Inflammation In Colorectal Cancer
745. Development And Evaluation Of Pet Tracers For Imaging Ÿø-Glucuronidase Activity In Cancer And Inflammation
746. Development And Maintenance Of Cancer Stem Cells Under Chronic Inflammation
747. Development Of A Screening Assay For Inhibitors Of Inflammation Useful Against Pancreatic Cancer
748. Development Of An Inflammation-Associated Colorectal Cancer Model And Its Application For Research On Carcinogenesis And Chemoprevention
749. Development Of Animal Models Underlining Mechanistic Connections Between Prostate Inflammation And Cancer
750. Development Of Gastric Cancer In Nonatrophic Stomach With Highly Active Inflammation Identified By Serum Levels Of Pepsinogen And Helicobacter Pylori Antibody …
751. Development Of Glucocorticoid Resistance And Systemic Inflammation In Mothers Whose Children Have Been Diagnosed With Cancer
752. Diagnosis Of Perifocal Inflammation In Cancer Of The Colon. Diagnostika Perifokal’Nogo Vospaleniya Pri Rake Obodochnoj Kishki
753. Diagnostic Value Of Colon Water Enema Msct For Large Bowel Cancer And Inflammation
754. Dielectric Imaging For Differentiation Between Cancer And Inflammation In Vivo
755. Diet And Inflammation In Colorectal Cancer Prevention
756. Diet And Lifestyle Factors Modify Immune/Inflammation Response Genes To Alter Breast Cancer Risk And Prognosis: The Breast Cancer Health Disparities Study
757. Diet And Postmenopausal Breast Cancer-With A Focus On Low-Grade Inflammation
758. Diet Components Can Suppress Inflammation And Reduce Cancer Risk
759. Diet Quality, Inflammation, And Quality Of Life In Breast Cancer Survivors: A Cross-Sectional Analysis Of Pilot Study Data
760. Diet, Inflammation And Cancer: A Journey From Prevention To Treatment
761. Diet, Inflammation And Colorectal Cancer
762. Dietary Acid Load In Relation To Inflammation And Glycemic Status In Women With Breast Cancer (P18-095-19)
763. Dietary Assessment As A Means To Modulate Inflammation In Patients With Prostate Cancer
764. Dietary Cancer Chemopreventive Agents–Targeting Inflammation And Nrf2 Signaling Pathway
765. Dietary Energy Density, Inflammation And Energy Balance In Palliative Care Cancer Patients
766. Dietary Fats As Mediators Of Obesity, Inflammation, And Colon Cancer
767. Dietary Fatty Acids And Adipose Tissue Inflammation At The Crossroad Between Obesity And Colorectal Cancer
768. Dietary Fibre In The Prevention Of Gastrointestinal Inflammation And Toxicity In Patients Undergoing Pelvic Radiotherapy For Cancer
769. Dietary Inflammation Potential And Postmenopausal Breast Cancer Risk In A German Case-Control Study
770. Dietary Legumes, Intestinal Microbiota, Inflammation And Colorectal Cancer
771. Dietary Lipids, Inflammation, And Colon Cancer
772. Dietary Modulation Of Colon Cancer: Effects On Intermediary Metabolism, Mucosal Cell Differentiation, And Inflammation
773. Dietary Modulation Of Inflammation-Induced Colorectal Cancer Through Ppar
774. Dietary Phytochemicals And Cancer Chemoprevention: A Perspective On Oxidative Stress, Inflammation, And Epigenetics
775. Dietary Polyphenols, Inflammation, And Cancer
776. Dietary Selenium Protects Adiponectin Knockout Mice Against Chronic Inflammation Induced Colon Cancer
777. Dietary Soy And Tea Mitigate Chronic Inflammation And Prostate Cancer Via Nfκb Pathway In The Noble Rat Model
778. Dietary Supplementation With Tart Cherries For Prevention Of Inflammation-Associated Colorectal Cancer In Mice
779. Diet-Induced Obesity, Inflammation, And Cancer.
780. Diet-Related Inflammation And Colorectal Cancer
781. Diet-Related Inflammation And Oesophageal Cancer By Histological Type: A Nationwide Case–Control Study In Sweden
782. Diet-Related Inflammation And Risk Of Prostate Cancer In The California Men’S Health Study
783. Differences Between Orofacial Inflammation And Cancer Pain
784. Differences In Pathological Features Of Histological Inflammation Between Benign Prostatic Hyperplasia And Prostate Cancer
785. Differences In Transport Mechanisms Of Trans-1-Amino-3-[18F]Fluorocyclobutanecarboxylic Acid In Inflammation, Prostate Cancer, And Glioma Cells: Comparison With L-[Methyl-11C] …
786. Differential Diagnosis Of Metastases Versus Inflammation In Cancer Patient With Spinal Abnormalities
787. Differential Role Of Cxcr3 In Inflammation And Colorectal Cancer
788. Differentiating Between Cancer And Inflammation: A Metabolic-Based Method For Functional Computed Tomography Imaging
789. Differentiating Between The Tumor Microenvironment And Inflammation In Order To Use Immune Cells As Living Cell Diagnostics For Early Cancer Detection
790. Diffusion-Weighted Mr Imaging Of Pancreatic Cancer And Inflammation: Prognostic Significance Of Pancreatic Inflammation In Pancreatic Cancer Patients
791. Dioscin: A Diverse Acting Natural Compound With Therapeutic Potential In Metabolic Diseases, Cancer, Inflammation And Infections
792. Discovering The Route From Inflammation To Pancreatic Cancer
793. Discovery And Preclinical Characterization Of Novel Small Molecule Trk And Ros1 Tyrosine Kinase Inhibitors For The Treatment Of Cancer And Inflammation
794. Discuss How Chronic Inflammation And The Immune System Both Promote And Protect Against Cancer And How This May Be Therapeutically Modulated
795. Disparity In Physical Performance Among Older Women With Newly Diagnosed Non-Metastatic Breast Cancer: Exploring The Role Of Inflammation And Physical Activity
796. Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, And Biogenesis During Cancer Cachexia: A Role For Inflammation
797. Disrupting Inflammation-Associated Cxcl8-Cxcr1 Signaling Inhibits Tumorigenicity Initiated By Sporadic-And Colitis-Colon Cancer Stem Cells
798. Dissecting Interleukin-6 Classic-And Trans-Signaling In Inflammation And Cancer
799. Dissecting The Potential Interplay Of Dek Functions In Inflammation And Cancer
800. Divisions Of Cancer Science And Infection, Inflammation & Repair: The Facilitative Role Of The Extracellular Matrix In The Development Of Colorectal Cancer Liver Metastases
801. Dmbt1 As An Archetypal Link Between Infection, Inflammation, And Cancer
802. Dna Damage By Lipid Peroxidation Products: Implications In Cancer, Inflammation And Autoimmunity
803. Dna Damage In Inflammation-Related Carcinogenesis And Cancer Stem Cells
804. Dna Destabilization, Cancer, And Inflammation
805. Dna From Dead Cancer Cells Induces Tlr9-Mediated Invasion And Inflammation In Living Cancer Cells
806. Dna Methylation Derived Systemic Inflammation Indices Are Associated With Head And Neck Cancer Development And Survival
807. Dna Methylation-Derived Neutrophil-To-Lymphocyte Ratio: An Epigenetic Tool To Explore Cancer Inflammation And Outcomes
808. Do We Really Need Another Special Issue On Nf-Κb In Cancer And Inflammation?
809. Dock2 In The Development Of Inflammation And Cancer
810. Docosahexaenoic Acid Inhibits Lipopolysaccharide-Induced Metastatic Activities By Decreasing Inflammation On Prostate Cancer Cell
811. Does Advanced Lung Inflammation Index (Ali) Have Prognostic Significance In Metastatic Non‐Small Cell Lung Cancer?
812. Drosophila As A Model To Study The Role Of Blood Cells In Inflammation, Innate Immunity And Cancer
813. Drosophila At The Intersection Of Infection, Inflammation, And Cancer
814. Dual Role Of S100A8 And S100A9 In Inflammation-Associated Cancer
815. Dual Roles Of Group Iid Phospholipase A2 In Inflammation And Cancer
816. Dual Time Point Imaging In Differentiating Post Biopsy Inflammation From Invasive Tumor In Patients With Newly Diagnosed Breast Cancer
817. Dyadic Study Of Depression On Inflammation And Diurnal Cortisol Variation In Cancer Patients And Caregivers
818. Dynamic Impact Of Inflammation-Based Indices In Colorectal Cancer Patients Receiving Folfox-Based Chemotherapy
819. Dysfunctional Endothelial Cells Directly Stimulate Cancer Inflammation And Metastasis
820. E-105 Mesenchymal Stromal Cells: Mediators Of Inflammation In Cancer
821. E27 Obesity And Colorectal Cancer: Adiponectin And Tumor Necrosis Factor Alfa A Representative Link Between Inflammation And Cancer
822. Early Dna Methylation Events In Bladder Carcinogenesis And Their Implications For Inflammation-Induced Bladder Cancer
823. Early Growth Response 3 Regulates Genes Of Inflammation And Directly Activates Il6 And Il8 Expression In Prostate Cancer
824. Early Small Cell Lung Cancer With Extensive Inflammation And Scar Formation
825. Early Stage Inflammation And Cancer As Reflected In The Gastrointestinal Mucus Composition: Implications For Diagnosis, Prognosis And Pathogenesis
826. Ectonucleotidases In Cancer And Inflammation
827. Ectopic Fibroblast Growth Factor Receptor 1 Promotes Inflammation By Promoting Nuclear Factor-Κb Signaling In Prostate Cancer Cells
828. Editorial [Hot Topic: Ido1, Cancer And Cancer-Associated Inflammation (Guest Editor: Sergio Rutella)]
829. Editorial [Hot Topic: Inflammation As Target For Pharmaceutical Intervention In Cancer (Executive Editors: Rm Schiffelers And Ke De Visser)]
830. Editorial [Hot Topic: Role Of Inflammation In The Evolution Of Cancer Disease (Guest Editor: Antonio Maccio)]
831. Editorial [Inflammatory Bowel Disease And Inflammation-Associated Colon Cancer: Partners In Crime Guest Editor: Silvio Danese]
832. Effect Of An Egf-Cancer Vaccine On Wound Healing And Inflammation Models
833. Effect Of Breast Cancer Adjuvant Therapies On Potential Biomarkers Of Pulmonary Inflammation
834. Effect Of Eicosapentaenoic Acid On Body Composition And Inflammation Markers In Patients With Head And Neck Squamous Cell Cancer From A Public Hospital In Mexico
835. Effect Of Glycogen Synthase Kinase-3B Inhibition By Apigenin On Markers Of Proliferation, Inflammation And Apoptosis In Pancreatic Cancer
836. Effect Of High-Dose Intravenous Vitamin C On Inflammation In Cancer Patients
837. Effect Of Histological Inflammation On Total And Free Serum Prostate-Specific Antigen Values In Patients Without Clinically Detectable Prostate Cancer
838. Effect Of Inflammation On Measures Of Antioxidant Status In Patients With Non-Small Cell Lung Cancer
839. Effect Of Inflammation On Prostate Cancer Incidence And Dutasteride Efficacy In The Reduction By Dutasteride Of Cancer Events (Reduce) Study.
840. Effect Of Inflammation-Associated Cytokines Of Biliary Tract Cancer On Chemoresistance And Therapeutic Implications.
841. Effect Of Medical Qigong On Cognitive Function, Quality Of Life, And A Biomarker Of Inflammation In Cancer Patients: A Randomized Controlled Trial
842. Effect Of Medical Qigong On Cognitive Function, Quality Of Life, And A Biomarker Of Inflammation In Patients With Cancer: A Randomized Controlled Trial.
843. Effect Of Minocycline On Symptom Burden And Inflammation Markers In Patients With Colorectal Cancer: A Randomized Phase Ii Trial.
844. Effect Of Obesity And Chronic Inflammation On Trail-Based Immunotherapy For Advanced Breast Cancer
845. Effect Of Probiotic Treatment On The Transition From Chronic Colonic Inflammation To Dysplasia And Cancer.
846. Effect Of Resistance Training On Markers Of Immune Function And Inflammation In Previously Sedentary Women Recovering From Breast Cancer: A Randomized Controlled …
847. Effect Of Subclinical Prostatic Inflammation On Serum Psa Levels In Men With Clinically Undetectable Prostate Cancer
848. Effect Of Tumor Cell-Derived Debris And Igg On Metastasis Of Pancreatic Cancer And Inflammation Through Tumor-Associated Macrophages.
849. Effects Of A Carrot Juice Intervention On Plasma Carotenoids, Oxidative Stress, And Inflammation In Overweight Breast Cancer Survivors
850. Effects Of A Multimodal Rehabilitation Programme On Inflammation And Oxidative Stress In Oesophageal Cancer Survivors: The Restore Feasibility Study
851. Effects Of A Physical Activity Behavior Change Intervention On Inflammation And Related Health Outcomes In Breast Cancer Survivors: Pilot Randomized Trial
852. Effects Of Acetyl Salicyclic Acid On Drosophila Models Of Cancer–Inflammation
853. Effects Of An Epidermal Growth Factor Receptor‐Based Cancer Vaccine On Wound Healing And Inflammation Processes In Murine Experimental Models
854. Effects Of Brewed Green And Black Tea On Inflammation, Apoptosis And Oxidation In Men With Prostate Cancer (136.3)
855. Effects Of Compound K, An Enteric Microbiome Metabolite Of Ginseng, In The Treatment Of Inflammation Associated Colon Cancer
856. Effects Of Curcumin On The Prevention And Treatment Of Mucosal Inflammation Caused By Radiation Therapy In Patients With Head And Neck Cancer.
857. Effects Of Genistein On The Gene Expression Related To Inflammation In Breast Cancer Cell Lines
858. Effects Of Growth Arrest And Dna Damage-Inducible Protein 34 (Gadd34) On Inflammation-Induced Colon Cancer In Mice
859. Effects Of Neoadjuvant Chemotherapy Combined With Enteral Nutrition On Perioperative Immunity, Inflammation And Intestinal Flora In Gastric Cancer Patients
860. Effects Of Nutritional Intervention In Non-Small Cell Lung Cancer Patients With Different Levels Of Systemic Inflammation
861. Effects Of Physical Exercise On Markers Of Inflammation In Breast Cancer Patients During Adjuvant Chemotherapy
862. Effects Of S -Adenosylmethionine And Methylthioadenosine On Inflammation-Induced Colon Cancer In Mice
863. Effects Of Stable Degradation Products Of Curcumin On Cancer Cell Proliferation And Inflammation
864. Effects Of Tumor Stroma And Inflammation On Survival Of Stage I-Iip Lung Cancer
865. Effects Of Wood Dust: Inflammation, Genotoxicity And Cancer
866. Efficacy Of Helicobacter Pylori Eradication On The Chronic Mucosal Inflammation Of The Remnant Stomach After Distal Gastrectomy For Early Gastric Cancer.
867. Egfr Inhibitors From Cancer To Inflammation: Discovery Of 4-Fluoro-N-(4-(3-(Trifluoromethyl) Phenoxy) Pyrimidin-5-Yl) Benzamide As A Novel Anti-Inflammatory Egfr …
868. Egfr Signaling Promotes Inflammation And Cancer Stem-Like Activity In Inflammatory Breast Cancer
869. Eicosanoids In Inflammation And Cancer: The Role Of Cox-2
870. Eicosanoids: Role In Gastrointestinal Inflammation And Cancer.
871. Electrophoretic Analysis Of The Glycan Microheterogeneity Of Orosomucoid In Cancer And Inflammation
872. Elevated Biomarkers Of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients
873. Elevated Gluconeogenesis In Aging And Lung Cancer Is Related To Inflammation And Blunted Insulin-Induced Protein Anabolism
874. Elevated Oxidative Stress/Innate Inflammation Markers In Porcine Model And Induce Apoptosis In Hct-116 P53+/+ And P53-/-Human Colon Cancer Cell Lines In …
875. Elevated Serum Levels Of Vascular Endothelial Growth Factor Is Effective As A Marker For Malnutrition And Inflammation In Patients With Ovarian Cancer
876. Elevated Tumour Interleukin-1Β Is Associated With Systemic Inflammation: A Marker Of Reduced Survival In Gastro-Oesophageal Cancer
877. Ellagic Acid Normalizes Mitochondrial Outer Membrane Permeabilization And Attenuates Inflammation-Mediated Cell Proliferation In Experimental Liver Cancer
878. Elucidation Of Potential Therapeutic Molecules Derived From Medicinal Plants For Role In Cancer And Inflammation
879. Emast Is A Form Of Microsatellite Instability That Is Initiated By Inflammation And Modulates Colorectal Cancer Progression
880. Emerging Avenues Linking Inflammation And Cancer
881. Emerging Links Between Thrombosis, Inflammation And Cancer: Role Of Heparin
882. Emerging Potential Of Natural Products For Targeting Mucins For Therapy Against Inflammation And Cancer
883. Emerging Regulatory Roles Of Wnt1 In Host-Pathogen Interactions In Inflammation And Colon Cancer
884. Emerging Role Of Nutri-Epigenetics In Inflammation And Cancer
885. Emerging Role Of Sphingosine-1-Phosphate In Inflammation, Cancer, And Lymphangiogenesis
886. Emerging Roles For Hmgb1 Protein In Immunity, Inflammation, And Cancer
887. Emodin: Its Role In Prostate Cancer‑Associated Inflammation
888. Emotional Acceptance, Inflammation, And Sickness Symptoms Across The First Two Years Following Breast Cancer Diagnosis
889. Encapsulation Of Vinorelbine In Polymeric Nanoparticles Improves Efficacy In Cancer Cells And Reduces Inflammation In Non-Cancer Cells
890. Encounter Of Cancer Cells With Bone. Cancer And Inflammation–Input And Output Of Nf-Κb
891. Endocannabinoids And Fatty Acid Amides In Cancer, Inflammation And Related Disorders
892. Endogenous Damage-Associated Molecular Pattern Molecules At The Crossroads Of Inflammation And Cancer
893. Endoscopic Ultrasound-Guided Fine-Needle Aspiration Can Lead To Nonresectability Of Pancreatic Cancer Due To Severe Biopsy-Induced Inflammation
894. Enhanced Proatherogenic Inflammation After Recombinant Human Tsh Administration In Patients Monitored For Thyroid Cancer Remnant
895. Enterococcus Faecalis Infection Causes Inflammation, Intracellular Oxphos-Independent Ros Production, And Dna Damage In Human Gastric Cancer Cells
896. Environment, Inflammation, And Cancer
897. Environmental Immune Disruptors, Inflammation And Cancer Risk
898. Environmentally Compatible Bioconjugated Gold Nanoparticles As Efficient Contrast Agents For Inflammation-Induced Cancer Imaging
899. Ep1. 03-25 Impact Of Preoperative Complete Blood Cell Count-Derived Inflammation Biomarkers In Early-Staged Non-Small Cell Lung Cancer Patients
900. Ep605 A Single Center Study Of The Role Of Inflammation Biomarkers In Endometrial Cancer
901. Ep919 Obesity And Inflammation Combined Are Risk Factor For Early Recurrence In High Grade Serous Ovarian Cancer
902. Epidemiology Of Inflammation And Prostate Cancer
903. Epigenetic Changes Associated With Inflammation In Breast Cancer Patients Treated With Chemotherapy
904. Epigenetic Changes Of Timp-3, Gstp-1 And 14-3-3 Sigma Genes As Indication Of Status Of Chronic Inflammation And Cancer
905. Epigenetic Mechanisms Of Inflammation And Fatigue In Patients With Cancer
906. Epigenetic Regulation Of The Extrinsic Oncosuppressor Ptx3 Gene In Inflammation And Cancer
907. Epigenetic Silencing Of Ubiquitin Specific Protease 4 By Snail1 Contributes To Macrophage-Dependent Inflammation And Therapeutic Resistance In Lung Cancer
908. Epigenetic Suppression Of Serpinb1 Promotes Inflammation-Mediated Prostate Cancer Progression
909. Epigenetics In Cancer And Inflammation
910. Epithelial Smad4 Deletion Up-Regulates Inflammation And Promotes Inflammation-Associated Cancer
911. Epithelial Toll-Like Receptor 9 Signaling In Colorectal Inflammation And Cancer: Clinico-Pathogenic Aspects
912. Epithelial Vanin-1 Controls Inflammation-Driven Carcinogenesis In The Colitis-Associated Colon Cancer Model
913. Epithelial–Mesenchymal Transition: A Link Between Cancer And Inflammation
914. Er-Alpha And Er-Beta Expression In Differentiated Thyroid Cancer: Relation With Tumor Phenotype Across The Tnm Staging And Peri-Tumor Inflammation
915. Erratum To “Inflammation And Its Role In Prostate Cancer”[Journal Of Cancer Therapy 5 (2014) 836-844]
916. Erratum To “The Role Of Neurokinin-1 Receptor In The Microenvironment Of Inflammation And Cancer”
917. Erratum To: Hierarchical Modeling Identifies Novel Lung Cancer Susceptibility Variants In Inflammation Pathways Among 10,140 Cases And 11,012 Controls.
918. Erratum: Inflammation-Induced Iga+ Cells Dismantle Anti-Liver Cancer Immunity.
919. Esophageal Cancer-Related Gene 4 At The Interface Of Injury, Inflammation, Infection, And Malignancy
920. Essential Fatty Acids And Their Metabolites As Modulators Of Stem Cell Biology With Reference To Inflammation, Cancer, And Metastasis
921. Essential Roles For The Non-Canonical Iκb Kinases In Linking Inflammation To Cancer, Obesity, And Diabetes
922. Establishment Of Inflammation Biomarkers-Based Nomograms To Predict Prognosis Of Advanced Colorectal Cancer Patients Based On Real World Data
923. Estrogen Receptor Β Suppresses Inflammation And The Progression Of Prostate Cancer
924. Estrogens, Obesity, Inflammation, And Breast Cancer—What Is The Link?
925. Ethanol‐Induced Mast Cell‐Mediated Inflammation Leads To Increased Susceptibility Of Intestinal Tumorigenesis In The Apcδ468 Min Mouse Model Of Colon Cancer
926. Evaluation Of Advanced Lung Cancer Inflammation As Potential Prognostic Markers In Patients With Colorectal Cancer.
927. Evaluation Of An Inflammation-Based Prognostic Score (Gps) In Patients Undergoing Resection For Colon And Rectal Cancer
928. Evaluation Of An Inflammation-Based Prognostic Score (Gps) In Patients With Metastatic Breast Cancer
929. Evaluation Of An Inflammation-Based Prognostic Score In Patients With Advanced Ovarian Cancer
930. Evaluation Of An Inflammation-Based Prognostic Score In Patients With Inoperable Gastro-Oesophageal Cancer
931. Evaluation Of An Inflammation-Based Prognostic Score In Patients With Inoperable Pancreatic Cancer
932. Evaluation Of An Inflammation‐Based Prognostic Score In Patients With Metastatic Renal Cancer
933. Evaluation Of Dietary Factors In Relation To The Biomarkers Of Oxidative Stress And Inflammation In Breast Cancer Patients
934. Evaluation Of Dietary Factors In Relation To The Biomarkers Of Oxidative Stress And Inflammation In Breast Cancer Risk
935. Evaluation Of Differences Between Cervical Cancer Recurrence And Inflammation After Chemoradiotherapy With Mpmri
936. Evaluation Of Pet Imaging Performance Of The Tspo Radioligand [18F]Dpa-714 In Mouse And Rat Models Of Cancer And Inflammation
937. Evaluation Of Prostatitis In Autopsied Prostates—Is Chronic Inflammation More Associated With Benign Prostatic Hyperplasia Or Cancer?
938. Evaluation Of Systemic Inflammation Based Prognostic Scores In Patients With Advanced Oesophageal Cancer Receiving Palliative Radiotherapy.
939. Evaluation Of Systemic Inflammation-Based Prognostic Scores In Patients With Advanced Colorectal Cancer Receiving Palliative Pelvic Radiotherapy (Rt).
940. Evaluation Of The Relationship Between Prostate Cancer And Serum Inflammation Markers
941. Evaluation Of The Serum N‐Linked Glycome For The Diagnosis Of Cancer And Chronic Inflammation
942. Evidences Of Dual Role Of Vitamin D Through Cellular Energy Homeostasis And Inflammation Pathway In Risk Of Cancer In Obese Subjects.
943. Examination Of The Relationship Between Dna Damage And Inflammation In Primary Non-Small Cell Lung Cancer Patients/Primer Küçük Hücreli Olmayan Akciger …
944. Examinations Of The Interior Relief Of The Gastro-Intestinal Tract. A Contribution To Clinical Roentgenology, With Special Reference To Inflammation, Ulcer, And Cancer
945. Excap Exercise Effects On Cognitive Impairment And Inflammation: A Urcc Ncorp Rct In 479 Cancer Patients.
946. Excessive Weight, Inflammation, Diabetes, And Cancer: Relationships And Differences By Race
947. Exercise And Inflammation In Cancer Survivorship Care
948. Exercise Has A Positive Effect On Low-Grade Inflammation In Women With Breast Cancer [Commentary]
949. Exercise Has A Positive Effect On Low-Grade Inflammation In Women With Breast Cancer [Synopsis]
950. Exercise In Regulation Of Inflammation-Immune Axis Function In Cancer Initiation And Progression
951. Exercise Protects From Cancer Through Regulation Of Immune Function And Inflammation
952. Exercise Training, Inflammatory Cytokines, And Other Markers Of Low-Grade Inflammation In Breast Cancer Survivors: A Systematic Review And Meta-Analysis.
953. Exercise, Inflammation, And Fatigue In Cancer Survivors
954. Exfoliated Black Phosphorus Promotes In Vitro Bone Regeneration And Suppresses Osteosarcoma Progression Through Cancer-Related Inflammation Inhibition
955. Exosome-Like Nanoplatform Modified With Targeting Ligand Improves Anti-Cancer And Anti-Inflammation Effects Of Imperialine
956. Expansion Of Myeloid-Derived Suppressor Cells In Chronic Obstructive Pulmonary Disease And Lung Cancer: Potential Link Between Inflammation And Cancer
957. Expansion Of The Lymphatic Vasculature In Cancer And Inflammation: New Opportunities For In Vivo Imaging And Drug Delivery
958. Experimental Evidence From An Animal Model Of Adenocarcinoma That Chronic Inflammation Enhances Lung Cancer Risk
959. Experimental Study On Differential Diagnosis Of Cancer From Inflammation Using/Sup 11/Cl-Methionine
960. Exploiting Inflammation For Therapeutic Gain In Pancreatic Cancer
961. Exploring And Exploiting The Molecular Function Of Endosialin (Cd248): A Clinical Biomarker In Inflammation And Cancer
962. Exploring Multilocus Associations Of Inflammation Genes And Colorectal Cancer Risk Using Hapconstructor
963. Exploring The Effect Of Chronic Inflammation On Response To Immune Checkpoint Inhibitors In Cancer
964. Exploring The Potential Of Pi3K Inhibitors For Inflammation And Cancer
965. Expression And Polymorphism Of Toll-Like Receptor 4 And Effect On Nf-Κb Mediated Inflammation In Colon Cancer Patients
966. Expression Of C-Terminal Modified Serine Palmitoyltransferase-1 Alters Chemosensitivity Of Inflammation-Associated Human Cancer Cell Lines
967. Expression Of Nf-Kb And Cox2 In Colorectal Cancer Among Native Indonesians: The Role Of Inflammation In Colorectal Carcinogenesis
968. Expression Profile Of Inflammation Related Genes In Laryngeal Cancer [J]
969. Expression Stability Of Common Housekeeping Genes Is Differently Affected By Bowel Inflammation And Cancer: Implications For Finding Suitable Normalizers For …
970. Extract Of Ilex Rotunda Thunb Alleviates Experimental Colitis-Associated Cancer Via Suppressing Inflammation-Induced Mir-31-5P/Yap Overexpression.
971. Extraocular Muscle Enlargement And Thyroid Eye Disease-Like Orbital Inflammation Associated With Immune Checkpoint Inhibitor Therapy In Cancer Patients
972. Extrapolation Of Phenolic Compounds As Multi-Target Agents Against Cancer And Inflammation
973. Extrapulmonary Cancer And Inflammation.
974. Ezh2 Inhibition In Kras-Driven Lung Cancer Amplifies Inflammation And Associated Vulnerabilities
975. Factor Are Increased And Correlate With Malnutrition, Immunosuppression Involving Mdscs And Systemic Inflammation In Patients With Cancer Of The Digestive …
976. Factor-Related Apoptosis-Inducing Ligand (Trail) Is Associated With Inflammation In Young Adult Survivors Of Childhood Cancer
977. Factors Associated With Post-Relapse Survival In Patients With Recurrent Cervical Cancer: The Value Of The Inflammation-Based Glasgow Prognostic Score
978. Fadd At The Crossroads Between Cancer And Inflammation
979. Fak Signaling In Neoplastic Disorders: A Linkage Between Inflammation And Cancer
980. False Positive Uptake Of I-131 During A I-131 Whole Body Follow Up Scan In A Patient With Differentiated Thyroid Cancer And Chronic Inflammation Of Parotid Gland
981. Fanning The Flames Of Cancer Chemoresistance: Inflammation And AntiCancer Therapy
982. Fas And Trail ‘Death Receptors’ As Initiators Of Inflammation: Implications For Cancer
983. Fas Ligand Mediates Immune Privilege And Not Inflammation In Human Colon Cancer, Irrespective Of Tgf-Β Expression
984. Faseb Science Research Conference On Phospholipid Cell Signaling And Metabolism In Inflammation And Cancer
985. Fatigue In Patients With Advanced Terminal Cancer Correlates With Inflammation, Poor Quality Of Life And Sleep, And Anxiety/Depression
986. Fatigue Is Associated With Inflammation In Patients With Head And Neck Cancer Before And After Intensity-Modulated Radiation Therapy
987. Fatigue, Inflammation, And Ω-3 And Ω-6 Fatty Acid Intake Among Breast Cancer Survivors
988. Fatty Acid–Mediated Stromal Reprogramming Of Pancreatic Stellate Cells Induces Inflammation And Fibrosis That Fuels Pancreatic Cancer
989. Fc Receptor-Targeted Therapies For The Treatment Of Inflammation, Cancer And Beyond
990. Fdg Uptake To Reflect Nlr And Expression Levels Of Tils And Pd-L1 In Patients With Primary Breast Cancer: Tumor Inflammation And Immunity.
991. Fighting Cancer With Inflammation
992. First Results For Agents Targeting Cancer-Related Inflammation
993. Fish Oil-Supplemented Parenteral Nutrition In Patients Following Esophageal Cancer Surgery: Effect On Inflammation And Immune Function
994. Flavonoid Apigenin Modified Gene Expression Associated With Inflammation And Cancer And Induced Apoptosis In Human Pancreatic Cancer Cells Through Inhibition Of …
995. Flavonoid Components In Scutellaria Baicalensis Inhibit Nicotine-Induced Proliferation, Metastasis And Lung Cancer-Associated Inflammation In Vitro
996. Flavonoids, Inflammation And Cancer
997. Flavonolignans And Other Constituents From Lepidium Meyenii With Activities In Anti-Inflammation And Human Cancer Cell Lines
998. Fluorescence Discrimination Of Cancer From Inflammation By Molecular Response To Cox-2 Enzymes
999. Fluorescent Nanoprobes As A Biomarker For Increased Vascular Permeability: Implications In Diagnosis And Treatment Of Cancer And Inflammation
1000. Fluorocoxib A Loaded Nanoparticles Enable Targeted Visualization Of Cyclooxygenase-2 In Inflammation And Cancer
1001. Folate Based Radiopharmaceuticals For Imaging And Therapy Of Cancer And Inflammation
1002. Folate Receptor Targeted Imaging Agents For The Differential Diagnosis Of Cancer From Inflammation
1003. Folic Acid Increases Global Dna Methylation And Reduces Inflammation To Prevent Helicobacter-Associated Gastric Cancer In Mice
1004. Food Patterns, Inflammation Markers And Incidence Of Cardiovascular Disease: The Malmö Diet And Cancer Study
1005. Formation And Function Of Lipid Droplets In Inflammation And Cancer
1006. Formyl Peptide Receptor 1 Suppresses Gastric Cancer Angiogenesis And Growth By Exploiting Inflammation Resolution Pathways
1007. Formyl-Peptide Receptors In Infection, Inflammation, And Cancer
1008. Foxp3 As A Missing Link Between Breast Cancer And Inflammation
1009. Foxp3 As A Missing Link Between Inflammation And Breast Cancer
1010. Frequency And Circadian Timing Of Eating May Influence Biomarkers Of Inflammation And Insulin Resistance Associated With Breast Cancer Risk
1011. From Ancient Medicine To Modern Medicine: Ayurvedic Concepts Of Health And Their Role In Inflammation And Cancer
1012. From Gastric Inflammation To Gastric Cancer
1013. From Inflammation To Cancer
1014. From Inflammation To Cancer In Inflammatory Bowel Disease: Molecular Perspectives
1015. From Inflammation To Cancer: Opportunities For Chemoprevention Via Dietary Intervention
1016. From Inflammation To Cancer: The Molecular Basis
1017. From Inflammation To Gastric Cancer: Role Of Helicobacter Pylori
1018. From Inflammation To Gastric Cancer–The Importance Of Hedgehog/Gli Signaling In Helicobacter Pylori-Induced Chronic Inflammatory And Neoplastic Diseases
1019. From Inflammation To Prostate Cancer: The Role Of Inflammasomes
1020. From Mango (Mangifera Indica L.) Modulate Pi3K/Akt/Mtor-Associated Micro-Rnas And Reduce Inflammation In Non-Cancer And Induce Cell Death In Breast Cancer …
1021. From Sentinel Cells To Inflammatory Culprits: Cancer‐Associated Fibroblasts In Tumour‐Related Inflammation
1022. From Traditional Ayurvedic Medicine To Modern Medicine: Identification Of Therapeutic Targets For Suppression Of Inflammation And Cancer
1023. Fucoxanthin-Rich Brown Algae Extract Decreases Inflammation And Attenuates Colitis-Associated Colon Cancer In Mice
1024. Functio Laesa: Cancer Inflammation And Therapeutic Resistance
1025. Function Of Csf1 And Il34 In Macrophage Homeostasis, Inflammation And Cancer
1026. Functional Evidence That Progenitor Cells Near Sites Of Inflammation Are Precursors For Aggressive Prostate Cancer
1027. Functional Regulation Of Phospholipase D Expression In Cancer And Inflammation
1028. Fusobacterium Nucleatum Contributes To The Carcinogenesis Of Colorectal Cancer By Inducing Inflammation And Suppressing Host Immunity
1029. Fusobacterium Nucleatum Infection In Colorectal Cancer: Linking Inflammation, Dna Mismatch Repair And Genetic And Epigenetic Alterations
1030. G Protein–Coupled Receptor Connectivity To Nf-Κb In Inflammation And Cancer
1031. G Protein-Coupled Receptors (Gpcrs)-Mediated Calcium Signaling In Ovarian Cancer: Focus On Gpcrs Activated By Neurotransmitters And Inflammation …
1032. Gab Docking Proteins In Cardiovascular Disease, Cancer, And Inflammation
1033. Galectin-1: An Emerging Target In Cancer Immunotherapy And Autoimmune Inflammation
1034. Gallotannin (Gt) Regulates Apoptosis And Inflammation Via Pi3-Kinase/P38 Map Kinase Pathway In Mda-Mb-231 Human Breast Cancer Cells
1035. Gastric Mucosal Inflammation And Epithelial Cell Turnover Are Associated With Gastric Cancer In Patients With Helicobacter Pylori Infection
1036. Gastro-Intestinal Toxicity Of Chemotherapeutics In Colorectal Cancer: The Role Of Inflammation
1037. Gen-27, A Newly Synthetic Isoflavonoid, Inhibits The Proliferation Of Colon Cancer Cells In Inflammation Microenvironment By Suppressing Nf-Κb Pathway
1038. Gene Expression Architecture Of Mouse Dorsal And Tail Skin Reveals Functional Differences In Inflammation And Cancer
1039. Gene Expression Profiling Of T-Cell Inflammation In Small Cell Lung Cancer.
1040. Gene Polymorphisms Related To Angiogenesis, Inflammation And Thrombosis That Influence Risk For Oral Cancer
1041. Gene Signatures Of Tumor Inflammation And Epithelial-To-Mesenchymal Transition (Emt) Predict Responses To Immune Checkpoint Blockade In Lung Cancer With …
1042. General Introduction To Inflammation And Cancer In The Digestive Tract
1043. Generation Of Myeloid-Derived Lymphatic Endothelial Cell Progenitors (M-Lecps) By Tlr4-Mediated Inflammation And De Novo Vegfr-3 Signaling In Breast Cancer
1044. Genetic Aspects Of Inflammation And Cancer
1045. Genetic Factors Regulating Inflammation And Dna Methylation Associated With Prostate Cancer
1046. Genetic Polymorphisms In Genes Involved In Inflammation And Prostate Cancer Risk
1047. Genetic Polymorphisms In Inflammation Pathway Genes And Prostate Cancer Risk
1048. Genetic Single-Nucleotide Polymorphisms Of Inflammation-Related Factors Associated With Risk Of Lung Cancer
1049. Genetic Variability In Inflammation Pathways And Prostate Cancer Risk
1050. Genetic Variants In Genes Related To Inflammation, Apoptosis And Autophagy In Breast Cancer Risk
1051. Genetic Variants In Inflammation-Related Genes Are Associated With Radiation-Induced Toxicity Following Treatment For Non-Small Cell Lung Cancer
1052. Genetic Variants In The Inflammation Pathway As Predictors Of Recurrence And Progression In Non-Muscle Invasive Bladder Cancer Treated With Bacillus …
1053. Genetic Variation In Genes Involved In Hormones, Inflammation And Energetic Factors And Breast Cancer Risk In An Admixed Population
1054. Genetic Variation In Innate Immunity And Inflammation Pathways Associated With Lung Cancer Risk
1055. Genetic Variation In The Inflammation And Innate Immunity Pathways And Colorectal Cancer Risk
1056. Genetically Engineered Mucin Mouse Models For Inflammation And Cancer
1057. Genetics Of Inflammation In The Gastrointestinal Tract And How It Can Cause Cancer
1058. Genomic Instability, Inflammation, And Cancer
1059. Genomic Landscape Of Colitis-Associated Cancer Indicates The Impact Of Chronic Inflammation And Its Stratification By Mutations In The Wnt Signaling
1060. Geographic Differences In Baseline Prostate Inflammation And Relationship With Subsequent Prostate Cancer Risk: Results From The Multinational Reduce Trial
1061. Germ-Line Mutations, Pancreatic Inflammation, And Pancreatic Cancer
1062. Gestational Age And Size At Birth And Risk Of Esophageal Inflammation And Cancer
1063. Gfi1 Downregulation Promotes Inflammation-Linked Metastasis Of Colorectal Cancer
1064. Ginseng Berry Polysaccharides On Inflammation-Associated Colon Cancer: Inhibiting T-Cell Differentiation, Promoting Apoptosis, And Enhancing The Effects Of 5 …
1065. Ginseng On Cancer: Potential Role In Modulating Inflammation-Mediated Angiogenesis
1066. Glucose-6-Phosphatase Expression–Mediated [18F]Fdg Efflux In Murine Inflammation And Cancer Models
1067. Glucosinolates From Pak Choi And Broccoli Induce Enzymes And Inhibit Inflammation And Colon Cancer Differently
1068. Glycans In Cancer And Inflammation—Potential For Therapeutics And Diagnostics
1069. Glycoforms Of Serum Α1-Acid Glycoprotein As Markers Of Inflammation And Cancer
1070. Glycogen Synthase Kinase 3 (Gsk‐3) Inhibitors As New Promising Drugs For Diabetes, Neurodegeneration, Cancer, And Inflammation
1071. Glycosaminoglycan Mimetics For The Treatment Of Cancer And Lung Inflammation
1072. Glycosaminoglycans And Glycosaminoglycan Mimetics In Cancer And Inflammation
1073. Gp130 At The Nexus Of Inflammation, Autoimmunity, And Cancer
1074. Granulocyte Colony Stimulating Factor-Producing Lung Cancer With Severe Anemia Of Inflammation
1075. Greater Extent Of Prostate Inflammation In Negative Biopsies Is Associated With Lower Risk Of Prostate Cancer On Repeat Biopsy: Results From The Reduce Study
1076. Group 3 Innate Lymphoid Cells: Regulating Host–Commensal Bacteria Interactions In Inflammation And Cancer
1077. Growth Signals, Inflammation, And Vascular Perturbations: Mechanistic Links Between Obesity, Metabolic Syndrome, And Cancer
1078. Gsk-3Β Governs Inflammation-Induced Nfatc2 Signaling Hubs To Promote Pancreatic Cancer Progression
1079. Gut Bacteria Signaling To Mitochondria In Intestinal Inflammation And Cancer
1080. Gut Commensal Bacteria Determine Cancer Response To Treatment By Modulating Systemic Inflammation
1081. Gut Microbiota, Inflammation And Colorectal Cancer
1082. Gut Microbiota, Inflammation, And Colorectal Cancer
1083. Gut Microbiota-Mediated Inflammation In Obesity: A Link With Gastrointestinal Cancer
1084. H. Pylori Infection Promotes Intestinal Inflammation And Colitis-Associated Colon Cancer In Mice With A Lineage-Restricted Deletion Of The Smad4 Gene In T Cells.
1085. H. Pylori Infection, Inflammation And Gastric Cancer
1086. H. Pylori Infection–The Route From Inflammation To Cancer
1087. Hcv-Related Hepatocellular Carcinoma: From Chronic Inflammation To Cancer
1088. Health Promoting Life-Style Behaviors And Systemic Inflammation In African American And Caucasian Women Prior To Chemotherapy For Breast Cancer
1089. Health, Immunity, And The Pursuit Of Happiness: The Relationship Between Positive Emotions And Inflammation In Breast Cancer Survivors
1090. Heat‐Induced Inflammation And Its Role In Esophageal Cancer
1091. Hedgehog Signaling Links Chronic Inflammation To Gastric Cancer Precursor Lesions
1092. Helicobacter Hepaticus Infection In Mice: Models For Understanding Lower Bowel Inflammation And Cancer
1093. Helicobacter Pylori And Gastric Cancer: A New Paradigm For Inflammation-Associated Epithelial Cancers
1094. Helicobacter Pylori Induced Gastric Inflammation, Ulcer, And Cancer: A Pathogenesis Perspective
1095. Helicobacter Pylori Infection Synergizes With Three Inflammation-Related Genetic Variants In The Gwass To Increase Risk Of Gastric Cancer In A Chinese …
1096. Helicobacter Pylori-Induced Gastric Inflammation And Gastric Cancer
1097. Helicobacter, Inflammation, And Gastric Cancer
1098. Helper T Cells And Cancer-Associated Inflammation: A New Direction For Immunotherapy?
1099. Hemorheological, Inflammation And Anemia Parameters Before, During And After Surgery In Patients With Stomach Cancer
1100. Hemorrhage, Obstruction, Perforation, And Inflammation In Gynecological Cancer
1101. Heparanase In Inflammation And Inflammation‐Associated Cancer
1102. Heparanase Regulation Of Cancer, Autophagy And Inflammation: New Mechanisms And Targets For Therapy
1103. Heparanase: A Target For Drug Discovery In Cancer And Inflammation
1104. Heparanase: From Basic Research To Therapeutic Applications In Cancer And Inflammation
1105. Heparin-Derived Heparan Sulfate Mimics To Modulate Heparan Sulfate-Protein Interaction In Inflammation And Cancer
1106. Hepatic Inflammation-Fibrosis-Cancer Axis In The Rat Hepatocellular Carcinoma Induced By Diethylnitrosamine
1107. Hepatitis B Virus X Induces Inflammation And Cancer In Mice Liver Through Dysregulation Of Cytoskeletal Remodeling And Lipid Metabolism
1108. Hepoxilins In Cancer And Inflammation—Use Of Hepoxilin Antagonists
1109. Hexim1 And The Control Of Transcription Elongation: From Cancer And Inflammation To Aids And Cardiac Hypertrophy
1110. Hierarchical Modeling Identifies Novel Lung Cancer Susceptibility Variants In Inflammation Pathways Among 10,140 Cases And 11,012 Controls
1111. Hif‐1 At The Crossroads Of Hypoxia, Inflammation, And Cancer
1112. Hif-1: A Target For Cancer, Ischemia And Inflammation—Too Good To Be True?
1113. Hif1Α Deficiency Reduces Inflammation In A Mouse Model Of Proximal Colon Cancer
1114. High Dietary Fiber Lowers Systemic Inflammation: Potential Utility In Copd And Lung Cancer
1115. High Salt And Fat Intake, Inflammation, And Risk Of Cancer
1116. High-Calorie Diet Induced Chronic Colonic Inflammation: A Human-Relevant Porcine Model To Assess Whole Food Approach To Reduce Colon Cancer Risk
1117. High-Fat, High-Calorie Diet Enhances Mammary Carcinogenesis And Local Inflammation In Mmtv-Pymt Mouse Model Of Breast Cancer
1118. High-Grade Inflammation In Prostate Cancer As A Prognostic Factor For Biochemical Recurrence After Radical Prostatectomy
1119. High-Intensity Interval Training Can Modulate The Systemic Inflammation And Hsp70 In The Breast Cancer: A Randomized Control Trial
1120. High-Serum Mmp-8 Levels Are Associated With Decreased Survival And Systemic Inflammation In Colorectal Cancer
1121. Histological Inflammation And Risk Of Subsequent Prostate Cancer Among Men With Initially Elevated Serum Prostate‐Specific Antigen (Psa) Concentration In The F Innish …
1122. Histone Deacetylases And The Immunological Network: Implications In Cancer And Inflammation
1123. Homeostatic Imbalance And Colon Cancer: The Dynamic Epigenetic Interplay Of Inflammation, Environmental Toxins, And Chemopreventive Plant Compounds
1124. Host Cytokine Genotype Is Related To Adverse Prognosis And Systemic Inflammation In Gastro-Oesophageal Cancer
1125. Host–Microbiota Interaction And Intestinal Stem Cells In Chronic Inflammation And Colorectal Cancer
1126. How And Why Systemic Inflammation Worsens Quality Of Life In Patients With Advanced Cancer
1127. How Chronic Inflammation Can Lead To Cancer
1128. How Does Inflammation Drive Mutagenesis In Colorectal Cancer?
1129. How The Association Between Obesity And Inflammation May Lead To Insulin Resistance And Cancer
1130. Human Chitinases And Chitinase-Like Proteins As Indicators For Inflammation And Cancer
1131. Human Colon Tumors Express A Dominant-Negative Form Of Sigirr That Promotes Inflammation And Colitis-Associated Colon Cancer In Mice
1132. Human Immunodeficiency Virus-Mediated Inflammation And Immune Dysregulation To Better Understand The Higher Risks Of Cancer, Cardiovascular Disease, And Other …
1133. Human Leukocyte Antigen Shared Epitope And Inflammation, Cardiovascular Disease, Cancer, And Mortality Among Postmenopausal Women In The Women’S Health …
1134. Human Organ Culture: Updating The Approach To Bridge The Gap From In Vitro To In Vivo In Inflammation, Cancer, And Stem Cell Biology
1135. Human Patients With Ovarian Cancer, And Overexpression Of Klotho Inhibits The Progression Of Ovarian Cancer Partly Via The Inhibition Of Systemic Inflammation …
1136. Human T Cell Responses To Il-6 And Il-27 Are Inhibited During Cancer And Chronic Inflammation (P2019)
1137. Humoral Immunity, Inflammation And Cancer
1138. Hyaluronan, Inflammation, And Breast Cancer Progression
1139. Hyaluronan: Molecular Size‐Dependent Signaling And Biological Functions In Inflammation And Cancer
1140. Hydrogel Spacer In Men Undergoing Radiation Therapy For Prostate Cancer: What The Radiologist Needs To Know Infection And Inflammation Of The Genitourinary …
1141. Hydrogen Gas From Inflammation Treatment To Cancer Therapy
1142. Hydrogen Peroxide Fuels Aging, Inflammation, Cancer Metabolism And Metastasis: The Seed And Soil Also Needs” Fertilizer”
1143. Hydroxyoctadecadienoic Acids: Oxidised Derivatives Of Linoleic Acid And Their Role In Inflammation Associated With Metabolic Syndrome And Cancer
1144. Hyperinsulinemia Enhances Interleukin-17-Induced Inflammation To Promote Prostate Cancer Development In Obese Mice Through Inhibiting Glycogen …
1145. Hypersialylation In Cancer: Modulation Of Inflammation And Therapeutic Opportunities
1146. Hypothesis: Bacterial Induced Inflammation Disrupts The Orderly Progression Of The Stem Cell Hierarchy And Has A Role In The Pathogenesis Of Breast Cancer
1147. Hypoxia And Inflammation In Cancer, Focus On Hif And Nf-Κb
1148. Hypoxia And Inflammation In Cancer, Focus On Hif And Nf-Кb
1149. Hypoxia And Inflammation In Prostate Cancer Progression. Cross-Talk With Androgen And Estrogen Receptors And Cancer Stem Cells
1150. Hypoxia Inducible Factors In Cancer And Inflammation
1151. Hypoxia-Inducible Factor-1Alpha Is A Key Player In Promotion Of Lung Cancer By Copd-Like Airway Inflammation In Mice
1152. Hypoxia-Inducible Factor-2Α Regulates Intestinal Inflammation And Colon Cancer
1153. Hypoxia-Inducible Factors In Cancer Stem Cells And Inflammation
1154. Hypoxia-Inducible Factors: A Central Link Between Inflammation And Cancer
1155. Hypoxic Influences On Myeloid Cells During Inflammation And Inflammation-Associated Cancer
1156. Iaps: From Caspase Inhibitors To Modulators Of Nf-Κb, Inflammation And Cancer
1157. Icariside Ii, A Broad-Spectrum Anti-Cancer Agent, Reverses Beta-Amyloid-Induced Cognitive Impairment Through Reducing Inflammation And Apoptosis In Rats
1158. Identification And Characterization Of Binding Sites On S100A7, A Participant In Cancer And Inflammation Pathways
1159. Identification And Verification Of Prdx1 As An Inflammation Marker For Colorectal Cancer Progression
1160. Identification Of A Genetic Locus Controlling Bacteria-Driven Colitis And Associated Cancer Through Effects On Innate Inflammation
1161. Identification Of Differentially Iga-Coated Bacteria In Inflammation-Induced Colorectal Cancer
1162. Identification Of Novel Targets For Shikonin As A Potent Drug For Inflammation And Cancer
1163. Igg4 Antibodies And Cancer-Associated Inflammation: Insights Into A Novel Mechanism Of Immune Escape
1164. Ikkβ Links Inflammation And Tumorigenesis In A Mouse Model Of Colitis-Associated Cancer
1165. Il-1 And Egf Regulate Expression Of Genes Important In Inflammation And Cancer
1166. Il-1 In Colon Inflammation, Colon Carcinogenesis And Invasiveness Of Colon Cancer
1167. Il-1 Receptor-Associated Kinase Signaling And Its Role In Inflammation, Cancer Progression, And Therapy Resistance
1168. Il-10-Related Cellular Cytokines And Their Receptors: New Targets For Inflammation And Cancer Therapy
1169. Il-15 Regulates Migration, Invasion, Angiogenesis And Genes Associated With Lipid Metabolism And Inflammation In Prostate Cancer
1170. Il-17 And Vegf Are Increased And Correlated To Systemic Inflammation, Immune Suppression, And Malnutrition In Patients With Breast Cancer
1171. Il-17+ Regulatory T Cells In The Microenvironments Of Chronic Inflammation And Cancer
1172. Il‐17A‐Producing Cd30+ Vδ1 T Cells Drive Inflammation‐Induced Cancer Progression
1173. Il-17C-Mediated Innate Inflammation Decreases The Response To Pd-1 Blockade In A Model Of Kras-Driven Lung Cancer
1174. Il-1B, Il-1Ra And Sil-1Rii In The Culture Supernatants Of Pmn And Pbmc And The Serum Levels In Patients With Inflammation And Patients With Cancer Disease Of The …
1175. Il-1Α Sustains The Inflammation In Human Pancreatic Cancer Microenvironment By Targeting Cancer Associated Fibroblasts
1176. Il-1Β-Induced Inflammation Regulates Epithelial-To-Mesenchymal Transition Memory Phenotypes Via Epigenetic Modification In Non-Small Cell Lung Cancer
1177. Il-22: Linking Inflammation And Cancer
1178. Il-23 In Infections, Inflammation, Autoimmunity And Cancer: Possible Role In Hiv-1 And Aids
1179. Il-32: A Novel Pluripotent Inflammatory Interleukin, Towards Gastric Inflammation, Gastric Cancer, And Chronic Rhino Sinusitis
1180. Il-32Α-Induced Inflammation Constitutes A Link Between Obesity And Colon Cancer
1181. Il-6 And Related Cytokines As The Critical Lynchpins Between Inflammation And Cancer
1182. Il-6 Signaling In Autoimmunity, Chronic Inflammation And Inflammation-Associated Cancer
1183. Imaging Of Angiogenesis In Inflammation And Cancer: Lessons For Novel Treatment Of Allergic Rhinitis
1184. Imaging Treatment-Related Carotid Artery Inflammation In Head And Neck Cancer
1185. Immature Myeloid-Derived Suppressor Cells: A Bridge Between Inflammation And Cancer
1186. Immediate Postoperative Inflammation Is An Important Prognostic Factor In Breast Cancer
1187. Immune Cell Types And Secreted Factors Contributing To Inflammation-To-Cancer Transition And Immune Therapy Response
1188. Immune Cells And Chronic Inflammation At The Tumor Site On Cancer Development, Progression, And Prognosis: Emphasis On Non-Small Cell Lung Cancer
1189. Immune Dysregulation And Pancreatic Cancer: Overactivity, Inflammation And Epigenetic Modifications Of Immune Function
1190. Immune Inflammation Indicators And Albi Score To Predict Liver Cancer In Hcv-Patients Treated With Direct-Acting Antivirals
1191. Immune Inflammation Indicators In Anal Cancer Patients Treated With Concurrent Chemoradiation: Training And Validation Cohort With Online Calculator (Arc …
1192. Immune Inflammation Indicators Predict Outcome In Anal Cancer Patients Undergoing Concurrent Chemoradiation
1193. Immune Regulation By T Regulatory Cells In Hepatitis B Virus‐Related Inflammation And Cancer
1194. Immune Regulatory Networks In Inflammation-Driven Cancer
1195. Immune Suppression And Inflammation In The Progression Of Breast Cancer
1196. Immune Suppression: A Link Between Inflammation And Cancer
1197. Immune-Inflammation Index And Ultrasonographic Classification Of Breast Imaging-Reporting And Data System Predict Outcomes Of Triple-Negative Breast Cancer
1198. Immunity And Tumor Inflammation After Vaccination With Bpx-101, A Drug-Activated Dendritic Cell Vaccine For Metastatic Castration-Resistant Prostate Cancer …
1199. Immunity, Inflammation And Cancer: A Leading Role For Adenosine
1200. Immunity, Inflammation And Cancer: The Role Of Foxp3, Tlr7 And Tlr8 In Gastrointestinal Cancer
1201. Immunity, Inflammation, And Cancer
1202. Immunity, Inflammation, And Cancer: An Eternal Fight Between Good And Evil
1203. Immunoglobulin Free Light Chains Are Biomarkers Of Poor Prognosis In Basal-Like Breast Cancer And Are Potential Targets In Tumor-Associated Inflammation
1204. Immunoglobulin Free Light Chains Are Linked With Tumour-Associated Inflammation And Poor Cancer Prognosis
1205. Immunohistochemical Assessment Of Bladder Cancer On The Background Of The Chronic Inflammation
1206. Immunological Approaches Towards Cancer And Inflammation: A Cross Talk
1207. Immunological Regulation Of Vascular Inflammation During Cancer Metastasis
1208. Immunology: Skin Inflammation Predisposes To Cancer
1209. Immunomodulatory Effects Of (N-3) Fatty Acids: Putative Link To Inflammation And Colon Cancer
1210. Immunoregulatory Functions And The Therapeutic Implications Of Garp-Tgf-Β In Inflammation And Cancer
1211. Immunosuppression, Inflammation, And Skin Cancer: Will Eczema Treatment Enhance Ultraviolet Light-Induced Skin Cancer?
1212. Immunosuppressive Therapy And Cancer Risk In Ocular Inflammation Patients: Fresh Evidence And More Questions
1213. Impact And Application Of Nutraceuticals On Inflammation-Induced Colorectal Cancer Development
1214. Impact Of A Novel Inflammation-Based Prognostic System On Patients Undergoing Surgery For Colorectal Cancer: A Retrospective Study Of 480 Japanese Patients.
1215. Impact Of Anesthetics On 3′-[18F]Fluoro-3′-Deoxythymidine ([18F]Flt) Uptake In Animal Models Of Cancer And Inflammation
1216. Impact Of Celecoxib On Inflammation During Cancer Surgery: A Randomized Clinical Trial
1217. Impact Of Elevated Circulating Histones On Systemic Inflammation After Radiofrequency Ablation In Lung Cancer Patients
1218. Impact Of Fish-Oil Supplement On Nutritional Parameters, Inflammation And Chemotherapy Induced Toxicity In Colorectal Cancer (Crc) Patients Receiving Folfiri-A Pilot …
1219. Impact Of Imaging Based Sarcopenia And Modified Advanced Lung Cancer Inflammation Index (Mali) On Clinical Outcomes In Advanced Nsclc: A Occult Killer And A …
1220. Impact Of Inflammation On Gene Expression In A Prostate Cancer Model
1221. Impact Of Inflammation-Based Prognostic Score On Survival After Curative Thoracoscopic Esophagectomy For Esophageal Cancer
1222. Impact Of Intratumoral Inflammation On Survival After Pancreatic Cancer Resection
1223. Impact Of Medical Qigong On Quality Of Life, Fatigue, Mood And Inflammation In Cancer Patients: A Randomized Controlled Trial
1224. Impact Of Nutrition Status And Systematic Inflammation On Patients With Colorectal Cancer.
1225. Impact Of Pretherapeutic Neutrophil-To-Lymphocyte Ratio, Serum Albumin, Body-Mass Index, And Advanced Lung Cancer Inflammation Index On Clinical Outcome In …
1226. Impact Of Systemic Inflammation Biomarkers On The Survival Outcomes Of Cervical Cancer Patients
1227. Impact Of Systemic Inflammation On Gastric Cancer Outcomes
1228. Impact Of Systemic Inflammation On The Relationship Between Insulin Resistance And All-Cause And Cancer-Related Mortality
1229. Impact Of The Regional Lymphotropic Therapy On Inflammation At Lung Cancer
1230. Implications Of Cancer-Associated Systemic Inflammation For Biomarker Studies
1231. Importance Of Soluble Cytokine Receptors For Inflammation Associated Cancer
1232. Important Roles Of P2Y Receptors In The Inflammation And Cancer Of Digestive System
1233. Improvement Of Diagnostic And Surgical Treatment Of Colon Cancer Complicated With Perifocal Inflammation In Patients Of The Elderly And Senile Age
1234. Improvement Of High-Sensitivity Inflammation-Based Glasgow Prognostic Score By Gastrectomy Is A Favorable Prognostic Factor In Patients With Gastric Cancer
1235. In Silico And In Vitro Studies On Begomovirus Induced Andrographolide Biosynthesis Pathway In Andrographis Paniculata For Combating Inflammation And Cancer
1236. In The Immune Response Are Generally Not Associated With Intraprostatic Inflammation In Men Without A Prostate Cancer Diagnosis: Results From The Prostate Cancer …
1237. In This Issue: On Mirnas Connecting Cancer With Inflammation And Novel Concepts In Immunology And Vaccine Design
1238. In Thyroidectomized Thyroid Cancer Patients, False-Positive I-131 Whole Body Scans Are Often Caused By Inflammation Rather Than Thyroid Cancer
1239. In Vitro Anti-Cancer, Anti-Diabetic, Anti-Inflammation And Wound Healing Properties Of Collagen Peptides Derived From Unicorn Leatherjacket (Aluterus Monoceros) …
1240. In Vivo Endoluminal Ultrasound Biomicroscopic Imaging Of Colon Lesions In Mouse Models Of Cancer And Inflammation
1241. In Vivo Selection For Spine-Derived Highly Metastatic Lung Cancer Cells Is Associated With Increased Migration, Inflammation And Decreased Adhesion
1242. Inactivation Of The Deubiquitinase Cyld In Hepatocytes Causes Apoptosis, Inflammation, Fibrosis, And Cancer
1243. Incidence Of Periprostatic White Adipose Tissue Inflammation In Men With Prostate Cancer.
1244. Increased Myeloid‑Derived Suppressor Cell Levels, Systemic Inflammation And Hypoalbuminemia Are Present In Patients With Anaplastic Thyroid Cancer
1245. Increased Risk Of Cancer Death In Patients With Chronic Heart Failure With A Special Reference To Inflammation-A Report From The Chart-2 Study
1246. Increased Risk Of Colorectal Cancer Among Patients With Biliary Tract Inflammation: A 5‐Year Follow‐Up Study
1247. Increased Systemic Immune-Inflammation Index Independently Predicts Poor Survival For Hormone Receptor-Negative, Her2-Positive Breast Cancer Patients
1248. Increasing B Vitamins In Foods To Prevent Intestinal Inflammation And Cancer
1249. Independent Prognostic Value Of Inflammation In Metastatic Pancreatic Cancer.
1250. Indices Of Hypercoagulation In Cancer As Compared With Those In Acute Inflammation And Acute Infarction
1251. Indoleamine 2, 3-Dioxygenase Amino Acid Metabolism And Tumour-Associated Macrophages: Regulation In Cancer-Associated Inflammation And Immune Escape
1252. Indoleamine 2, 3-Dioxygenase As A Modifier Of Pathogenic Inflammation In Cancer And Other Inflammation-Associated Diseases
1253. Indoleamine 2, 3-Dioxygenase Pathways Of Pathogenic Inflammation And Immune Escape In Cancer
1254. Induction Of Nitric-Oxide Metabolism In Enterocytes Alleviates Colitis And Inflammation-Associated Colon Cancer
1255. Infection Induced Chronic Inflammation And It’S Association With Prostate Cancer Initiation And Progression
1256. Infection, Inflammation And Cancer
1257. Infection, Inflammation And Gastric Cancer.
1258. Infection, Inflammation, And Cancer
1259. Infection, Inflammation, And Cancer Mediated By Oxygen Radicals And Nitric Oxide
1260. Infection, Inflammation, And Cancer: Overview
1261. Infection, Inflammation, And Gastrointestinal Cancer
1262. Infections And Inflammation In Prostate Cancer
1263. Infections, Inflammation And Cancer: Roles Of Reactive Oxygen And Nitrogen Species
1264. Inflammasome In Intestinal Inflammation And Cancer
1265. Inflammasome, Inflammation And Cancer: An Interrelated Pathobiological Triad
1266. Inflammasome-Mediated Suppression Of Inflammation-Induced Colorectal Cancer Progression Is Mediated By Direct Regulation Of Epithelial Cell Proliferation
1267. Inflammasomes As Molecular Mediators Of Inflammation And Cancer: Potential Role In Melanoma
1268. Inflammasomes In Inflammation-Induced Cancer
1269. Inflammasomes In Intestinal Inflammation And Cancer
1270. Inflammation & Prostate Cancer
1271. Inflammation Aging Cancer
1272. Inflammation And Altered Drug Clearance In Cancer: Transcriptional Repression Of A Human Cyp3A4 Transgene In Tumor‐Bearing Mice
1273. Inflammation And Antiangiogenesis In Cancer
1274. Inflammation And Attentional Bias In Breast Cancer Survivors
1275. Inflammation And Behavioral Symptoms After Breast Cancer Treatment: Do Fatigue, Depression, And Sleep Disturbance Share A Common Underlying Mechanism?
1276. Inflammation And Body Composition In Over-And Undernutrition: Overweight And Cancer Cachexia
1277. Inflammation And Breast Cancer
1278. Inflammation And Breast Cancer Prevention By Phyllostachys Edulis Extract
1279. Inflammation And Breast Cancer Risk
1280. Inflammation And Breast Cancer: A Mini Review
1281. Inflammation And Breast Cancer: Clinical Markers And Impact On Breast Cancer Incidence, Severity And Survival
1282. Inflammation And Cancer
1283. Inflammation And Cancer Development In Pancreatic And Biliary Tract Cancer
1284. Inflammation And Cancer I. Rodent Models Of Infectious Gastrointestinal And Liver Cancer
1285. Inflammation And Cancer Ii. Role Of Chronic Inflammation And Cytokine Gene Polymorphisms In The Pathogenesis Of Gastrointestinal Malignancy
1286. Inflammation And Cancer Iii. Somatostatin And The Innate Immune System
1287. Inflammation And Cancer Iv. Colorectal Cancer In Inflammatory Bowel Disease: The Role Of Inflammation
1288. Inflammation And Cancer Of The Prostate
1289. Inflammation And Cancer Prevention: Is There A Link?
1290. Inflammation And Cancer Revisited: An Hypothesis On The Oncogenic Potential Of The Apoptotic Tumor Cell
1291. Inflammation And Cancer Stem Cells
1292. Inflammation And Cancer V. Chronic Pancreatitis And Pancreatic Cancer
1293. Inflammation And Cancer, The Mastocytoma P815 Tumor Model Revisited: Triggering Of Macrophage Activation In Vivo With Pro‐Tumorigenic Consequences
1294. Inflammation And Cancer: A Comparative View
1295. Inflammation And Cancer: A Double-Edged Sword
1296. Inflammation And Cancer: A Failure Of Resolution?
1297. Inflammation And Cancer: A Multifaceted Link
1298. Inflammation And Cancer: Advances And New Agents
1299. Inflammation And Cancer: An Ancient Link With Novel Potentials
1300. Inflammation And Cancer: An Epidemiological Perspective
1301. Inflammation And Cancer: Back To Virchow?
1302. Inflammation And Cancer: Breast Cancer As A Prototype
1303. Inflammation And Cancer: Causes And Consequences
1304. Inflammation And Cancer: Chemical Approaches To Mechanisms, Imaging, And Treatment
1305. Inflammation And Cancer: Critical View
1306. Inflammation And Cancer: Divergent Roles For Leukotriene B4 Receptor-1 And Chemokine Decoy Receptor D6
1307. Inflammation And Cancer: Extra-And Intracellular Determinants Of Tumor-Associated Macrophages As Tumor Promoters
1308. Inflammation And Cancer: Friend Or Foe?
1309. Inflammation And Cancer: Hepatitis B, Hepatitis C And Hcc
1310. Inflammation And Cancer: How Friendly Is The Relationship For Cancer Patients?
1311. Inflammation And Cancer: How Hot Is The Link?
1312. Inflammation And Cancer: Il-6 And Stat3 Complete The Link
1313. Inflammation And Cancer: In Medio Stat Nano
1314. Inflammation And Cancer: Inhibiting The Progression Of Residual Hepatic Vx2 Carcinoma By Anti-Inflammatory Drug After Incomplete Radiofrequency Ablation
1315. Inflammation And Cancer: Interweaving Microrna, Free Radical, Cytokine And P53 Pathways
1316. Inflammation And Cancer: Is Aid Aiding?
1317. Inflammation And Cancer: Is Trophism The Link?
1318. Inflammation And Cancer: Macrophage Migration Inhibitory Factor (Mif)—The Potential Missing Link
1319. Inflammation And Cancer: Methods And Protocols
1320. Inflammation And Cancer: Methods And Protocols: Volume 2, Molecular Analysis And Pathways
1321. Inflammation And Cancer: Organ-Specific Regulation Of Cancer Development
1322. Inflammation And Cancer: Relevance Of Myeloid Cells Recruitment And Plasticity In Tumor Biology
1323. Inflammation And Cancer: Role Of Annexin A1 And Fpr2/Alx In Proliferation And Metastasis In Human Laryngeal Squamous Cell Carcinoma
1324. Inflammation And Cancer: Role Of Nuclear Factor‐Kappab Activation
1325. Inflammation And Cancer: The Link Grows Stronger
1326. Inflammation And Cancer: The Long Reach Of Ras
1327. Inflammation And Cancer: The Macrophage Connection
1328. Inflammation And Cancer: The Oncogene-Driven Connection
1329. Inflammation And Cancer: The Role Of Lipid Signaling In The Continuum Between Two Ends Of The Tumor Spectrum
1330. Inflammation And Cancer: The Role Of The Human Neutrophil
1331. Inflammation And Cancer: Till Death Tears Them Apart
1332. Inflammation And Cancer: Tissue Regeneration Gone Awry
1333. Inflammation And Cancer: Triggers, Mechanisms, And Consequences
1334. Inflammation And Cancer: What A Surgical Oncologist Should Know
1335. Inflammation And Cancer: What Can We Therapeutically Expect From Checkpoint Inhibitors?
1336. Inflammation And Cancer: When Nf-Κb Amalgamates The Perilous Partnership
1337. Inflammation And Cancer-Colorectal Carcinoma As An Example
1338. Inflammation And Cancer-Related Fatigue In Breast Cancer Survivors
1339. Inflammation And Cancer-Related Fatigue: Mechanisms, Contributing Factors, And Treatment Implications
1340. Inflammation And Chemerin In Colorectal Cancer
1341. Inflammation And Colon Cancer
1342. Inflammation And Colorectal Cancer
1343. Inflammation And Colorectal Cancer, When Microbiota-Host Mutualism Breaks
1344. Inflammation And Colorectal Cancer: Colitis-Associated Neoplasia
1345. Inflammation And Colorectal Cancer: Does Aspirin Affect The Interaction Between Cancer And Immune Cells?
1346. Inflammation And Colorectal Cancer: Elucidation Of The Cellular And Molecular Mechanisms By Which Interleukin 22 Contributes To The Development And Progression Of …
1347. Inflammation And Colorectal Cancer: Ibd-Associated And Sporadic Cancer Compared
1348. Inflammation And Cyp3A4-Mediated Drug Metabolism In Advanced Cancer: Impact And Implications For Chemotherapeutic Drug Dosing
1349. Inflammation And Dna Damage: Probing Pathways To Cancer And Neurodegeneration
1350. Inflammation And Emt: An Alliance Towards Organ Fibrosis And Cancer Progression
1351. Inflammation And Endometrial Cancer: A Hypothesis
1352. Inflammation And Endothelial Activation In Benign Prostatic Hyperplasia And Prostate Cancer
1353. Inflammation And Fatigue Dimensions In Advanced Cancer Patients And Cancer Survivors
1354. Inflammation And Fatigue Dimensions In Advanced Cancer Patients And Cancer Survivors: An Explorative Study
1355. Inflammation And Gastrointestinal Cancer: An Overview
1356. Inflammation And Hemostatic Activation May Contribute To Postsurgical Thrombosis In Patients With Bladder Cancer
1357. Inflammation And Human Cancer
1358. Inflammation And Igf‐I Activate The Akt Pathway In Breast Cancer
1359. Inflammation And Immune Surveillance In Cancer
1360. Inflammation And Immunity In Cancer
1361. Inflammation And Immunosurveillance In Breast Cancer
1362. Inflammation And Infection In The Etiology Of Prostate Cancer
1363. Inflammation And Inflammatory Cytokine Contribute To The Initiation And Development Of Ulcerative Colitis And Its Associated Cancer
1364. Inflammation And Inflammatory Mediators In Kidney Disease: Il-33 Deficiency Slows Cancer Growth But Does Not Protect Against Cisplatin-Induced Aki In Mice …
1365. Inflammation And Intestinal Homeostasis-Associated Genes In Colorectal Cancer
1366. Inflammation And Invasive Margin In Colorectal Cancer
1367. Inflammation And Its Role In Prostate Cancer
1368. Inflammation And Liver Cancer: Molecular Mechanisms And Therapeutic Targets
1369. Inflammation And Liver Cancer: New Molecular Links
1370. Inflammation And Lung Cancer
1371. Inflammation And Lung Cancer Oxidative Stress, Ros, And Dna Damage
1372. Inflammation And Lung Cancer: Addressing Inflammation With Immunotherapy
1373. Inflammation And Lung Cancer: Eicosanoids
1374. Inflammation And Lung Cancer: Molecular Pathology
1375. Inflammation And Lung Cancer: Prevention
1376. Inflammation And Lung Cancer: Roles Of Reactive Oxygen/Nitrogen Species
1377. Inflammation And Lung Cancer: The Link To Angiogenesis
1378. Inflammation And Lung Cancer: The Relationship To Chronic Obstructive Pulmonary Disease
1379. Inflammation And Lung Cancer: The Role Of Epithelial–Mesenchymal Transition
1380. Inflammation And Matrix Metalloproteinases: Implications For Cancer Development
1381. Inflammation And Metabolism In Cancer Cell–Mitochondria Key Player
1382. Inflammation And Mir-21 Pathways Functionally Interact To Downregulate Pdcd4 In Colorectal Cancer
1383. Inflammation And Neural Signaling: Etiologic Mechanisms Of The Cancer Treatment-Related Symptom Cluster
1384. Inflammation And Nf-Κb Signaling In Prostate Cancer: Mechanisms And Clinical Implications
1385. Inflammation And Oral Cancer: An Update Review On Targeted Therapies.
1386. Inflammation And Ovarian Cancer
1387. Inflammation And Ovarian Cancer–Current Views
1388. Inflammation And Oxidative Dna Damage: A Dangerous Synergistic Pathway To Cancer
1389. Inflammation And Pancreatic Cancer: A Tale Of Two Cytokines
1390. Inflammation And Pancreatic Cancer: An Evidence-Based Review
1391. Inflammation And Pancreatic Cancer: An Updated Review
1392. Inflammation And Pancreatic Cancer: Disease Promoter And New Therapeutic Target
1393. Inflammation And Pancreatic Cancer: Focus On Metabolism, Cytokines, And Immunity
1394. Inflammation And Pancreatic Cancer: Molecular And Functional Interactions Between S100A8, S100A9, Nt-S100A8 And Tgfβ1
1395. Inflammation And Pancreatic Cancer: Recent Development With Focusing On Potential New Drug Targets
1396. Inflammation And Preneoplastic Lesions In Benign Prostate As Risk Factors For Prostate Cancer
1397. Inflammation And Prognosis In Breast Cancer. A Search For Host Resistance
1398. Inflammation And Prognosis In Colorectal Cancer
1399. Inflammation And Prostate Cancer
1400. Inflammation And Prostate Cancer Development: The Role Of Chemokine (Cxc Motif) Ligand 12 And Its Receptors Cxcr4 And Cxcr7 …
1401. Inflammation And Prostate Cancer.
1402. Inflammation And Prostate Cancer: A Focus On Infections
1403. Inflammation And Prostate Cancer: A Future Target For Prevention And Therapy?
1404. Inflammation And Prostate Cancer: Effects On Carcinogenesis And The Role Of 1, 25-Dihydroxyvitamin D3 On The Biology Of Infiltrating Myeloid Cells
1405. Inflammation And Prostate Cancer: Friends Or Foe?
1406. Inflammation And Prostate Cancer: The Role Of Interleukin 6 (Il‐6)
1407. Inflammation And Prostate Cancer-Correlations Between The Degree Of Inflammation And The Gleason Score.
1408. Inflammation And Psychosocial Factors Mediate Exercise Effects On Sleep Quality In Breast Cancer Survivors: Pilot Randomized Controlled Trial
1409. Inflammation And Skin Cancer Mediated Through C-Fos/Ap-1
1410. Inflammation And The Development Of Pancreatic Cancer
1411. Inflammation And Tobacco-Specific Carcinogens In The Pathogenesis Of Lung Cancer.
1412. Inflammation And Urothelial Bladder Cancer. What We Need To Know?
1413. Inflammation As A Cancer Co-Initiator: New Mechanistic Model Predicts Low/Negligible Risk At Noninflammatory Carcinogen Doses
1414. Inflammation As A Target For Prostate Cancer Chemoprevention: Pathological And Laboratory Rationale
1415. Inflammation As A Target In Cancer Therapy
1416. Inflammation As A Target In Prostate Cancer
1417. Inflammation As A Tumor Promoter In Cancer Induction
1418. Inflammation As Target In Cancer Therapy
1419. Inflammation As The Primary Aetiological Agent Of Human Prostate Cancer: A Stem Cell Connection?
1420. Inflammation Associated Factors Induce Epithelial-Mesenchymal Transition In Breast Cancer Cells
1421. Inflammation At The Inception Of Cancer: Using Fish And Fly To Tell The Story
1422. Inflammation Based Regulation Of Cancer Cachexia
1423. Inflammation By The Intrapleural Administration Of Streptococcal Preparation (Ok‐432) On The Prognosis Of Completely Resected Non‐Small‐Cell Lung Cancer
1424. Inflammation Caused By Radiofrequency Ablation For Lung Cancer Is Worse After Radiotherapy And In Large Tumours
1425. Inflammation Decreases Keratin Level In Ulcerative Colitis; Inadequate Restoration Associates With Increased Risk Of Colitis-Associated Cancer
1426. Inflammation Detected By Bronchoscopy With Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration In Patients With Suspected Cancer Recurrence In The …
1427. Inflammation Driven By Tumour-Specific Th1 Cells Protects Against B-Cell Cancer
1428. Inflammation Enhanced Colon Cancer & Natural Anti-Cancer Plant Compounds
1429. Inflammation Factors And Element Supplementation In Cancer
1430. Inflammation Fires Up Cancer Metastasis
1431. Inflammation For Predicting Survival And Chemotherapeutic Outcomes And Monitoring Tumor Progression In Patients With Unresectable Metastatic Colorectal Cancer
1432. Inflammation Genes And Pain Severity In Lung Cancer Patients
1433. Inflammation Has A Role In Urethane‑Induced Lung Cancer In C57Bl/6J Mice
1434. Inflammation In Benign Prostate Tissue And Prostate Cancer In The Finasteride Arm Of The Prostate Cancer Prevention Trial
1435. Inflammation In Cancer And Depression: A Starring Role For The Kynurenine Pathway
1436. Inflammation In Cancer Cachexia: To Resolve Or Not To Resolve (Is That The Question?)
1437. Inflammation In Cancer: Part Of The Problem Or Part Of The Solution?
1438. Inflammation In Chronic Obstructive Pulmonary Disease And Its Role In Cardiovascular Disease And Lung Cancer
1439. Inflammation In Colorectal Cancer Inflammatory Bowel Disease, And Diabetes Mellitus: The Link
1440. Inflammation In Colorectal Cancer Risk: The Role Of Nutritional Determinants And Genetic Variation
1441. Inflammation In Gastric Adenocarcinoma Of The Cardia: How Do Ebv Infection, Her2 Amplification And Cancer Progression Influence Tumor-Infiltrating Lymphocytes?
1442. Inflammation In Gastric Cancer: Interplay Of The Cox‐2/Prostaglandin E2 And Toll‐Like Receptor/Myd88 Pathways
1443. Inflammation In Lung Carcinogenesis: New Targets For Lung Cancer Chemoprevention And Treatment
1444. Inflammation In Non-Small Cell Lung Cancer: Associations With Risk And Survival In Women
1445. Inflammation In Prostate Cancer Progression And Therapeutic Targeting
1446. Inflammation In Sporadic Colorectal Cancer.
1447. Inflammation In The Context Of Oral Cancer
1448. Inflammation In The Development Of Lung Cancer: Epidemiological Evidence
1449. Inflammation In The Etiology Of Prostate Cancer: An Epidemiologic Perspective
1450. Inflammation In The Molecular Pathogenesis Of Cancer And Atherosclerosis
1451. Inflammation Increases Notch1 Activity Via Mmp9 And Is Counteracted By Eicosapentaenoic Acid-Free Fatty Acid In Colon Cancer Cells
1452. Inflammation Index Predicts The Combined Clinical Outcome After Sequential Therapy With Abiraterone And Docetaxel For Metastatic Castration‐Resistant Prostate Cancer …
1453. Inflammation Index, Neutrophil‐To‐Lymphocyte Ratio, Platelet‐To‐Lymphocyte Ratio Can Predict Clinical Outcomes In Patients With Metastatic Non‐Small‐Cell Lung Cancer …
1454. Inflammation Induced By Mmp-9 Enhances Tumor Regression Of Experimental Breast Cancer
1455. Inflammation Initiates Cancer By Depleting Stem Cells
1456. Inflammation Intersection: Gp130 Balances Gut Irritation And Stomach Cancer
1457. Inflammation Is A Key Contributor To Ovarian Cancer Cell Seeding
1458. Inflammation Linking Emt And Cancer Stem Cells
1459. Inflammation Marker And Risk Of Pancreatic Cancer: A Nested Case–Control Study Within The Epic Cohort
1460. Inflammation Markers: New Actors In The Cancer Biomarker Tale
1461. Inflammation Mediated Metastasis: Immune Induced Epithelial-To-Mesenchymal Transition In Inflammatory Breast Cancer Cells
1462. Inflammation Mediates The Effect Of Discrimination, Religiosity, And Friendship Network On Expression Of The Tp53 Cancer Suppressor Gene
1463. Inflammation Meets Cancer, With Nf-Κb As The Matchmaker
1464. Inflammation Modifies The Association Of Obesity With Circulating 25‐Hydroxyvitamin D Levels In Cancer Survivors
1465. Inflammation Of Actinic Keratoses With Capecitabine Therapy For Colon Cancer
1466. Inflammation Of Mammary Adipose Tissue Occurs In Overweight And Obese Patients Exhibiting Early-Stage Breast Cancer
1467. Inflammation On Prostate Needle Biopsy Is Associated With Lower Prostate Cancer Risk: A Meta-Analysis
1468. Inflammation Polymorphisms And Prostate Cancer Risk In Jamaican Men: Role Of Obesity/Body Size
1469. Inflammation Promotes The Development Of Colitis-Associated Colorectal Cancer
1470. Inflammation Related Cancer-Highlights
1471. Inflammation Score As A Novel Prognostic Indicator For Patients Undergoing Video-Assisted Thoracoscopic Surgery Lobectomy For Non-Small-Cell Lung Cancer
1472. Inflammation To Cancer: The Molecular Biology In The Pancreas
1473. Inflammation Versus Adaptive Immunity In Cancer Pathogenesis
1474. Inflammation, A Double-Edge Sword For Cancer And Other Age-Related Diseases
1475. Inflammation, A Key Event In Cancer Development
1476. Inflammation, A Key Factor In Cancer Ambush
1477. Inflammation, Adenoma And Cancer: Objective Classification Of Colon Biopsy Specimens With Gene Expression Signature
1478. Inflammation, Ageing And Cancer
1479. Inflammation, Aging And Cancer: Friend Or Foe?
1480. Inflammation, Aging, And Cancer Vaccines
1481. Inflammation, Aging, And Cancer: Tumoricidal Versus Tumorigenesis Of Immunity
1482. Inflammation, Anti-Inflammatory Drug Use And Risk Of Ovarian Cancer
1483. Inflammation, Apoptosis, And Necrosis Induced By Neoadjuvant Fas Ligand Gene Therapy Improves Survival Of Dogs With Spontaneous Bone Cancer
1484. Inflammation, Apoptosis, And Necrosis Induced By Neoadjuvant Fas Ligand Gene Therapy Improves Survival Of Dogs With Spontaneous Bone Cancer (156.18)
1485. Inflammation, Atrophy, And Gastric Cancer
1486. Inflammation, Atrophy, Gastric Cancer: Connecting The Molecular Dots
1487. Inflammation, Autophagy, And Obesity: Common Features In The Pathogenesis Of Pancreatitis And Pancreatic Cancer
1488. Inflammation, Biomarkers And Immuno-Oncology Pathways In Pancreatic Cancer
1489. Inflammation, Biomarkers And Personalized Therapies In Pancreatic Cancer
1490. Inflammation, Cancer And Chemoresistance: Taking Advantage Of The Toll‐Like Receptor Signaling Pathway
1491. Inflammation, Cancer And Immunity–Implication Of Trpv1 Channel.
1492. Inflammation, Cancer And Oxidative Lipoxygenase Activity Are Intimately Linked
1493. Inflammation, Cancer, And Bone Loss
1494. Inflammation, Cancer, And Targets Of Ginseng
1495. Inflammation, Carcinogenesis And Cancer
1496. Inflammation, Cardiometabolic Markers, And Functional Changes In Men With Prostate Cancer
1497. Inflammation, Cardiovascular Disease And Cancer: Moving Toward Predictive Medicine
1498. Inflammation, Cardiovascular Disease, And Cancer: A Common Link With Far-Reaching Implications
1499. Inflammation, Chronic Disease, And Cancer: Is Psychological Distress The Common Thread?
1500. Inflammation, Cox-2 Inhibitors, And Cancer
1501. Inflammation, C-Reactive Protein, And Breast Health: Future Directions To Predict, Prevent, Personalize And Inspire Consumerism In The Mitigation Of Breast Cancer
1502. Inflammation, Dna Methylation And Colitis-Associated Cancer
1503. Inflammation, Dysregulated Metabolism And Aromatase In Obesity And Breast Cancer
1504. Inflammation, Focal Atrophic Lesions, And Prostatic Intraepithelial Neoplasia With Respect To Risk Of Lethal Prostate Cancer
1505. Inflammation, High Grade Prostatic Intraepithelial Neoplasia (Hgpin) And Prostate Cancer: Evidence For A Link At Spectroscopic Magnetic Resonance And Dynamic …
1506. Inflammation, Immunity, And Cancer
1507. Inflammation, Immunosuppressive Microenvironment And Breast Cancer: Opportunities For Cancer Prevention And Therapy
1508. Inflammation, Infection, Cancer And All That… The Role Of Paraoxonases
1509. Inflammation, Macrophage In Cancer Progression And Chinese Herbal Treatment
1510. Inflammation, Microbiota, And Prostate Cancer
1511. Inflammation, Microenvironment, And The Immune System In Cancer Progression
1512. Inflammation, Necrosis, And Cancer
1513. Inflammation, Obesity, And Colon Cancer
1514. Inflammation, Oxidative Stress, And Cancer: Dietary Approaches For Cancer Prevention
1515. Inflammation, Phagocytosis And Cancer: Another Step In The Cd47 Act
1516. Inflammation, Proliferation, And Repair In Thoracic Oncology: Targeted Therapy Of Lung Cancer: The Role Of Osteopontin For Cancer Evolution …
1517. Inflammation, Prostate Cancer And Negative Regulation Of Androgen Receptor Expression
1518. Inflammation, Prostatitis, Proliferative Inflammatory Atrophy:’Fertile Ground’For Prostate Cancer Development?
1519. Inflammation, Proteases And Cancer
1520. Inflammation, Proteases And Cancer.
1521. Inflammation, Reproduction, Cancer And All That…. The Regulation And Role Of The Inducible Prostaglandin Synthase
1522. Inflammation, Senescence And Cancer: Interweaving Microrna, Inflammatory Cytokines And P53 Networks
1523. Inflammation, Tumor Necrosis Factor And Wnt Promotion In Gastric Cancer Development
1524. Inflammation: A Common Contributor To Cancer, Aging, And Cardiovascular Diseases—Expanding The Concept Of Cardio-Oncology
1525. Inflammation: A Driving Force Speeds Cancer Metastasis
1526. Inflammation: A Hidden Path To Breaking The Spell Of Ovarian Cancer
1527. Inflammation: An Important Parameter In The Search Of Prostate Cancer Biomarkers
1528. Inflammation: Gearing The Journey To Cancer
1529. Inflammation: Its Role And Interplay In The Development Of Cancer, With Special Focus On Gynecological Malignancies
1530. Inflammation: Targeting Inflammatory Pathways To Treat Atherosclerosis And Cancer
1531. Inflammation: The Gut Takes A Toll On Liver Cancer
1532. Inflammation: What Role In Pediatric Cancer?
1533. Inflammation:’Immune Tsunami’Or Erosion Of Integrity In Immune-Privileged And Immune-Responsive Tissues And Acute And Chronic Inflammatory Diseases Or Cancer
1534. Inflammation‐And Angiogenesis‐Related Biomarkers Are Correlated With Cancer‐Related Fatigue In Colorectal Cancer Patients: Results From The Colocare Study
1535. Inflammation-And Cancer-Associated Neurolymphatic Remodeling And Cachexia In Pancreatic Ductal Adenocarcinoma
1536. Inflammation-And Cancer-Related Cytokine Production In Immunocompromised Hosts. Benefits And Risks
1537. Inflammation-Associated Cancer Development In Digestive Organs: Mechanisms And Roles For Genetic And Epigenetic Modulation
1538. Inflammation-Associated Cancer: Nf-Κb Is The Lynchpin
1539. Inflammation-Associated Cns Pathways To Fatigue In Breast Cancer Patients
1540. Inflammation-Associated Genes And Genetic Variations In Colorectal Cancer
1541. Inflammation-Associated Genomic Instability In Cancer
1542. Inflammation-Associated Immune Suppression In Cancer: The Roles Played By Cytokines, Chemokines And Additional Mediators
1543. Inflammation-Associated Microsatellite Alterations: Mechanisms And Significance In The Prognosis Of Patients With Colorectal Cancer
1544. Inflammation-Associated Regulation Of The Macrophage Inhibitory Cytokine (Mic-1) Gene In Prostate Cancer
1545. Inflammation-Based Factors And Prognosis In Patients With Colorectal Cancer
1546. Inflammation-Based Indexes And Clinicopathologic Features Are Strong Predictive Values Of Preoperative Circulating Tumor Cell Detection In Gastric Cancer Patients
1547. Inflammation-Based Markers Can Predict The Prognosis Of Geriatric Patients With Metastatic Colorectal Cancer Receiving First-Line Chemotherapy
1548. Inflammation-Based Prognostic Score As A Predictor Of Postoperative Gastric Cancer Recurrence
1549. Inflammation-Based Prognostic Score Predicts Postoperative Survival Of Patients With Interstitial Pneumonia After Undergoing Lung Cancer Resection
1550. Inflammation-Based Prognostic Score Predicts Survival In Patients With Advanced Gastric Cancer Receiving Biweekly Docetaxel And S-1 Combination Chemotherapy
1551. Inflammation-Based Prognostic Scores And Nutritional Prognostic Index In Patients With Locally-Advanced Unresectable Colorectal Cancer
1552. Inflammation-Based Prognostic Scores As Indicators To Select Candidates For Primary Site Resection Followed By Multimodal Therapy Among Colorectal Cancer Patients …
1553. Inflammation-Based Prognostic Scores To Predict Outcome In Patients With Cancer.
1554. Inflammation-Based Prognostic System Predicts Postoperative Survival Of Colorectal Cancer Patients With A Normal Preoperative Serum Level Of Carcinoembryonic …
1555. Inflammation-Based Prognostic System Predicts Survival After Surgery For Stage Iv Colorectal Cancer
1556. Inflammation-Based Score (Glasgow Prognostic Score) As An Independent Prognostic Factor In Colorectal Cancer Patients
1557. Inflammation-Based Scores: A New Method For Patient-Targeted Strategies And Improved Perioperative Outcome In Cancer Patients
1558. Inflammation-Based Scoring Is A Useful Prognostic Predictor Of Pulmonary Resection For Elderly Patients With Clinical Stage I Non-Small-Cell Lung Cancer
1559. Inflammation—Cancer Link Confirmed
1560. Inflammation‐Dependent Overexpression Of C‐Myc Enhances Crl4Dcaf4 E3 Ligase Activity And Promotes Ubiquitination Of St7 In Colitis‐Associated Cancer
1561. Inflammation‐Induced Activation Of The Indoleamine 2, 3‐Dioxygenase Pathway: Relevance To Cancer‐Related Fatigue
1562. Inflammation-Induced Cancer: Crosstalk Between Tumours, Immune Cells And Microorganisms
1563. Inflammation-Induced Colon Cancer In Upa-Deficient Mice Is Associated With A Deregulated Expression Of Notch Signaling Pathway Components
1564. Inflammation-Induced Dna Damage, Mutations And Cancer
1565. Inflammation-Induced Iga+ Cells Dismantle Anti-Liver Cancer Immunity
1566. Inflammation-Induced Oxidative Stress In Breast Cancer Patients
1567. Inflammation-Induced Oxidative Stress Mediates Gene Fusion Formation In Prostate Cancer
1568. Inflammation-Induced Radioresistance Is Mediated By Ros-Dependent Inactivation Of Protein Phosphatase 1 In Non-Small Cell Lung Cancer Cells
1569. Inflammation-Mediated Genetic And Epigenetic Alterations Drive Cancer Development In The Neighboring Epithelium Upon Stromal Abrogation Of Tgf-Β …
1570. Inflammation-Modulating Effect Of Butyrate In The Prevention Of Colon Cancer By Dietary Fiber
1571. Inflammation-Related Aberrant Patterns Of Dna Methylation: Detection And Role In Epigenetic Deregulation Of Cancer Cell Transcriptome
1572. Inflammation-Related Cancer
1573. Inflammation-Related Cancer Or Cancer-Related Inflammation
1574. Inflammation-Related Dna Damage And Cancer Stem Cell Markers In Nasopharyngeal Carcinoma
1575. Inflammation-Related Dna Damage In Relation To The Expression Of Cancer Stemness Markers In Human Nasopharyngeal Carcinoma
1576. Inflammation-Related Factors Predicting Prognosis Of Gastric Cancer
1577. Inflammation-Related Gene Variants As Risk Factors For Pancreatic Cancer
1578. Inflammation-Related Gene Variants As Risk Factors For Pancreatic Cancer And Predictors Of Overall Survival After Surgery
1579. Inflammation‐Related Genetic Variants Predict Toxicity Following Definitive Radiotherapy For Lung Cancer
1580. Inflammation‐Related Genetic Variations And Survival In Patients With Advanced Non–Small Cell Lung Cancer Receiving First‐Line Chemotherapy
1581. Inflammation-Related Scores Are More Effective Than Systemic Inflammation Ratios In Predicting Prognosis Of Patients With Unresectable Or Metastatic Pancreatic Cancer …
1582. Inflammation-Responsive Functional Ru Nanoparticles Combining A Tumor-Associated Macrophage Repolarization Strategy With Phototherapy For Colorectal Cancer …
1583. Inflammation‐Triggered Cancer Immunotherapy By Programmed Delivery Of Cpg And Anti‐Pd1 Antibody
1584. Inflammatory Bowel Disease And Cancer: The Role Of Inflammation, Immunosuppression, And Cancer Treatment
1585. Inflammatory Bowel Disease And Intestinal Cancer: A Paradigm Of The Yin–Yang Interplay Between Inflammation And Cancer
1586. Inflammatory Bowel Disease: A Model Of Chronic Inflammation-Induced Cancer
1587. Inflammatory Parameters And Inflammation Scores Are Associated With Poor Prognosis In Patients Undergoing Pulmonary Metastasectomy For Colorectal Cancer
1588. Inflammatory Potential Of Diet, Inflammation-Related Lifestyle Factors And Risk Of Pancreatic Cancer: Results From The Nih-Aarp Diet And Health Study
1589. Influence Of Anti-Infection Therapy On Changes Of Dendritic Cells In Rabbits With Buccal Vx2 Cancer Accompanied By Infectious Inflammation.
1590. Influence Of Urinary Tract Instrumentation And Inflammation On The Performance Of Urine Markers For The Detection Of Bladder Cancer
1591. Influencing Cox-2 Activity By Cox Related Pathways In Inflammation And Cancer
1592. Inherited Syndromes Predisposing To Inflammation And Gi Cancer
1593. Inhibition Of Angiogenesis-And Inflammation-Inducing Factors In Human Colon Cancer Cells In Vitro And In Ovo By Free And Nanoparticle-Encapsulated Redox Dye …
1594. Inhibition Of Bcl6B Promotes Gastric Cancer By Amplifying Inflammation In Mice
1595. Inhibition Of Mpges-1 As Therapeutic Strategy In Inflammation And Cancer
1596. Inhibition Of Nf-Κb In Cancer Cells Converts Inflammation-Induced Tumor Growth Mediated By Tnfα To Trail-Mediated Tumor Regression
1597. Inhibition Of Transcription Factors By Plant-Derived Compounds And Their Implications In Inflammation And Cancer
1598. Inhibitors Of Bruton’S Tyrosine Kinase (Btk) May Treat Inflammation, Immunological Disorders, And Cancer
1599. Inhibitory Properties Of Camel Whey Protein Hydrolysates Toward Liver Cancer Cells, Dipeptidyl Peptidase-Iv, And Inflammation
1600. Innate Immunity Gone Awry: Linking Microbial Infections To Chronic Inflammation And Cancer
1601. Innate Immunity, Inflammation And Colorectal Cancer
1602. Innate Inflammation And Cancer: Is It Time For Cancer Prevention?
1603. Innate Γδt17 Cells Convert Cancer-Elicited Inflammation Into Immunosuppression Through Myeloid-Derived Suppressor Cells
1604. Insight In Inflammation And Cancer
1605. Insights Into Lung Cancer Ii: Hydrogen-Supplemented Drinking Water Protects Against Naphthalene-Gefitinib Induced Lung Injury From Inflammation …
1606. Insights Into The Role Of Inflammation In Colitis-Associated Cancer: Targeting Tumor Necrosis Factor Receptors
1607. Insulin Resistance And Inflammation In Black Women With And Without Breast Cancer: Cause For Concern
1608. Insulin Resistance-Related Biomarker Clustering And Subclinical Inflammation As Predictors Of Cancer Mortality During 21.5 Years Of Follow-Up
1609. Integrated Molecular Epidemiology Of Colorectal Cancer: An Exploration Of Chronic Inflammation And The Gut Microbiome
1610. Integration Of Inflammation, Fibrosis, And Cancer Induced By Carbon Nanotubes
1611. Integrative Assessment Of Pretreatment Inflammation-, Nutrition-, And Muscle-Based Prognostic Markers In Patients With Muscle-Invasive Bladder Cancer Undergoing …
1612. Integrin-Type Extracellular Matrix Receptors In Cancer And Inflammation
1613. Interaction Between Hyaluronic Acid And Its Receptors (Cd44, Rhamm) Regulates The Activity Of Inflammation And Cancer
1614. Interaction Of Cigarette Smoking On The Association Between Genetic Polymorphisms Involved In Inflammation And The Risk Of Lung Cancer: A Case-Control Study …
1615. Interaction Of Dietary Fatty Acids With Tumour Necrosis Factor Family Cytokines During Colon Inflammation And Cancer
1616. Interaction Of Gonadal Status With Systemic Inflammation And Opioid Use In Determining Nutritional Status And Prognosis In Advanced Pancreatic Cancer
1617. Interaction Of Vascular Endothelial Cells With Leukocytes, Platelets And Cancer Cells In Inflammation, Thrombosis And Cancer Growth And Metastasis
1618. Interaction Of Vascular Endothelial Cells With Leukocytes, Platelets And Cancer Cells In Inflammation, Thrombosis And Cancer Growth And Metastasis.
1619. Interactions Between Hyaluronan And Its Receptors (Cd44, Rhamm) Regulate The Activities Of Inflammation And Cancer
1620. Interactions Of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand (Trail) With The Immune System: Implications For Inflammation And Cancer
1621. Interactions: Their Impact On Progression From Gastric Inflammation To Carcinogenesis And On Development Of New Approaches To Prevent And Treat Gastric Cancer
1622. Interconnection Between Dna Damage, Senescence, Inflammation, And Cancer
1623. Interface Between Thrombosis, Inflammation, And Angiogenesis In Cancer Progression
1624. Interleukin 32, Inflammation And Cancer
1625. Interleukin 33: An Innate Alarm For Adaptive Responses Beyond Th2 Immunity–Emerging Roles In Obesity, Intestinal Inflammation, And Cancer
1626. Interleukin 6 Downregulates P53 Expression And Activity By Stimulating Ribosome Biogenesis: A New Pathway Connecting Inflammation To Cancer
1627. Interleukin-32 In Infection, Inflammation And Cancer Biology
1628. Interleukin-6 And Its Receptor, Key Players In Hepatobiliary Inflammation And Cancer
1629. Interleukin‐6 Biology Is Coordinated By Membrane‐Bound And Soluble Receptors: Role In Inflammation And Cancer
1630. Interleukin-6 Is Required For The Promotion Of Lung Cancer By Copd-Like Airway Inflammation In Mice
1631. Interleukin‐6 Trans‐Signalling In Chronic Inflammation And Cancer
1632. Interleukins 1 And 6 As Main Mediators Of Inflammation And Cancer
1633. Interplay Between Dna Repair And Inflammation, And The Link To Cancer
1634. Interplay Between Heat Shock Proteins, Inflammation And Cancer: A Potential Cancer Therapeutic Target
1635. Interplay Between Inflammation And Epigenetic Changes In Cancer
1636. Interplay Between Inflammation And Stemness In Cancer Cells: The Role Of Toll-Like Receptor Signaling
1637. Interrelationship Of Depression, Stress And Inflammation In Cancer Patients: A Preliminary Study
1638. Intersecting Pathways In Inflammation And Cancer: Hepatocellular Carcinoma As A Paradigm
1639. Interstitial Fluid And Lymph Formation And Transport: Physiological Regulation And Roles In Inflammation And Cancer
1640. Intestinal And Skin Homeostasis: Targeting Inflammation And Cancer
1641. Intestinal Cancer: Linking Infection, Inflammation And Neoplasia
1642. Intestinal Inflammation And Cancer
1643. Intestinal Inflammation And Cancer Of The Gastrointestinal Tract
1644. Intestinal Inflammation And Colorectal Cancer: A Double-Edged Sword?
1645. Intestinal Inflammation And Colorectal Cancer: Magnitude Worldwide And Its Implications
1646. Intestinal Inflammation Targets Cancer-Inducing Activity Of The Microbiota
1647. Intestinal Microbiota, Chronic Inflammation, And Colorectal Cancer
1648. Intramural Inflammation Of The Colon Simulating Cancer
1649. Intraoperative Near-Infrared Imaging Can Distinguish Cancer From Normal Tissue But Not Inflammation
1650. Intraprostatic Chronic Inflammation Is Associated With A Reduced Risk Of Prostate Cancer In Patients Elected To A First Random Biopsy Set
1651. Intraprostatic Inflammation Is Positively Associated With Serum Psa In Men With Psa <4 Ng Ml−1, Normal Dre And Negative For Prostate Cancer
1652. Intratumoral Inflammation Is Associated With More Aggressive Prostate Cancer
1653. Intrinsic Mutagenic Properties Of 5-Chlorocytosine: A Mechanistic Connection Between Chronic Inflammation And Cancer
1654. Introduction For Inflammation And Cancer
1655. Introduction To Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, And Aging, Volume 6
1656. Introduction To Autophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, And Aging, Volume 7
1657. Introduction To Interrelated Biology Of Age-Associated Chronic Diseases And Cancer: Chronic Inflammation, A Common Denominator In Morbidity And Mortality
1658. Introduction To Mammalian Genome Special Issue: Inflammation And Immunity In Cancer
1659. Introduction To Tumor Microenvironment Regulation Of Cancer Cell Survival, Metastasis, Inflammation, And Immune Surveillance.
1660. Inverse Association Between Histologic Inflammation In Needle Biopsy Specimens And Prostate Cancer In Men With Serum Psa Of 10-50 Ng/Ml
1661. Inverse Association Of Prostatic Chronic Inflammation Among Prostate Cancer Tumor Grade Groups: Retrospective Study Of 738 Consecutive Cases Elected To A First …
1662. Investigating The Effects Of Chronic Low-Grade Inflammation On Cancer Immunotherapy
1663. Investigating Two Hallmarks Of Cancer–Genome Instability And Tumor Promoting Inflammation
1664. Investigation Of The Relationship Between Serum Hepcidin And Prohepcidin In Anemia Of Cancer (Aoc) Patients With The Anemia Of Inflammation (Ai)
1665. Invited Commentary: Circulating Inflammation Markers And Cancer Risk—Implications For Epidemiologic Studies
1666. Ionizing Radiation At The Proteome And Metabolome Levels In The Blood Of Cancer Patients Treated With Radiotherapy: The Influence Of Inflammation And Radiation Toxicity
1667. Iron (Iii)-Sodium-Edta, As Used For Food Fortification, Aggravates Intestinal Inflammation And Drives Tumorigenesis In Mouse Models Of Colitis-Associated Cancer
1668. Iron And Chronic Inflammation In Obese And Lean Men With Colon Cancer: The Link With Hepcidin
1669. Iron In Immunity: Cancer And Inflammation
1670. Iron, Inflammation And Invasion Of Cancer Cells
1671. Iron-Binding Proteins And C-Reactive Protein In Nipple Aspirate Fluids: Role Of Iron-Driven Inflammation In Breast Cancer Microenvironment?
1672. Irreversible And Sustained Upregulation Of Endothelin Axis During Oncogene-Associated Pancreatic Inflammation And Cancer
1673. Irw And Iqw Reduce Colitis-Associated Cancer Risk By Alleviating Dss-Induced Colonic Inflammation
1674. Is C-Reactive Protein An Inflammation Opsonin That Signals Colon Cancer Risk?
1675. Is Glutamine Deficiency The Link Between Inflammation, Malnutrition, And Fatigue In Cancer Patients?
1676. Is Histological Prostate Inflammation In An Initial Prostate Biopsy A Predictor Of Prostate Cancer On Repeat Biopsy?
1677. Is It Necessary To Cure Prostate Cancer When It Is Possible?(Understanding The Role Of Prostate Inflammation Resolution To Prostate Cancer Evolution)
1678. Is Nuclear Factor Kappa-B The Missing Link Between Inflammation, Cancer And Alteration In Hepatic Drug Metabolism In Patients With Cancer?
1679. Is Perioperative Systemic Inflammation The Result Of Insufficient Cortisol Production In Patients With Colorectal Cancer?
1680. Is Systemic Inflammation The Result Of Insufficient Cortisol Production In Patients With Colorectal Cancer?
1681. Is The Exhaled Breath Temperature In Lung Cancer Influenced By Airways Neoangiogenesis Or By Inflammation?
1682. Islet Inflammation: A Causal Link Between Diabetes And Pancreatic Cancer?
1683. Isolated Lymphoid Follicles In Colon: Switch Points Between Inflammation And Colorectal Cancer?
1684. Isolation Of Lung Cancer From Inflammation
1685. Iκb Kinase Ɛ (Ikkɛ): A Therapeutic Target In Inflammation And Cancer
1686. Jak-Stat-Mediated Chronic Inflammation Impairs Cytotoxic T Lymphocyte Activation To Decrease Anti-Pd-1 Immunotherapy Efficacy In Pancreatic Cancer
1687. Jnk1 Stress Signaling Is Hyper-Activated In High Breast Density And The Tumor Stroma: Connecting Fibrosis, Inflammation, And Stemness For Cancer Prevention
1688. Joint Effects Of Inflammation And Androgen Metabolism On Prostate Cancer Severity
1689. Joint Prognostic Effect Of Obesity And Chronic Systemic Inflammation In Patients With Metastatic Colorectal Cancer
1690. Kallikrein And Kinin Receptor Expression In Inflammation And Cancer
1691. Kca3. 1: Target And Marker For Cancer, Autoimmune Disorder And Vascular Inflammation?
1692. Key Role Of Damp In Inflammation, Cancer, And Tissue Repair
1693. Kiaa1199 Is Induced By Inflammation And Enhances Malignant Phenotype In Pancreatic Cancer
1694. Kinase Inhibitors For Treatment Of Cancer And Inflammation
1695. Klf4 Overexpression Activates Epithelial Cytokines And Inflammation-Mediated Esophageal Squamous Cell Cancer In Mice
1696. Know Your Enemy: Genetics, Aging, Exposomic And Inflammation In The War Against Triple Negative Breast Cancer
1697. L Oss Of Ffar 2 Promotes Colon Cancer By Epigenetic Dysregulation Of Inflammation Suppressors
1698. Label-Free Proteomics Revealed Oxidative Stress And Inflammation As Factors That Enhance Chemoresistance In Luminal Breast Cancer
1699. Lactate As A Regulator Of Cancer Inflammation And Immunity
1700. Lactate Dehydrogenase Inhibitors Can Reverse Inflammation Induced Changes In Colon Cancer Cells
1701. Lactobacillus Rhamnosus Induced Epithelial Cell Apoptosis, Ameliorates Inflammation And Prevents Colon Cancer Development In An Animal Model
1702. Laparoscopic Surgery For Colorectal Cancer Is Not Associated With An Increase In The Circulating Levels Of Several Inflammation-Related Factors
1703. Ldl Receptor–Related Protein-1: A Regulator Of Inflammation In Atherosclerosis, Cancer, And Injury To The Nervous System
1704. Leptin, Adipocytes And Breast Cancer: Focus On Inflammation And Anti-Tumor Immunity
1705. Leuconostoc Mesenteroides-Derived AntiCancer Pharmaceuticals Hinder Inflammation And Cell Survival In Colon Cancer Cells By Modulating Nf-Κb/Akt/Pten/Mapk …
1706. Leukocyte-Depleting Chemotherapy Does Not Alter Induced Sputum Markers Of Neutrophilic Inflammation In Copd Patients With Unresectable Non-Small Cell Lung Cancer
1707. Leukocytes, Inflammation, And Angiogenesis In Cancer: Fatal Attractions
1708. Leukotriene A4 Signaling, Inflammation, And Cancer
1709. Levels Of Mmp2, Mmp9 In Expressed Prostatic Secretions As A Discriminatory Marker Between Prostate Cancer And Inflammation
1710. Leydig Cell Dysfunction, Systemic Inflammation And Metabolic Syndrome In Long-Term Testicular Cancer Survivors
1711. Link Found Between Inflammation And Cancer
1712. Link Of Obesity And Gastrointestinal Cancer: Crossroad Of Inflammation And Oxidative Stress.
1713. Linking Anemia To Inflammation And Cancer: The Crucial Role Of Tnfα
1714. Linking Autophagy With Inflammation Through Irf1 Signaling In Er+ Breast Cancer
1715. Linking Colorectal Cancer Risk, Inflammation And Diet
1716. Linking Inflammation And Cancer: The Unexpected Syk World
1717. Linking Inflammation Reactions To Cancer: Novel Targets For Therapeutic Strategies
1718. Linking Inflammation To Tumorigenesis In A Mouse Model Of High Fat Diet-Enhanced Colon Cancer: Does Fat Type Matter?
1719. Linking Inflammation To Tumorigenesis In A Mouse Model Of High-Fat-Diet-Enhanced Colon Cancer
1720. Links Between Inflammation, Amygdala Reactivity, And Social Support In Breast Cancer Survivors
1721. Links Between Obesity, Inflammation And Breast Cancer
1722. Lipid Droplets In Inflammation And Cancer
1723. Lipid Raft-Mediated Regulation Of Hyaluronan–Cd44 Interactions In Inflammation And Cancer
1724. Lipidomes Of Lung Cancer And Tumour-Free Lung Tissues Reveal Distinct Molecular Signatures For Cancer Differentiation, Age, Inflammation, And Pulmonary …
1725. Lipocalin 2 Regulation And Its Complex Role In Inflammation And Cancer
1726. Lipolysis—Not Inflammation, Cell Death, Or Lipogenesis—Is Involved In Adipose Tissue Loss In Cancer Cachexia
1727. Lipopolysaccharide Enhances Mouse Lung Tumorigenesis: A Model For Inflammation-Driven Lung Cancer
1728. Lipopolysaccharide Induces Inflammation And Facilitates Lung Metastasis In A Breast Cancer Model Via The Prostaglandin E2-Ep2 Pathway
1729. Lipopolysaccharide-Induced Tumor Necrosis Factor-Α Factor Enhances Inflammation And Is Associated With Cancer
1730. Lipopolysaccharide-Pathway Proteins Are Associated With Gallbladder Cancer Among Adults In Shanghai, China With Mediation By Systemic Inflammation
1731. Liposomal Pravastatin Inhibits Tumor Growth By Targeting Cancer-Related Inflammation
1732. Liver Cancer: A Complex Interplay Between Inflammation And Immunity In Liver Cancer
1733. Liver Lipid Metabolism Disruption In Cancer Cachexia Is Aggravated By Cla Supplementation-Induced Inflammation
1734. Liver Transplantation: A Simple Inflammation Marker Predicts Liver Cancer Prognosis
1735. Local And Systemic Neutrophilic Inflammation In Patients With Lung Cancer And Chronic Obstructive Pulmonary Disease
1736. Long Term Consequences Of Acute Inflammation In Cancer Surgery
1737. Longitudinal Study Of Weight, Appetite, Performance Status, And Inflammation In Advanced Gastrointestinal Cancer
1738. Long-Term Exposure To Widespread Drinking Water Chemicals, Blood Inflammation Markers And Colorectal Cancer
1739. Long-Term Survival Of Psychiatric Disorder, Inflammation, Malnutrition, And Radiotherapy-Related Toxicity In Patients With Locally Advanced Head And Neck Cancer
1740. Loss Of Bcl-G, A Bcl-2 Family Member, Augments The Development Of Inflammation-Associated Colorectal Cancer
1741. Loss Of Nf-Κb1 Causes Gastric Cancer With Aberrant Inflammation And Expression Of Immune Checkpoint Regulators In A Stat-1-Dependent Manner
1742. Loss Of P120 Catenin And Links To Mitotic Alterations, Inflammation, And Skin Cancer
1743. Loss Of P53 Triggers Wnt-Dependent Systemic Inflammation To Drive Breast Cancer Metastasis
1744. Loss Of Tgf-Β Signaling And Pten Promotes Head And Neck Squamous Cell Carcinoma Through Cellular Senescence Evasion And Cancer-Related Inflammation
1745. Loss Of Tgfβ Signaling Promotes Colon Cancer Progression And Tumor-Associated Inflammation
1746. Low Cd38 Identifies Progenitor-Like Inflammation-Associated Luminal Cells That Can Initiate Human Prostate Cancer And Predict Poor Outcome
1747. Low Dose Radiation, Inflammation, Cancer And Chemoprevention
1748. Low Risk Of Gastrointestinal Cancer Among Patients With Celiac Disease, Inflammation, Or Latent Celiac Disease
1749. Low Vitamin D Status Is Associated With Inflammation In Patients With Prostate Cancer
1750. Low-Grade Dietary-Related Inflammation And Survival After Colorectal Cancer Surgery
1751. Low-Grade Inflammation And Exercise Training In Women With Breast Cancer: A Meta-Analysis With Meta-Regression.
1752. Low-Grade Inflammation, Immune Capacity, And Cancer
1753. Low-Grade Inflammation, Oxidative Stress And Risk Of Invasive Post-Menopausal Breast Cancer-A Nested Case-Control Study From The Malmö Diet And Cancer Cohort
1754. Low-Grade Inflammation, Oxidative Stress And Risk Of Invasive Post-Menopausal Breast Cancer-A Nested Case-Control Study From The Malmö Diet And Cancer …
1755. Lsc 2011 Abstract: Suppression Of Antitumor Immunity As A Potential Link Between Inflammation And Cancer In Copd
1756. Lung Cancer And Inflammation: Interaction Of Chemokines And Hnrnps
1757. Lung Cancer–Associated Pulmonary Hypertension: Role Of Microenvironmental Inflammation Based On Tumor Cell–Immune Cell Cross-Talk
1758. Lymphocyte Profile In The Balf From Affected Lung In Comparison To Healthy Lung And Systemic Inflammation In Lung Cancer
1759. Lymphocyte-To-C-Reactive Protein Ratio And Score Are Clinically Feasible Nutrition-Inflammation Markers Of Outcome In Patients With Gastric Cancer
1760. Lz-207, A Newly Synthesized Flavonoid, Induces Apoptosis And Suppresses Inflammation-Related Colon Cancer By Inhibiting The Nf-Κb Signaling Pathway
1761. Macrophage Depletion Decreases Inflammation And Tumorigenesis In The Aom/Dss Mouse Model Of Colon Cancer
1762. Macrophage Migration Inhibitory Factor: A Probable Link Between Inflammation And Cancer
1763. Macrophages And Associated Inflammation Differentially Impact Obesity, Colorectal Cancer And Obesity-Enhanced Colorectal Cancer
1764. Macrophages, Inflammation, And Lung Cancer
1765. Macrophages: A Link Between Cancer And Inflammation
1766. Major Mediators Linking Inflammation And Cancer
1767. Mammary Tissue Microenvironment Determines T Cell‐Dependent Breast Cancer‐Associated Inflammation
1768. Mango Polyphenols Reduce Inflammation In Mda-Mb231 Breast Cancer Cell And Targets Microrna-21
1769. Mannitou Monoclonal Antibody Uniquely Recognizes Paucimannose, A Marker For Human Cancer, Stemness, And Inflammation
1770. Mapk Signaling In Inflammation-Associated Cancer Development
1771. Mapping Inflammation And Cancer-Modifying Regions In Broccoli Genome
1772. Marine Natural Product Drug Discovery: Leads For Treatment Of Inflammation, Cancer, Infections, And Neurological Disorders
1773. Markers Of Inflammation And Incident Breast Cancer Risk In The Women’S Health Study
1774. Markers Of Inflammation And Risk Of Ovarian Cancer In Los Angeles County
1775. Markers Of Mitochondrial Metabolism In Tumor Hypoxia, Systemic Inflammation, And Adverse Outcome Of Rectal Cancer
1776. Markers Of Systemic Inflammation Predict Survival In Patients With Advanced Renal Cell Cancer
1777. Mast Cell Plasticity And Sphingosine-1-Phosphate In Immunity, Inflammation And Cancer
1778. Master Regulator Of Intestinal Disease: Il-6 In Chronic Inflammation And Cancer Development
1779. Mathematical Analysis Of The Cancitis Model And The Role Of Inflammation In Blood Cancer Progression
1780. Mathematical Modeling Of Cell Adhesion In Shear Flow: Application To Targeted Drug Delivery In Inflammation And Cancer Metastasis
1781. Mathematical Modelling As A Proof Of Concept For Mpns As A Human Inflammation Model For Cancer Development
1782. Matricellular Proteins At The Crossroad Of Inflammation And Cancer
1783. Matricellular Proteins: From Homeostasis To Inflammation, Cancer, And Metastasis
1784. Matrilysin (Matrix Metalloproteinase-7): A New Promising Drug Target In Cancer And Inflammation?
1785. Matrix Metalloproteinase And Cytokine Profiles From Cell Co-Cultures And Their Role In Oral Inflammation And Head And Neck Cancer
1786. Matrix Metalloproteinases In Gastric Inflammation And Cancer: Clinical Relevance And Prognostic Impact
1787. Mdm2 Beyond Cancer: Podoptosis, Development, Inflammation, And Tissue Regeneration.
1788. Mechanical Stress As The Common Denominator Between Chronic Inflammation, Cancer, And Alzheimer’S Disease
1789. Mechanism Of Action Of Flavonoids In Prevention Of Inflammation-Associated Skin Cancer
1790. Mechanisms By Which Inflammation May Increase Intestinal Cancer Risk In Inflammatory Bowel Disease
1791. Mechanisms Linking Pathogens-Associated Inflammation And Cancer
1792. Mechanisms Of Age-Related Inflammation And Cancer: The Synergistic Effect Of Oxidants And Calcium
1793. Mechanisms Of Disease: Chronic Inflammation And Cancer In The Pancreas—A Potential Role For Pancreatic Stellate Cells?
1794. Mechanisms Of Disease: Inflammation And The Origins Of Cancer
1795. Mechanisms Of Osteopontin-Mediated Effects On Chronic Hepatic Inflammation And Cancer
1796. Mechanisms Of Phytonutrient Modulation Of Cyclooxygenase-2 (Cox-2) And Inflammation Related To Cancer
1797. Mechanisms Of Virus Immune Evasion Lead To Development From Chronic Inflammation To Cancer Formation Associated With Human Papillomavirus Infection
1798. Mediators Of Inflammation: Inflammation In Cancer, Chronic Diseases, And Wound Healing
1799. Medical Qigong For Cancer Patients: Pilot Study Of Impact On Quality Of Life, Side Effects Of Treatment And Inflammation
1800. Meeting Report: 4Th Amsterdam Zoo Meeting:“Cell Adhesion And Migration In Inflammation And Cancer”
1801. Mesenchymal Stem Cell Treatment Of Inflammation-Induced Cancer
1802. Mesenchymal Stem Cells Recruited By Castration-Induced Inflammation Activation Accelerate Prostate Cancer Hormone Resistance Via Chemokine Ligand 5 …
1803. Metabolic And Dietary Acids Are The Fuel That Lights The Fuse That Ignites Inflammation That Leads To Cancer
1804. Metabolic Disorder, Inflammation, And Deregulated Molecular Pathways Converging In Pancreatic Cancer Development: Implications For New Therapeutic Strategies
1805. Metabolic Syndrome Is Not Associated With Greater Evidences Of Proliferative Inflammatory Atrophy And Inflammation In Patients With Suspected Prostate Cancer
1806. Metabolic Syndrome, Inflammation, And Cancer
1807. Metabolic Syndrome, Insulin Resistance, And Inflammation In Breast Cancer: Impact On Prognosis And Adjuvant Interventions
1808. Metabolism Of 2-Aminofluorene By Human Polymorphonuclear Leukocytes: More Evidence For The Association Between Inflammation And Cancer.
1809. Metabolism Of Sphingolipids In The Gut And Its Relation To Inflammation And Cancer Development
1810. Metabolite Profiling Of Marine Organisms: Modulation Of Er-Stress In Cancer And Inflammation
1811. Metabotropic Glutamate Receptor-1 Regulates Inflammation In Triple Negative Breast Cancer
1812. Meta-Regression Analysis Of The Effect Of Lifestyle Interventions On Mediators Of Inflammation In Postmenopausal Breast Cancer Women With Cardiovascular Risk …
1813. Metformin Promotes The Inhibitory Effect Of 5-Aminosalicylic Acid On Inflammation-Mediated Proliferation And Progression Of Colorectal Cancer Cell Lines
1814. Methylxanthines, Inflammation, And Cancer: Fundamental Mechanisms
1815. Micheliolide, A New Sesquiterpene Lactone That Inhibits Intestinal Inflammation And Colitis-Associated Cancer
1816. Micro Rna S Play A Central Role In Molecular Dysfunctions Linking Inflammation With Cancer
1817. Microalbuminuria, Decreased Fibrinolysis, And Inflammation As Early Signs Of Atherosclerosis In Long-Term Survivors Of Disseminated Testicular Cancer
1818. Microbes-Induced Emt At The Crossroad Of Inflammation And Cancer
1819. Microbial Deprivation, Inflammation And Cancer
1820. Microbial Genomic Analysis Reveals The Essential Role Of Inflammation In Bacteria-Induced Colorectal Cancer
1821. Microbial Induction Of Immunity, Inflammation, And Cancer
1822. Microbial Infection, Inflammation And Epithelial Ovarian Cancer
1823. Microbial Metabolites, Short‐Chain Fatty Acids, Restrain Tissue Bacterial Load, Chronic Inflammation, And Associated Cancer In The Colon Of Mice
1824. Microbiome, Inflammation And Cancer
1825. Microbiome, Inflammation And Colorectal Cancer
1826. Microbiota And Chronic Inflammation As Targets For Colorectal Cancer Prevention
1827. Microbiota, Inflammation And Colorectal Cancer
1828. Microbiota-Induced Activation Of Epithelial Il-6 Signaling Links Inflammasome-Driven Inflammation With Transmissible Cancer
1829. Microencapulated Rapamycin Prevents Carcinogen And Inflammation Driven Colon Cancer Through Immune Mechanisms
1830. Microenvironment And Cancer: Inflammation, Cytokines, Microrna And P53
1831. Microenvironment Proteinases, Proteinase-Activated Receptor Regulation, Cancer And Inflammation
1832. Micronome Revealed Mir-19A/B As Key Regulator Of Socs3 During Cancer Related Inflammation Of Oral Squamous Cell Carcinoma
1833. Microrna 301A Promotes Intestinal Inflammation And Colitis-Associated Cancer Development By Inhibiting Btg1
1834. Microrna Circuits Regulate The Cancer–Inflammation Link
1835. Microrna Expression Profiling Signatures To Separate Chronic Inflammation From Pancreatic Cancer. Preliminary Results
1836. Microrna May Link Inflammation And Cancer
1837. Microrna‑139‑5P Regulates Chronic Inflammation By Suppressing Nuclear Factor‑Κb Activity To Inhibit Cell Proliferation And Invasion In Colorectal Cancer
1838. Microrna‑144 Mediates Chronic Inflammation And Tumorigenesis In Colorectal Cancer Progression Via Regulating C‑X‑C Motif Chemokine Ligand 11
1839. Microrna-155 Broadly Orchestrates Inflammation-Induced Changes Of Microrna Expression In Breast Cancer
1840. Microrna-184 Acts As A Potential Diagnostic And Prognostic Marker In Epithelial Ovarian Cancer And Regulates Cell Proliferation, Apoptosis And Inflammation
1841. Microrna-26A/-26B-Cox-2-Mip-2 Loop Regulates Allergic Inflammation And Allergic Inflammation-Promoted Enhanced Tumorigenic And Metastatic Potential Of Cancer …
1842. Micrornas And Inflammation In Colorectal Cancer
1843. Micrornas And Inflammation In The Pathogenesis And Progression Of Colon Cancer
1844. Micrornas And Nonresolving Inflammation-Related Cancer
1845. Micro-Rnas In Inflammatory Diseases And As A Link Between Inflammation And Cancer
1846. Micrornas Linking Cancer And Inflammation: Focus On Liver Cancer
1847. Microsomal Prostaglandin E2 Synthase-1 As A New Macromolecular Drug Target In The Prevention Of Inflammation And Cancer
1848. Midkine In The Pathology Of Cancer, Neural Disease, And Inflammation
1849. Minireview: Obesity And Breast Cancer: A Tale Of Inflammation And Dysregulated Metabolism
1850. Mir-155: On The Crosstalk Between Inflammation And Cancer
1851. Mir‐223: Infection, Inflammation And Cancer
1852. Mir-302B Inhibits Cancer-Related Inflammation By Targeting Erbb4, Irf2 And Cxcr4 In Esophageal Cancer
1853. Mir-663, A Microrna Linked With Inflammation And Cancer That Is Under The Influence Of Resveratrol
1854. Mirna-223 At The Crossroads Of Inflammation And Cancer
1855. Mirnas Of The Immune System: Roles In Inflammation And Cancer
1856. Mirnas: Dynamic Regulators Of Immune Cell Functions In Inflammation And Cancer
1857. Mismatch Repair Protein Expression And Inflammation In Human Pancreatic Cancer
1858. Missing The Target: Matrix Metalloproteinase Antitargets In Inflammation And Cancer
1859. Mitochondria, Calcium, And Tumor Suppressor Fus1: At The Crossroad Of Cancer, Inflammation, And Autoimmunity
1860. Mitochondrial Dna Sensing By Sting Signaling Participates In Inflammation, Cancer And Beyond
1861. Mixed Hcc-Icc Liver Cancer Derives From Hepatic Progenitor Cells-A Lineage Tracing Investigation In Mouse Liver Inflammation Model.
1862. Mk2 Pathway Mediates Radiation-Induced Tumor Inflammation And Is A Poor Prognostic Factor In Head And Neck Cancer
1863. Modeling Framework Linking Inflammation And Cancer Using Evolutionary Principles: Description Of A Generative Hierarchy For The Hallmarks Of Cancer And Developing A …
1864. Modeling Hologenome Imbalances In Inflammation And Cancer
1865. Modeling Human Liver Cancer Heterogeneity: Virally Induced Transgenic Models And Mouse Genetic Models Of Chronic Liver Inflammation
1866. Modeling The Dichotomy Of The Immune Response To Cancer: Cytotoxic Effects And Tumor-Promoting Inflammation
1867. Modulating Inflammation For Cancer Therapy
1868. Modulation Of Annexin I And Cyclooxygenase-2 In Smokeless Tobacco-Induced Inflammation And Oral Cancer
1869. Modulation Of Cadmium Induced Apoptotic, Cancer And Inflammation Related Cytokines By Diallyl Disulfide In Rat Liver Cells
1870. Modulation Of Cell Signaling Pathways By Phyllanthus Amarus And Its Major Constituents: Potential Role In The Prevention And Treatment Of Inflammation And Cancer
1871. Modulation Of Lipid Rafts By Ω‐3 Fatty Acids In Inflammation And Cancer: Implications For Use Of Lipids During Nutrition Support
1872. Modulation Of The Ccr6-Ccl20 Axis: A Potential Therapeutic Target In Inflammation And Cancer
1873. Molecular Analysis Of A Multistep Lung Cancer Model Induced By Chronic Inflammation Reveals Epigenetic Regulation Of P16 And Activation Of The Dna Damage …
1874. Molecular Characterization Of Defcap: A Novel Apoptosis Protein Implicated In Cancer And Inflammation.
1875. Molecular Determinants Of Cancer-Related Inflammation
1876. Molecular Imaging Of Pulmonary Cancer And Inflammation
1877. Molecular Link Mechanisms Between Inflammation And Cancer
1878. Molecular Links Between Inflammation And Cancer
1879. Molecular Links Between Tumor Angiogenesis And Inflammation: Inflammatory Stimuli Of Macrophages And Cancer Cells As Targets For Therapeutic Strategy
1880. Molecular Mechanisms And Therapeutic Effects Of (−)-Epicatechin And Other Polyphenols In Cancer, Inflammation, Diabetes, And Neurodegeneration
1881. Molecular Mechanisms Linking Inflammation, Cancer And Chemoresistance
1882. Molecular Mechanisms Of Anti-Inflammation And Anti-Cancer By 6-(Methylsulfinyl) Hexyl Isothiocyanate
1883. Molecular Mechanisms Of Bioactive Compounds In Fruits And Vegetables That Inhibit Pancreatic Cancer And Their Relationship With Inflammation
1884. Molecular Mechanisms Of Hmgb1, A Key Mediator Of Inflammation, And Role In Diseases Such As Cancer And Diabetes Mellitus
1885. Molecular Mechanisms Of Inflammation-Induced Cancer: T-Cells As Targets For Prevention And Cure Of Helicobacter-Related Gastric Preneoplasia
1886. Molecular Mechanisms Of Inflammation-Induced Cancer: T-Cells As Targets For Prevention And Cure Of Heliobacter-Related Gastric Preneoplasia
1887. Molecular Mechanisms Of Intestinal Inflammation Leading To Colorectal Cancer
1888. Molecular Mechanisms Of Obesity, Inflammation And Cancer: The Use Of In Vitro Model Approaches For Targeted Prevention Strategies
1889. Molecular Pathogenesis In Alcoholic Liver Disease󰠏 Inflammation, Fibrosis, And Cancer
1890. Molecular Pathways And Targets In Cancer-Related Inflammation
1891. Molecular Pathways Linking Inflammation And Cancer
1892. Molecular Regulation Of Dendritic Cell Development And Function In Homeostasis, Inflammation, And Cancer
1893. Molecular Regulation Of Macrophages In Unleashing Cancer-Related Inflammation
1894. Molecular Signatures For Inflammation Vary Across Cancer Types And Correlate Significantly With Tumor Stage, Gender And Vital Status Of Patients
1895. Molecular Study Of The Hepatic Inflammation To Fibrosis To Cancer Axis
1896. Monitoring Of Tumor Promotion And Progression In A Mouse Model Of Inflammation-Induced Colon Cancer With Magnetic Resonance Colonography
1897. Month Resistance Training And Dried Plum Consumption Intervention On Strength, Body Composition, Blood Markers Of Bone Turnover, And Inflammation In Breast Cancer …
1898. More Than A Sidekick: The Il‐6 Family Cytokine Il‐11 Links Inflammation To Cancer
1899. Mouse Colitis Model. Relevance To Colitis-Associated Neoplasia In The Human: A Study Of Histopathology, B-Catenin And P53 Expression And The Role Of Inflammation
1900. Mouse Model Of Mutated In Colorectal Cancer Gene Deletion Reveals Novel Pathways In Inflammation And Cancer
1901. Mouse Models Of Inflammation And Obesity’S Role In Cancer
1902. Mouse Models Of Inflammatory Bowel Disease-Insights Into The Mechanisms Of Inflammation-Associated Colorectal Cancer
1903. Mp14-09 Geographic Disparities In Prevalence Of Baseline Prostate Inflammation And Prostate Cancer Risk
1904. Mp4-02 Inflammation In Benign Prostate Tissue And Prostate Cancer In The Finasteride Arm Of The Prostate Cancer Prevention …
1905. Mp99-06 High Fat Diet-Induced Inflammation Accelerates Tumor Progression In Mice Model For Prostate Cancer
1906. Mtorc1 Prevents Epithelial Damage During Inflammation And Inhibits Colitis-Associated Colorectal Cancer Development
1907. Muc1 In The Relationship Between Inflammation And Cancer In Ibd
1908. Mucosal Inflammation, Not Microbiome, Drives The Development Colorectal Cancer During Colitis-Associated Microbial Dysbiosis
1909. Mucus And Adiponectin Deficiency: Role In Chronic Inflammation-Induced Colon Cancer
1910. Multifaceted Link Between Cancer And Inflammation
1911. Multifaceted Modulation Of Sirt1 In Cancer And Inflammation
1912. Multifaceted Role Of Parp-1 In Dna Repair And Inflammation: Pathological And Therapeutic Implications In Cancer And Non-Cancer Diseases
1913. Multifaceted Roles Of Pge2 In Inflammation And Cancer
1914. Multifunctional Proteins Bridge Mitosis With Motility And Cancer With Inflammation And Arthritis
1915. Multi‑Layered Prevention And Treatment Of Chronic Inflammation, Organ Fibrosis And Cancer Associated With Canonical Wnt/Β‑Catenin Signaling Activation
1916. Multistage Analysis Of Variants In The Inflammation Pathway And Lung Cancer Risk In Smokers
1917. Muscle Wasting, Visceral And Subcutaneous Adiposity, Inflammation, Nutritional Deficiencies, And Metastatic Esophageal Cancer (Mec) Prognosis.
1918. Mutant P53 Prolongs Nf-Κb Activation And Promotes Chronic Inflammation And Inflammation-Associated Colorectal Cancer
1919. Mutator Activity Induced By Microrna-155 (Mir-155) Links Inflammation And Cancer
1920. Mycoplasma Genitalium Infection And Chronic Inflammation In Human Prostate Cancer: Detection Using Prostatectomy And Needle Biopsy Specimens
1921. Myd88 In Hematopoietic Cells, But Not In Cerebrovascular Endothelial Cells Or Neural Cells, Is Critical For Inflammation-And Cancer-Induced Loss Of Appetite
1922. Myd88 Regulates Lps-Induced Nf-ĸb/Mapk Cytokines And Promotes Inflammation And Malignancy In Colorectal Cancer Cells
1923. Myeloid Cells In Cancer-Related Inflammation
1924. Myeloid-Derived Suppressor Cells (Mdsc) And Correlation To Poor Prognosis, Th2-Polarization, Inflammation, And Nutritional Damages In Patients With Gastric Cancer.
1925. Myeloid-Derived Suppressor Cells Link Inflammation To Cancer
1926. Myeloid-Derived Suppressor Cells: Linking Inflammation And Cancer
1927. Myeloid-Specific Glut1 Ablation Attenuates Mammary Gland Inflammation And Claudin-Low Breast Cancer Progression
1928. Myocyte Enhancer Factor 2D Provides A Cross-Talk Between Chronic Inflammation And Lung Cancer
1929. Myo-Inositol Reduces Pro-Tumoral Il6 Inflammation In A Mouse Model Of Lung Cancer Chemoprevention
1930. Myosteatosis In A Systemic Inflammation‐Dependent Manner Predicts Favorable Survival Outcomes In Locally Advanced Esophageal Cancer
1931. N-6 Linoleic Acid Induces Epigenetics Alterations Associated With Colonic Inflammation And Cancer
1932. Nano-Biocaptures For Research And Diagnostics In Inflammation Diseases And Cancer
1933. Nanoemulsions For Pharmaceutical And Nutraceutical Delivery In Cancer And Inflammation
1934. Nanoparticles Targeting Macrophages As Potential Clinical Therapeutic Agents Against Cancer And Inflammation
1935. Natural And Synthetic Agents Targeting Inflammation And Angiogenesis For Chemoprevention Of Prostate Cancer
1936. Natural Antibodies, Intravenous Immunoglobulin And Their Role In Autoimmunity, Cancer And Inflammation
1937. Natural Compounds Against Cancer, Inflammation, And Oxidative Stress
1938. Natural Heat Shock Protein 90 Inhibitors In Cancer And Inflammation
1939. Natural Killer Cell Memory In Infection, Inflammation And Cancer
1940. Natural Killer T Cells In Liver Injury, Inflammation And Cancer
1941. Natural Products Targeting Clinically Relevant Enzymes Of Eicosanoid Biosynthesis Implicated In Inflammation And Cancer
1942. Natural Variation Of Macrophage Activation As Disease-Relevant Phenotype Predictive Of Inflammation And Cancer Survival
1943. Negative Regulation Of Inflammation: Implications For Inflammatory Bowel Disease And Colitis Associated Cancer
1944. Negative Regulation Of Innate Lymphoid Cell Responses In Inflammation And Cancer
1945. Nemosis, A Novel Way Of Fibroblast Activation, In Inflammation And Cancer
1946. Network Comparison Of Inflammation In Colorectal Cancer And Alzheimer’S Disease
1947. Network Of Mediators For Vascular Inflammation And Leakage Is Dysbalanced During Cytoreductive Surgery For Late-Stage Ovarian Cancer
1948. Neural Regulation Of Cancer: From Mechanobiology To Inflammation
1949. Neural Regulation Of Hematopoiesis, Inflammation, And Cancer
1950. Neuroblastoma-Related Inflammation: May Small Doses Of Aspirin Be Suitable For Small Cancer Patients?
1951. Neuroimmune Semaphorin 4A In Cancer Angiogenesis And Inflammation
1952. Neuroimmune Semaphorin 4A In Cancer Angiogenesis And Inflammation: A Promoter Or A Suppressor?
1953. Neurotransmitter Signaling, Longevity, And Inflammation Pathways In 366 Breast Cancer (Bc) Patients And 366 Age-Matched Cancer-Free Controls: A …
1954. Neutralizing Tumor-Promoting Inflammation With Polypeptide-Dexamethasone Conjugate For Microenvironment Modulation And Colorectal Cancer Therapy
1955. Neutrophil Extracellular Traps Produced During Inflammation Awaken Dormant Cancer Cells In Mice
1956. Neutrophil Lymphocyte Ratio (Nlr) In Patients With Lung Cancer-An Index Of Cancer Related Systemic Inflammation
1957. New Concepts In Phospholipase D Signaling In Inflammation And Cancer
1958. New Insights From Animal Models Of Colon Cancer: Inflammation Control As A New Facet On The Tumor Suppressor Apc Gem
1959. New Insights Of Lxr Signalling In Inhibition Of Cancer Proliferation And Inflammation
1960. New Insights On Cox-2 In Chronic Inflammation Driving Breast Cancer Growth And Metastasis
1961. New Paradigms In Chronic Intestinal Inflammation And Colon Cancer: Role Of Melatonin
1962. New Perspectives In Cancer: Modulation Of Lipid Metabolism And Inflammation Resolution
1963. Nf-[Kappa] B: A Network Hub Controlling Immunity, Inflammation, And Cancer: A Subject Collection From Cold Spring Harbor Perspectives In Biology
1964. Nfat Gene Family In Inflammation And Cancer
1965. Nf-Kappab: Key Mediator Of Inflammation-Associated Cancer
1966. Nf-Kb Is The Essential Regulator Of Lung Cancer Promotion By Copd-Like Airway Inflammation In Mice
1967. Nfkb1: A Suppressor Of Inflammation, Ageing And Cancer
1968. Nf-Κb Activation In Response To Toxical And Therapeutical Agents: Role In Inflammation And Cancer Treatment
1969. Nf-Κb Activation: A Molecular Link Between Chronic Inflammation And Cancer
1970. Nf-Κb And Stat3 Signaling Pathways Collaboratively Link Inflammation To Cancer
1971. Nf-Κb And Stat3–Key Players In Liver Inflammation And Cancer
1972. Nf‐Κb And The Link Between Inflammation And Cancer
1973. Nf-Κb As A Critical Link Between Inflammation And Cancer
1974. Nf-Κb Functions As A Tumour Promoter In Inflammation-Associated Cancer
1975. Nf-Κb Signaling Pathway, Inflammation And Colorectal Cancer
1976. Nf-Κb, Inflammation, Immunity And Cancer: Coming Of Age
1977. Nf-Κb: Linking Inflammation And Immunity To Cancer Development And Progression
1978. Nicotinamide Phosphoribosyl Transferase (Nampt) Inhibitors: Novel Modulators Of Cancer-Related Inflammation
1979. Nitric Oxide And Oxygen Radicals In Infection, Inflammation, And Cancer
1980. Nitric Oxide And P53 In Cancer‐Prone Chronic Inflammation And Oxyradical Overload Disease
1981. Nitric Oxide And Redox Inflammation In Cancer
1982. Nitric Oxide As A Target Of Complementary And Alternative Medicines To Prevent And Treat Inflammation And Cancer
1983. Nivolumab Enhances The Inflammation Of The Irradiation Field In Advanced Non–Small Cell Lung Cancer
1984. Nlrp3 Inflammasome Activation Inhibitors In Inflammation-Associated Cancer Immunotherapy: An Update On The Recent Patents
1985. Nlrp3 Inflammasome In Fibroblasts Links Tissue Damage With Inflammation In Breast Cancer Progression And Metastasis
1986. Nlrp3 Inflammasome: A New Player In Immunometabolism Linking Obesity-Associated Low-Grade Chronic Inflammation And Colorectal Cancer Development
1987. Nlrp3 Inflammasome: A Possible Link Between Obesity-Associated Low-Grade Chronic Inflammation And Colorectal Cancer Development
1988. Nlrp3 Promotes Inflammation‐Induced Skin Cancer But Is Dispensable For Asbestos‐Induced Mesothelioma
1989. No Association Between Genetic Variants In Angiogenesis And Inflammation Pathway Genes And Breast Cancer Survival Among Chinese Women
1990. No Inflammation? No Cancer! Clear Hbv Early And Live Happily
1991. Nod‐Like Receptors In Intestinal Homeostasis, Inflammation, And Cancer
1992. Nod-Like Receptors In The Development Of Intestinal Inflammation And Cancer
1993. Nod-Like Receptors: Master Regulators Of Inflammation And Cancer
1994. Nomogram Based On Systemic Immune-Inflammation Index To Predict Overall Survival In Gastric Cancer Patients
1995. Non-Coding Rnas As Regulators Of Lymphangiogenesis In Lymphatic Development, Inflammation And Cancer Metastasis
1996. Noncoding Rnas In Inflammation And Colorectal Cancer
1997. Non-Extractable Polyphenols From Cranberries: Potential Anti-Inflammation And Anti-Colon-Cancer Agents
1998. Noninvasive Detection Of Inflammation-Associated Colon Cancer In A Mouse Model
1999. Noninvasive Imaging And Expression Profile Of Matrix Metalloproteinases In Inflammation-Induced Colon Cancer
2000. Non-Psychotropic Phytocannabinoids In Intestinal Inflammation And Colon Cancer
2001. Non-Resolving Inflammation And Cancer
2002. Nonsteroidal Anti-Inflammation Drug Ns398 Regulates The Expression Of The Reck Gene In The Prostate Cancer Cell Line
2003. Non-Steroidal Anti-Inflammatory Drugs, Chronic Inflammation And Colorectal Cancer Risk
2004. Non-Viral Causes Of Liver Cancer: Does Obesity Led Inflammation Play A Role?
2005. Normocytic Anaemia Is Associated With Systemic Inflammation And Poorer Survival In Patients With Colorectal Cancer Treated With Curative Intent
2006. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties And Cxcl8 Expression In Triple-Negative Breast Cancer
2007. Novel Cr (Iii), Fe (Iii) And Ru (Iii) Vanillin Based Metallo‐Pharmaceuticals For Cancer And Inflammation Treatment: Experimental And Theoretical Studies
2008. Novel Dual-Targeting Anti-Proliferative Dihydrotriazine-Chalcone Derivatives Display Suppression Of Cancer Cell Invasion And Inflammation By Inhibiting The Nf-Κb …
2009. Novel Matrix Metalloproteinases In Intestinal Inflammation And In Cancer Of The Gastrointestinal Tract
2010. Novel Natural Product Therapeutics Targeting Both Inflammation And Cancer
2011. Novel Patents Targeting Interleukin-17A; Implications In Cancer And Inflammation
2012. Novel Rodent Model Of Breast Cancer Survival With Persistent Anxiety-Like Behavior And Inflammation
2013. Novel Roles Of Peroxiredoxins In Inflammation, Cancer And Innate Immunity
2014. Novel Systemic Inflammation Response Index To Predict Prognosis After Thoracoscopic Lung Cancer Surgery: A Propensity Score‐Matching Study
2015. Novel Therapeutic Agents Targeting The Glucocorticoid Receptor For Inflammation And Cancer.
2016. Npr-A: A Therapeutic Target In Inflammation And Cancer
2017. Nuclear Factor-Kappab Provides Mechanistic Link Between Inflammation And Prostate Cancer (93.8)
2018. Nuclear Factor‐Κb And The Hepatic Inflammation‐Fibrosis‐Cancer Axis
2019. Nuclear Receptors Agonists Exert Opposing Effects On The Inflammation Dependent Survival Of Breast Cancer Stem Cells
2020. Nuclear Receptors And Coregulators In Inflammation And Cancer
2021. Nutrition, Inflammation And Cancer
2022. Nutritional Status, Systemic Inflammation And Prognosis Of Patients With Gastrointestinal Cancer
2023. O017 Tlr2 Promotes Tumorigenesis Independent Of Inflammation In Stat3-Driven Gastric Cancer
2024. O-038 Loss Of Intestinal Mucin-Type O-Glycans Promotes Inflammation-Associated Colon Cancer In An Inflammasome-Dependent Manner
2025. O-205 Obesity And Breast Cancer: Role Of Inflammation And Dysregulated Metabolism?
2026. Obesity And Breast Cancer: Adipose Tissue, Adipocytokines, Chronic Inflammation, And Hypoxia
2027. Obesity And Breast Cancer: Role Of Inflammation And Aromatase
2028. Obesity And Cancer Mechanisms: Tumor Microenvironment And Inflammation
2029. Obesity And Cancer: Inflammation And Molecular Pathogenesis
2030. Obesity And Cancer: Inflammation Bridges The Two
2031. Obesity And Cancer: The Role Of Adipose Tissue And Adipo-Cytokines-Induced Chronic Inflammation
2032. Obesity And Inflammation: New Insights Into Breast Cancer Development And Progression
2033. Obesity And Obese-Related Chronic Low-Grade Inflammation In Promotion Of Colorectal Cancer Development
2034. Obesity And Resistance To Cancer Chemotherapy: Interacting Roles Of Inflammation And Metabolic Dysregulation
2035. Obesity Associated Inflammation As A Risk Factor To Cancer Development: Clinical Implications (P3113)
2036. Obesity, Inflammation And Cancer
2037. Obesity, Inflammation, And Breast Cancer
2038. Obesity, Inflammation, And Cancer
2039. Obesity, Inflammation, And Liver Cancer
2040. Obesity, Inflammation, And Postmenopausal Breast Cancer: Therapeutic Implications
2041. Obesity, Inflammation, And Prostate Cancer
2042. Obesity, Thrombotic Risk, And Inflammation In Cancer
2043. Obesity-Associated Inflammation Promotes Angiogenesis And Breast Cancer Via Angiopoietin-Like 4
2044. Obesity-Driven Inflammation And Cancer Risk: Role Of Myeloid Derived Suppressor Cells And Alternately Activated Macrophages
2045. Obesity-Driven Inflammation And Colorectal Cancer
2046. Obesity-Induced Inflammation In Human Mammary Tissues: A Microenvironment Favorable For The Development Of Postmenopausal Breast Cancer
2047. Obstruction, Perforation, Inflammation, And Haemorrhage In Urological Cancer
2048. Of A Legume-Enriched, Low-Glycemic Index Diet Is Associated With Biomarkers Of Insulin Resistance And Inflammation Among Men At Risk For Colorectal Cancer
2049. Of A Platelet Activating Factor Receptor Agonist Suppresses Phorbol Ester-Induced Acute And Chronic Inflammation And Has Cancer Chemopreventive Activity In …
2050. Of An Inflammation‐Based Prognostic Score (Gps) With Performance Status (Ecog‐Ps) In Patients Receiving Palliative Chemotherapy For Gastroesophageal Cancer
2051. Of An Inflammation-Based Prognostic Score For The Identification Of Patients Requiring Postoperative Adjuvant Chemotherapy For Stage Ii Colorectal Cancer
2052. Of Copd On Inflammation, Lymphoid Functions And Progression-Free Survival During First-Line Chemotherapy In Advanced Non-Small Cell Lung Cancer
2053. Of C-Reactive Protein/Albumin Ratio In Predicting Overall Survival Of Chinese Cervical Cancer Patients Overall Survival: Comparison Among Various Inflammation …
2054. Of Cxcl8 (− 251) Are Associated With The Susceptibility Of Helicobacter Pylori Infection Increased The Risk Of Inflammation And Gastric Cancer In Thai Gastroduodenal …
2055. Of Dietary Antioxidant Intake, Antioxidant Serum Capacity, Physical Activity And Inflammation In Breast Cancer Survivors And Individuals Without A History Of Cancer.
2056. Of Dysregulated Inflammation, Proliferation, And Repair In Thoracic Oncology: Myo-Inositol Reduces Pro-Tumoral Il6 Inflammation In A Mouse …
2057. Of Essential Oil From Selected Medicinal Plants Against Microbes, Inflammation, Oxidative Stress And Lung Cancer
2058. Of Hydrogen Sulfide-Induced Angiogenesis And Inflammation In Vascular Endothelial Cells: Potential Mechanisms Of Gastric Cancer Prevention By Korean Red …
2059. Of Inflammation‐Associated Dihydrodiol Dehydrogenases (Akr1C1 And Akr1C2) Overexpression And Drug Resistance In Nonsmall Cell Lung Cancer Cells By Wogonin …
2060. Of Inflammation-Related Genes As Predictive Risk Factors Of Radiation Pneumonitis After Stereotactic Body Radiation Therapy For Stage I Non-Small Cell Lung Cancer
2061. Of Mini Nutritional Assessment (Mna) In Metastatic Lung Cancer Patients: Correlation Of Laboratory Values Indicating Malnutrition, Inflammation, And Cachexia With …
2062. Of Neurotoxic Symptoms As A Result Of Breast Cancer And Its Treatment: Considerations On The Contribution Of Stress, Inflammation, And Cellular Bioenergetics
2063. Of Neutrophil-Lymphocyte Ratio (Nlr), Platelet-Lymphocyte Ratio (Plr), Lymphocyte-Monocyte Ratio (Lmr) And Advanced Lung Cancer Inflammation Index (Ali) At …
2064. Of Nfκb Inhibitors To Block Inflammation And Induce Sensitisation To Fasl-Induced Apoptosis In Hnscc Cell Lines Is Critical For Their Use As A Prospective Cancer …
2065. Of Oxidative Stress And Inflammation In Ascites And Plasma In Patients With Platinum-Sensitive, Platinum-Resistant, And Platinum-Refractory Epithelial Ovarian Cancer
2066. Of Polymorphonuclear Leukocytes, Mononuclear Leukocytes And Cervical Epithelial Cancer Cells For Improved Spectroscopic Discrimination Of Inflammation From …
2067. Of Preoperative Systemic Inflammation Score In Short-Term And Long-Term Outcomes Of Patients With Pathological T2–4 Gastric Cancer After Radical Gastrectomy
2068. Of Prostate Cancer Gene 3 Score, Prostate Health Index And Percentage Free Prostate-Specific Antigen For Differentiating Histological Inflammation From Prostate Cancer …
2069. Of Radiation Response: Upregulation Of Inflammation-Related Factors And Downregulation Of Apolipoproteins And Coagulation Factors In Cancer Patients Treated With …
2070. Of Selected Markers Of Local And Systemic Inflammation In Patients With Community-Acquired Pneumonia And Pneumonia Co-Existing With Lung Cancer
2071. Of Serum High Mobility Group Box 1 By Liquid Chromatography/High-Resolution Mass Spectrometry: Implications For Its Role In Immunity, Inflammation, And Cancer
2072. Of The Colon Cancer Cell Phenotype By Pro-Inflammatory Macrophages: A Preclinical Model Of Surgery-Associated Inflammation And Tumor Recurrence
2073. Of The Prognostic Value Of Inflammation-Based Pathologic And Biochemical Criteria In Patients Undergoing Potentially Curative Resection For Colorectal Cancer
2074. Of Tumor Necrosis Factor-Α And Interleukin-6 In Regulating Bone Cancer Pain Via Trpa1 Signal Pathway And Beneficial Effects Of Inhibition Of Neuro-Inflammation …
2075. Of Tumour Suppressor P53 And Phase-Ii Antioxidant Enzymes Via Activation Of Nrf2 Signalling And Modulation Of Inflammation In Prevention Of Cancer
2076. Oldhamianoside Inhibits The Growth Of Ovarian Cancer Both In Vitro And In Vivo Via Adjusting Inflammation And Angiogenesis Signals
2077. Olfactomedin 4 Expression And Functions In Innate Immunity, Inflammation, And Cancer
2078. On The Lymphatic System Of The Abdomen In Relation To The Extension Of Inflammation, Tuberculosis, And Cancer
2079. On The Missing Link Between Inflammation And Cancer
2080. On The Relative Local Influence Of Coexisting Tuberculous Inflammation And Cancer In The Lung
2081. Oncology: Prostate/Testis/Penis/Urethra Inflammation On Prostate Needle Biopsy Is Associated With Lower Prostate Cancer Risk: A Meta-Analysis
2082. Optical Imaging Of Cancer And Inflammation In A Mouse Model Of Colorectal Cancer
2083. Optical Imaging Of Mmp Expression And Cancer Progression In An Inflammation‐Induced Colon Cancer Model
2084. Oral Administration Of Glucose Solution Combined With Postoperative Probiotics On Inflammation And Intestinal Barrier Function In Patients After Colorectal Cancer …
2085. Oral Lichen Planus Is A Unique Disease Model For Studying Chronic Inflammation And Oral Cancer
2086. Oral Rapamycin (Erapa) Prevents Carcinogen And Inflammation-Induced Dermal Cancer Through Immune And Dna Damage Mechanisms
2087. Oral Rapamycin (Erapa) Requires Ifn-Γ And Promotes Γδ T Cell Cytotoxicity To Prevent Carcinogen And Inflammation-Induced Dermal Cancer (Tum9P. 1003)
2088. Organoids Provide An Important Window On Inflammation In Cancer
2089. Origination Of Gastric Cancer Related With Bone Marrow Stem Cells And Chronic Inflammation
2090. Osteopontin As A Link Between Inflammation And Cancer: The Thorax In The Spotlight
2091. Otulin Protects The Liver Against Cell Death, Inflammation, Fibrosis, And Cancer
2092. Ovarian Cancer And Inflammation. Part 1. Pro-Inflammatory Cytokines
2093. Ovarian Cancer And Inflammation. Part 2. Anti-Inflammatory Cytokines
2094. Ovarian Cancer Stem Cells And Inflammation
2095. Ovarian Cancer, Inflammation, And Ca-125
2096. Ovarian Cancer, The Coagulation Pathway, And Inflammation
2097. Overall And Cancer Related Mortality Among Patients With Ocular Inflammation Treated With Immunosuppressive Drugs: Retrospective Cohort Study
2098. Overcoming Therapeutic Resistance By Targeting Cancer Inflammation
2099. Overexpression In Chronic Inflammation Associated With Benign Prostatic Hyperplasia: Is It Related To Apoptosis And Angiogenesis Of Prostate Cancer?
2100. Overexpression Of Cd44 Variant 9: A Novel Cancer Stem Cell Marker In Human Cholangiocarcinoma In Relation To Inflammation
2101. Overexpression Of Interleukin-1Β Induces Gastric Inflammation And Cancer And Mobilizes Myeloid-Derived Suppressor Cells In Mice
2102. Overview Of Animal Models Of Cancer, Neurodegenerative Disease And Inflammation
2103. Oxidants And Redox Signaling: Perspectives In Cancer Therapy, Inflammation, And Plasma Medicine
2104. Oxidative Metabolism Drives Inflammation-Induced Platinum Resistance In Human Ovarian Cancer
2105. Oxidative Stress And Inflammation Contribute To Lung Toxicity After A Common Breast Cancer Chemotherapy Regimen
2106. Oxidative Stress And Inflammation In The Normal Airways And Blood Of Patients With Lung Cancer And Copd
2107. Oxidative Stress In Oral Cavity: Interplay Between Reactive Oxygen Species And Antioxidants In Health, Inflammation, And Cancer
2108. Oxidative Stress, Inflammation, And Cancer: How Are They Linked?
2109. Oxytocin In The Tumor Microenvironment Is Associated With Lower Inflammation And Longer Survival In Advanced Epithelial Ovarian Cancer Patients
2110. P0025 Comparison Of The Prognostic Value Of Preoperative Inflammation-Based Scores And Tnm Stage In Patients With Gastric Cancer
2111. P-065 Prognostic Value Of Carbohydrate Tumor Markers And Inflammation-Based Markers In Gastric Cancer
2112. P071 Cancer Preventive Effect Of Recombinant Trail By Ablation Of Oncogenic Inflammation In Colitis-Associated Cancer Rather Than AntiCancer Effect
2113. P08: Effects Of Inflammation-Related Cytokine Gene Polymorphisms On Gastric Cancer Risk Among Atomic Bomb Survivors
2114. P1. 04-010 Neutrophil To Lymphocyte, Platelet To Lymphocyte Ratios And Systemic Inflammation In Lung Cancer Stages: Topic: Pulmonology
2115. P124 The Ubiquitin Editing Enzyme A20 Links Inflammation And Colitis Associated Cancer
2116. P-149 Yi Il-33/St2 Axis Modulates Carcinogenesis In Inflammation-Associated Colorectal Cancer
2117. P-159 Adiponectin Administration Reduces The Severity Of Intestinal Inflammation And Cancer
2118. P-164 Yi Epithelial Derived-Matrix Metalloproteinase (Mmp9) Has A Defensive Role In Inflammation Associated Colorectal Cancer By Activating Mmp9-Arf-P53 Axis
2119. P16Ink4A Promoter Hypermethylation In Sputum, Blood, And Tissue From Non-Small Cell Lung Cancer And Pulmonary Inflammation
2120. P16Ink4A Promoter Hypermethylation Of Non‐Tumorous Tissue Adjacent To Gastric Cancer Is Correlated With Glandular Atrophy And Chronic Inflammation
2121. P-175 Clinical Implication Of Inflammation Markers For Identifying Radiotherapy Candidates In Inoperable Locally Advanced Pancreas Cancer
2122. P-183 Abrogation Of Alcohol Dehydrogenase-1B Expression By Cd90+ Stromal Cells Supports Tumor-Promoting Inflammation In Colorectal Cancer
2123. P-191Systemic Inflammation Response Index (Siri): A Prognostic Factor In Pancreatic Cancer (Pc)
2124. P2. 03A-015 Systemic Inflammation Alters Carboplatin Pharmacokinetics Explaining Poor Survival In Advanced Lung Cancer Patients: Topic: Clinical Trials
2125. P2. 04-29 Association Of Inflammation Related Genes With Lung Cancer Risk In Moroccan Population
2126. P2-060: Altered Iron Metabolism, Inflammation, Transferrin Receptors And Ferritin Expression In Lung Cancer
2127. P2Rx7: A Receptor With A Split Personality In Inflammation And Cancer
2128. P3. 01-052 Dna Adductomics To Identify The Role Of Inflammation In Nnk-Induced Lung Carcinogenesis: Topic: Models Of Lung Cancer
2129. P3. 01-11 Depression And Inflammation In Patients With Egfr-Mutated Non-Small Cell Lung Cancer
2130. P53 Mutations And Inflammation-Associated Cancer Are Linked Through Tnf Signaling
2131. P53, Ghrh, Inflammation And Cancer
2132. P53-The Link Between Inflammation And Cancer?
2133. P6215 Prognostic Value Of Advanced Lung Cancer Inflammation Index In Patients With Chronic Heart Failure: A Prospective Comparative Study With Cardiac I-123 …
2134. P-A8 Therapeutic Targeting Of Intracellular Toll-Like And Interleukin-1 Receptor Signaling For Inhibiting Infection, Inflammation, And Cancer
2135. Pain And Inflammation In Women With Early-Stage Breast Cancer Prior To Induction Of Chemotherapy
2136. Palliative Radiotherapy And Inflammation Study (Prais)-Protocol For A Longitudinal Observational Multicenter Study On Patients With Cancer Induced Bone Pain
2137. Pan-Cancer Adaptive Immune Resistance As Defined By The Tumor Inflammation Signature (Tis): Results From The Cancer Genome Atlas (Tcga)
2138. Pancreatic Cancer And Inflammation
2139. Pancreatic Cancer Microenvironment Has A High Degree Of Inflammation And Infiltrating Immune Cells In Its Stroma
2140. Pancreatic Cancer, Inflammation And Microbiome
2141. Pancreatic Cancer-Associated Inflammation Drives Dynamic Regulation Of P35 And Ebi3
2142. Pancreatic Inflammation And Atrophy Are Not Associated With Pancreatic Cancer Concomitant With Intraductal Papillary Mucinous Neoplasm
2143. Pancreatic Inflammation And Cancer T109-T112
2144. Pancreatitis-Induced Inflammation Contributes To Pancreatic Cancer By Inhibiting Oncogene-Induced Senescence
2145. Pas De Deux: Control Of Anti-Tumor Immunity By Cancer-Associated Inflammation
2146. Pathogen Recognition Receptors, Cancer And Inflammation In The Gut
2147. Pathogenic Role Of Exosomes And Micrornas In Hpv‐Mediated Inflammation And Cervical Cancer: A Review
2148. Pathogenic Roles Of Cyclooxygenase-2 In Inflammation And Cancer
2149. Pathologies At The Nexus Of Blood Coagulation And Inflammation: Thrombin In Hemostasis, Cancer, And Beyond
2150. Pathophysiological Role Of Osteopontin In Hepatic Inflammation, Toxicity, And Cancer
2151. Pathways Connecting Inflammation And Cancer
2152. Pattern-Recognition Receptors And Neutrophils In Cancer Inflammation
2153. Patterns Of Tigit Expression In Lymphatic Tissue, Inflammation, And Cancer
2154. Pectin Oligosaccharides Ameliorate Colon Cancer By Regulating Oxidative Stress-And Inflammation-Activated Signaling Pathways
2155. Pelvic Inflammation And The Pathogenesis Of Ovarian Cancer: A Cohort Study
2156. Pentraxin-3 Silencing Suppresses Gastric Cancer-Related Inflammation By Inhibiting Chemotactic Migration Of Macrophages
2157. Peptide Amidating Activity In Human Bronchoalveolar Lavage Fluid: Relationship To Lung Cancer, Inflammation And Infection.
2158. Peptide Growth Factors And Inflammation, Tissue Repair, And Cancer.
2159. Peptide-1/Interleukin-8 Detection In Human Urine During Acute Bladder Inflammation Caused By Transurethral Resection Of Superficial Cancer And Bacillus Calmette …
2160. Peptides Derived From In Vitro Gastrointestinal Digestion Of Germinated Soybean Proteins Inhibit Human Colon Cancer Cells Proliferation And Inflammation
2161. Peptidylarginine Deiminase Inhibitors Regulate Autophagy Of Human Cancer Cells And Inflammation Response Of Immune Cells
2162. Perceived Cognitive Function For Breast Cancer Survivors: Association Of Genetic And Behaviorally Related Variables For Inflammation
2163. Perforin Deficiency Attenuates Inflammation And Tumor Growth In Colitis-Associated Cancer
2164. Periodontal Disease And Cancer: Chronic Inflammation-The Oral-Systemic Link
2165. Periodontal Inflammation Recruits Distant Metastatic Breast Cancer Cells By Increasing Myeloid-Derived Suppressor Cells
2166. Perioperative Stress, Inflammation, And Cancer Progression: Opportunities For Intervention In Breast And Colorectal Cancer Surgery Utilizing Beta-Adrenergic …
2167. Peripheral Inflammation Markers Of Chemosensitivity To Induction Chemotherapy In Hypopharyngeal Cancer Patients
2168. Peripheral Inflammation/Immune Indicators Of Chemosensitivity And Prognosis In Breast Cancer Patients Treated With Neoadjuvant Chemotherapy
2169. Peripheral Zone Inflammation Is Not Strongly Associated With Lower Urinary Tract Symptom Incidence And Progression In The Placebo Arm Of The Prostate Cancer …
2170. Periprostatic Adipose Inflammation Is Associated With High-Grade Prostate Cancer
2171. Peritoneal Inflammation–A Microenvironment For Epithelial Ovarian Cancer (Eoc)
2172. Persistent Chronic Inflammation Contributes To The Development Of Cancer In Patients With Rheumatoid Arthritis From A Defined Population Of Northwestern Spain
2173. Persistent Inflammation With Loss Of Nk Cell Cytotoxicity After Differentiation Of Brain Cancer Stem Cells By Nk Cells
2174. Perspectives On Pulmonary Inflammation And Lung Cancer Risk In Cigarette Smokers
2175. Perspectives On Sesquiterpene Lactones In Inflammation And Cancer
2176. Pet And Pet-Ct Imaging In Infection And Inflammation: Its Critical Role In Assessing Complications Related To Therapeutic Interventions In Patients With Cancer
2177. Phagocytes As Corrupted Policemen In Cancer-Related Inflammation
2178. Pharmacological Intervention Of Cyclooxygenase-2 And 5-Lipoxygenase Pathways. Impact On Inflammation And Cancer
2179. Phase 2 Prospective Trial Of Triphasic Pet/Ct: Primary Site Inflammation Versus Cancer At 3 Months After Completion Of Radiation For Head And Neck Squamous Cell …
2180. Phase Ii Trial Of Inflammation Markers And Symptom Control In Metastatic Lung Cancer: Insync.
2181. Phenethyl Isothiocyanate, Indole-3-Carbinol/3, 3′-Diindolylmethane: Antioxidative Stress/Inflammation, Nrf2, Epigenetics/Epigenomics And In Vivo Cancer …
2182. Phosphatidylinositol 3-Kinase Γ Inhibition Ameliorates Inflammation And Tumor Growth In A Model Of Colitis-Associated Cancer
2183. Phosphatidylinositol 3-Kinase: A Link Between Inflammation And Pancreatic Cancer
2184. Phosphoinositide 3-Kinases In The Gut: A Link Between Inflammation And Cancer?
2185. Phospholipase Cγ1 Links Inflammation And Tumorigenesis In Colitis-Associated Cancer
2186. Phosphorylation Of Nf-Κb And Iκb Proteins: Implications In Cancer And Inflammation
2187. Photodynamic Therapeutic Role Of Indocyanine Green In Tumor-Associated Inflammation In Skin Cancer
2188. Phytofabricated Silver Nanoparticles Of Phyllanthus Emblica Attenuated Diethylnitrosamine-Induced Hepatic Cancer Via Knock-Down Oxidative Stress And Inflammation
2189. Phytotherapeutic Effects Of The Fruits Of Poncirus Trifoliata (L.) Raf. On Cancer, Inflammation, And Digestive Dysfunction
2190. Pi3K Inhibitors In Inflammation, Autoimmunity And Cancer
2191. Pi3Ks—Drug Targets In Inflammation And Cancer
2192. Pkb/Akt-Dependent Regulation Of Inflammation In Cancer
2193. Placebo In Combination With Capecitabine In Patients With Advanced Her2-Negative Breast Cancer And Elevated C-Reactive Protein, A Marker Of Systemic Inflammation
2194. Plasma Biomarkers Of Inflammation, The Kynurenine Pathway, And Risks Of All-Cause, Cancer, And Cardiovascular Disease Mortality: The Hordaland Health Study
2195. Plasma Mic-1 Correlates With Systemic Inflammation But Is Not An Independent Determinant Of Nutritional Status Or Survival In Oesophago-Gastric Cancer
2196. Plasma Proteome Profiles Associated With Inflammation, Angiogenesis, And Cancer
2197. Plasma Transferable Inhibition Of Bcg Induced Subcutaneous Inflammation In Human Cancer
2198. Plasma Variation And Reproducibility Of Oxidized Ldl-Cholesterol And Low-Grade Inflammation Biomarkers Among Participants Of The Malmö Diet And Cancer Cohort
2199. Platelet Score (Nps), A Predictive Systemic Inflammation Score For Pd-1 Immune Checkpoint Inhibitors (Ici) In Pretreated Advanced Non-Small Cell Lung Cancer (Nsclc …
2200. Platelets, Thrombo-Inflammation And Cancer: Collaborating With The Enemy
2201. Pleiotropic Actions Of Peroxisome Proliferator-Activated Receptors (Ppars) In Dysregulated Metabolic Homeostasis, Inflammation And Cancer: Current Evidence And …
2202. Pleural Mesothelioma And Lung Cancer: The Role Of Asbestos Exposure And Genetic Variants In Selected Iron Metabolism And Inflammation Genes
2203. Pod-5.09: The Effect Of Inflammation In The Prostate Gland On Tissue Molecular Markers For Prostate Cancer In Arab Men
2204. Podoplanin In Inflammation And Cancer
2205. Polycomb Repressive Complex 2 Is A Barrier To Kras-Driven Inflammation And Epithelial-Mesenchymal Transition In Non-Small-Cell Lung Cancer
2206. Polymorphisms In Chronic Inflammation Mediated Pathway Genes Associated With Risk Of Postmenopausal Breast Cancer (Pmbc).
2207. Polymorphisms In Genes Related To Inflammation, Nsaid Use, And The Risk Of Prostate Cancer Among Danish Men
2208. Polymorphisms In Inflammation Genes And Bladder Cancer: From Initiation To Recurrence, Progression, And Survival
2209. Polymorphisms In Inflammation Pathway Genes And Endometrial Cancer Risk
2210. Polymorphisms In Inflammation-Related Genes And Risk Of Gastric Cancer (Finland)
2211. Polymorphisms In Inflammation-Related Genes And Risk Of Smoking-Associated Lung Cancer And Chronic Obstructive Pulmonary Disease
2212. Polymorphisms In Oxidative Stress And Inflammation Pathway Genes, Low-Dose Ionizing Radiation, And The Risk Of Breast Cancer Among Us Radiologic Technologists
2213. Polymorphisms Of Inflammation‐Related Genes And Colorectal Cancer Risk: A Population‐Based Case–Control Study In C Hina
2214. Polyphenolics From Pomegranate Prevent Inflammation In Breast Cancer Cells In Vitro And In Vivo And Target Mirna155
2215. Polyphenol-Induced Anti-Inflammatory And Cytotoxic Activities In Breast And Colon Cancer: Potential Role Of Mirna’S In Cell Survival And Inflammation
2216. Polyunsaturated Fatty Acids, Polyphenols, Amino Acids, Prebiotics: Can They Help To Tackle Cancer Cachexia And Related Inflammation?
2217. Positive Affect And Inflammation During Radiation Treatment For Breast And Prostate Cancer
2218. Possible Contribution Of Chronic Inflammation In The Induction Of Cancer In Rheumatic Diseases
2219. Possible Molecular Targets For Therapeutic Applications Of Caffeic Acid Phenethyl Ester In Inflammation And Cancer
2220. Possible Role Of Ovarian Epithelial Inflammation In Ovarian Cancer
2221. Possible Role Of Peritoneal Nf-Κb In Peripheral Inflammation And Cancer: Lessons From The Inhibitor Dhmeq
2222. Postdiagnosis Diet Quality Is Inversely Related To A Biomarker Of Inflammation Among Breast Cancer Survivors
2223. Postoperative Inflammation As A Possible Cause Of Portal Vein Thrombosis After Irreversible Electroporation For Locally Advanced Pancreatic Cancer
2224. Post-Radiotherapy Inflammation Predicts Recurrence And Mortality In Stage I-Iii Triple-Negative Breast Cancer
2225. Post-Surgical Skin Inflammation Of Tumor Site In Skin Cancer Patient: How Long Does It Last?
2226. Post-Transcriptional Control During Chronic Inflammation And Cancer: A Focus On Au-Rich Elements
2227. Potential And Importance Of Metalloproteinases And Interleukins In Inflammation And Metastasization In Non-Small Cell Lung Cancer
2228. Potential And Inflammation-Induced Secretion Profile Of Human Adipose-Derived Stromal Vascular Cells Are Influenced By Donor Variability And Prior Breast Cancer …
2229. Potential Usefulness Of Dna Methylation As A Risk Marker For Digestive Cancer Associated With Inflammation
2230. Powerful Protection Against Heart Disease, Cancer, And Inflammation
2231. Pp2A Plays A Key Role In Inflammation And Cancer Through Tristetraprolin Activation
2232. Ppars Mediate Lipid Signaling In Inflammation And Cancer
2233. Ppars, Cancer Cells And Inflammation
2234. Pparα: Energy Combustion, Hypolipidemia, Inflammation And Cancer
2235. Ppar-Γ Agonists: Therapeutic Role In Diabetes, Inflammation And Cancer
2236. Pparδ And Pge2 Signaling Pathways Communicate And Connect Inflammation To Colorectal Cancer
2237. Pre-Cachexia In Patients With Stages I–Iii Non-Small Cell Lung Cancer: Systemic Inflammation And Functional Impairment Without Activation Of Skeletal Muscle …
2238. Preclinical Cancer Chemoprevention Studies Using Animal Model Of Inflammation-Associated Colorectal Carcinogenesis
2239. Prediagnostic Circulating Inflammation Markers And Endometrial Cancer Risk In The Prostate, Lung, Colorectal And Ovarian Cancer (Plco) Screening Trial
2240. Prediagnostic Circulating Markers Of Inflammation And Risk Of Oesophageal Adenocarcinoma: A Study Within The National Cancer Institute Cohort Consortium
2241. Prediagnostic Circulating Markers Of Inflammation And Risk Of Prostate Cancer
2242. Pre-Diagnostic Serum Levels Of Inflammation Markers And Risk Of Ovarian Cancer In The Prostate, Lung, Colorectal And Ovarian Cancer (Plco) Screening Trial
2243. Prediagnostic Serum Levels Of Inflammation Markers And Risk Of Ovarian Cancer In The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial: Preliminary …
2244. Predictive Impact Of The Inflammation‐Based Indices In Colorectal Cancer Patients With Adjuvant Chemotherapy
2245. Predictive Significance Of Preoperative Systemic Immune-Inflammation Index Determination In Postoperative Liver Metastasis Of Colorectal Cancer
2246. Predictive Value Of Hematological Markers Of Systemic Inflammation For Managing Cervical Cancer
2247. Predictive Value Of The Asymptomatic Prostatic Inflammation In The Development Of Prostate Cancer
2248. Predictive Values Of Postoperative And Dynamic Changes Of Inflammation Indexes In Survival Of Patients With Resected Colorectal Cancer
2249. Predictors Of Inflammation In Response To Anthracycline-Based Chemotherapy For Breast Cancer
2250. Pre-Existing Inflammation Induced By Tnf-Alpha Augments Cryosurgery On Human Prostate Cancer
2251. Preliminary Insights On The Role Of Inflammation In Cancer
2252. Preliminary Study On Selected Markers Of Oxidative Stress, Inflammation And Angiogenesis In Patients With Bladder Cancer
2253. Preoperative Anemia In Colorectal Cancer: Relationships With Tumor Characteristics, Systemic Inflammation, And Survival
2254. Preoperative Biliary Drainage-Related Inflammation Is Associated With Shorter Survival In Biliary Tract Cancer Patients
2255. Preoperative Increased Systemic Immune-Inflammation Index Predicts Poor Prognosis In Patients With Operable Non-Small Cell Lung Cancer
2256. Preoperative Oral Health Care Reduces Postoperative Inflammation And Complications In Oral Cancer Patients
2257. Preoperative Systemic Inflammation Predicts Postoperative Infectious Complications In Patients Undergoing Curative Resection For Colorectal Cancer
2258. Preparation Of Polyethylene Glycol-Ginsenoside Rh1 And Rh2 Conjugates And Their Efficacy Against Lung Cancer And Inflammation
2259. Pretreatment Advanced Lung Cancer Inflammation Index (Ali) For Predicting Early Progression In Nivolumab‐Treated Patients With Advanced Non–Small Cell Lung Cancer
2260. Pre-Treatment Inflammation Induced By Tnf-Α Augments Cryosurgical Injury On Human Prostate Cancer
2261. Pre-Treatment Systemic Immune-Inflammation Represents A Prognostic Factor In Patients With Advanced Non-Small Cell Lung Cancer
2262. Pretreatment With The Probiotic Vsl# 3 Delays Transition From Inflammation To Dysplasia In A Rat Model Of Colitis-Associated Cancer
2263. Prevalence And Characteristics Of Inflammation In Prostate Cancer
2264. Preventing Cancer In The Colon: Effect Of Ginger Root Extract On Markers Of Inflammation In Colon Mucosa In People At High Risk For Colorectal Cancer.
2265. Prevention And Treatment Of Cancer Targeting Chronic Inflammation: Research Progress, Potential Agents, Clinical Studies And Mechanisms
2266. Prevention Of Colorectal Cancer By Targeting Obesity-Related Disorders And Inflammation
2267. Prevents Early Phase Inflammation Associated With Azoxymethane/Dextran Sulfate Sodium-Induced Colon Cancer And Induces Apoptosis In Human Colon Cancer …
2268. Primary Pulmonary Hypertension Between Inflammation And Cancer
2269. Primary Tumor Resection In Patients With Metastatic Colorectal Cancer Is Associated With Reversal Of Systemic Inflammation And Improved Survival
2270. Procalcitonin–A Sensitive Inflammation Marker Of Febrile Episodes In Neutropenic Children With Cancer
2271. Prognostic And Predictive Inflammation-Based Markers For Advanced Colorectal Cancer Of The Elderly Patients.
2272. Prognostic Dynamic Nomogram Integrated With Inflammation-Based Factors For Non-Small Cell Lung Cancer Patients With Chronic Hepatitis B Viral Infection
2273. Prognostic Efficacy Of Inflammation-Based Markers In Patients With Curative Colorectal Cancer Resection
2274. Prognostic Factors In Patients With Metastatic Or Recurrent Pancreatic Cancer Treated With First-Line Nab-Paclitaxel Plus Gemcitabine: Implication Of Inflammation-Based …
2275. Prognostic Impact Of Intra-Abdominal/Pelvic Inflammation After Radical Surgery For Locally Recurrent Rectal Cancer
2276. Prognostic Implication Of Inflammation-Based Scores In Patients With Metastatic Pancreatic Cancer (Mpc) Treated With First-Line Nab-Paclitaxel Plus Gemcitabine (Ag)
2277. Prognostic Importance Of The Inflammation-Based Glasgow Prognostic Score In Patients With Gastric Cancer
2278. Prognostic Importance Of The Preoperative Modified Systemic Inflammation Score For Patients With Gastric Cancer
2279. Prognostic Inflammation Score In Surgical Patients With Colorectal Cancer
2280. Prognostic Performance Of Inflammation‑Based Prognostic Indices In Locally Advanced Non-Small‑Lung Cancer Treated With Endostar And Concurrent …
2281. Prognostic Performance Of Inflammation-Based Prognostic Indices In Primary Operable Non-Small Cell Lung Cancer
2282. Prognostic Role Of The Advanced Lung Cancer Inflammation Index In Cancer Patients: A Meta-Analysis
2283. Prognostic Significance Of Inflammation-Based Indexes In Patients With Stage Iii/Iv Colorectal Cancer After Adjuvant Chemoradiotherapy
2284. Prognostic Significance Of Modified Advanced Lung Cancer Inflammation Index (Ali) In Patients With Small Cell Lung Cancer_ Comparison With Original Ali
2285. Prognostic Significance Of Sarcopenia With Inflammation In Patients With Head And Neck Cancer Who Underwent Definitive Chemoradiotherapy
2286. Prognostic Significance Of Systemic Immune-Inflammation Index In Triple-Negative Breast Cancer
2287. Prognostic Significance Of Systemic Inflammation-Based Lymphocyte-Monocyte Ratio In Patients With Lung Cancer: Based On A Large Cohort Study
2288. Prognostic Significance Of The Skeletal Muscle Index And An Inflammation Biomarker In Patients With Breast Cancer Who Underwent Postoperative Adjuvant Radiotherapy
2289. Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical …
2290. Prognostic Value And Association Of Sarcopenia And Systemic Inflammation For Patients With Gastric Cancer Following Radical Gastrectomy
2291. Prognostic Value Of Advanced Lung Cancer Inflammation Index In Head And Neck Squamous Cell Carcinoma
2292. Prognostic Value Of An Inflammation-Based Score In Patients Undergoing Pre-Operative Chemotherapy Followed By Surgery For Esophageal Cancer
2293. Prognostic Value Of Blood-Biomarkers Related To Hypoxia, Inflammation, Immune Response And Tumour Load In Non-Small Cell Lung Cancer–A Survival Model …
2294. Prognostic Value Of Carbohydrate Tumor Markers And Inflammation-Based Markers In Chinese Advanced Gastric Cancer Patients.
2295. Prognostic Value Of Carbohydrate Tumor Markers And Inflammation-Based Markers In Metastatic Or Recurrent Gastric Cancer
2296. Prognostic Value Of Dietary Intake And Inflammation On Survival In Patients With Advanced Cancer: Relationship With Performance Status, Pain, And Digestive Disorders
2297. Prognostic Value Of Inflammation Or Granuloma After Intravesival Bcg In Non-Muscle-Invasive Bladder Cancer.
2298. Prognostic Value Of Inflammation Scores In Liver Cancer Post Transarterial Chemoembolization
2299. Prognostic Value Of Inflammation-Based Markers In Patients With Pancreatic Cancer Administered Gemcitabine And Erlotinib
2300. Prognostic Value Of Preoperative Inflammation-Based Prognostic Scores In Patients With Stage Iv Colorectal Cancer Who Undergo Palliative Resection Of Asymptomatic …
2301. Prognostic Value Of Preoperative Inflammation-Based Prognostic Scores On Hospital Mortality After Gastric Cancer Surgery
2302. Prognostic Value Of Preoperative Systemic Immune-Inflammation Index In Patients With Cervical Cancer
2303. Prognostic Value Of Selected Preoperative Inflammation-Based Scores In Patients With High-Risk Localized Prostate Cancer Who Underwent Radical Prostatectomy
2304. Prognostic Value Of Single Nucleotide Polymorphisms (Snps) Of Candidate Genes Associated With Inflammation In Early-Stage Breast Cancer.
2305. Prognostic Value Of Single Nucleotide Polymorphisms Of Candidate Genes Associated With Inflammation In Early Stage Breast Cancer
2306. Prognostic Value Of Systemic Immune Inflammation Index In Advanced Non Small Cell Lung Cancer
2307. Prognostic Value Of Systemic Immune-Inflammation Index In Cancer: A Meta-Analysis
2308. Prognostic Value Of Systemic Immune-Inflammation Index In Elderly Patients With Esophageal Squamous Cell Cancer.
2309. Prognostic Value Of Systemic Immune-Inflammation Index In Patients With Advanced Non-Small-Cell Lung Cancer
2310. Prognostic Value Of Systemic Inflammation‐Based Markers In Advanced Pancreatic Cancer
2311. Prognostic Value Of The Advanced Lung Cancer Inflammation Index In Patients With Lung Cancer: A Meta-Analysis
2312. Prognostic Value Of The Crp/Alb Ratio, A Novel Inflammation-Based Score In Pancreatic Cancer
2313. Prognostic Value Of The Pretreatment Advanced Lung Cancer Inflammation Index (Ali) In Diffuse Large B Cell Lymphoma Patients Treated With R-Chop Chemotherapy
2314. Prognostic Value Of The Pretreatment Systemic Immune-Inflammation Index (Sii) In Patients With Non-Small Cell Lung Cancer: A Meta-Analysis
2315. Prognostic Value Of The Systematic Immune-Inflammation Index Among Patients With Operable Colon Cancer: A Retrospective Study
2316. Prognostic Value Of The Systemic Immune-Inflammation Index (Sii) After Neoadjuvant Therapy For Patients With Resected Pancreatic Cancer
2317. Prognostic Values Of Systemic Inflammation Response (Sir) Parameters In Resectable Cervical Cancer
2318. Prognostication By Inflammation-Based Score In Patients With Locally Advanced Pancreatic Cancer Treated With Chemoradiotherapy
2319. Prognostication In Advanced Cancer: A Study Examining An Inflammation-Based Score
2320. Programmed Cell Clearance: Molecular Mechanisms And Role In Autoimmune Disease, Chronic Inflammation, And Anti-Cancer Immune Responses
2321. Prohibitin: A New Player In Immunometabolism And In Linking Obesity And Inflammation With Cancer
2322. Pro-Inflammation Nf-Κb Signaling Triggers A Positive Feedback Via Enhancing Cholesterol Accumulation In Liver Cancer Cells
2323. Proline-Rich Protein Tyrosine Kinase 2 In Inflammation And Cancer
2324. Prolonged Cancer-Related Distress Is Associated With Elevated Inflammation During Breast Cancer Survivorship
2325. Promotion Of Lung Cancer Progression By Copd-Like Chronic Inflammation In A Mouse Model
2326. Propionibacterium Acnes Associated With Inflammation In Radical Prostatectomy Specimens: A Possible Link To Cancer Evolution
2327. Propionibacterium Acnes Associated With Inflammation In Radical Prostatectomy Specimens: A Possible Link To Cancer Evolution?
2328. Prospective Cohort Study Of Fatal Lung Cancer, Inflammation, Smoking And Lifestyle Risk Factors: Results From The Third National Health And Nutrition Examination …
2329. Prospective Evaluation Of Intraprostatic Inflammation And Focal Atrophy As A Predictor Of Risk Of High-Grade Prostate Cancer And Recurrence After Prostatectomy
2330. Prospective Study Of The Role Of Inflammation In Renal Cancer
2331. Prostaglandin And Its Receptors: Potential Targets For Gastrointestinal Inflammation And Cancer
2332. Prostaglandin E Synthase: A Novel Drug Target For Inflammation And Cancer
2333. Prostaglandin E2: At The Crossroads Between Stem Cell Development, Inflammation And Cancer
2334. Prostaglandin Receptor Ep2 In The Crosshairs Of Anti-Inflammation, Anti-Cancer, And Neuroprotection
2335. Prostate Cancer And Inflammation: A New Molecular Imaging Challenge In The Era Of Personalized Medicine
2336. Prostate Cancer And Inflammation: The Evidence
2337. Prostate Cancer And Inflammation: The Role Of Mirnas
2338. Prostate Cancer Risk And Inflammation: Association With Aspirinand Other Nsaid Use & Selected Inflammation Pathway-Related Gene Polymorphisms
2339. Prostate Cancer: Intriguing Data On Inflammation And Prostate Cancer
2340. Prostate Cancer-The Role Of Inflammation And Chemokines
2341. Prostate Chronic Inflammation Type Iv And Prostate Cancer Risk In Patients Undergoing First Biopsy Set: Results Of A Large Cohort Study
2342. Prostate Inflammation And Its Potential Impact On Prostate Cancer: A Current Review
2343. Prostate Inflammation And Prostate Cancer
2344. Prostate Volume Index And Chronic Inflammation Of The Prostate Type Iv With Respect To The Risk Of Prostate Cancer
2345. Prostate Volume Index Is Able To Differentiate Between Prostatic Chronic Inflammation And Prostate Cancer In Patients With Normal Digital Rectal Examination And …
2346. Prostate–Specific Antigen (Psa) Value Change After Antibacterial Therapy Of Prostate Inflammation, As A Diagnostic Method For Prostate Cancer Screening In Cases …
2347. Prostate-Specific G-Protein Coupled Receptor, An Emerging Biomarker Regulating Inflammation And Prostate Cancer Invasion
2348. Prostatic Inflammation And Prostate Cancer
2349. Prostatic Inflammation Enhances Basal-To-Luminal Differentiation And Accelerates Initiation Of Prostate Cancer With A Basal Cell Origin
2350. Prostatic Inflammation Is Associated With Benign Prostatic Hyperplasia Rather Than Prostate Cancer
2351. Protease-Activated Receptors In The Intestine: Focus On Inflammation And Cancer
2352. Proteases And Their Receptors As Mediators Of Inflammation-Associated Colon Cancer
2353. Protection Against Colonic Inflammation And Colon Cancer By Commensal Bacterial Metabolites: An Obligatory Role For The Short-Chain Fatty Acid Transporter Slc5A8
2354. Protection Against Peroxynitrite-Induced Dna Damage By Mesalamine: Implications For Anti-Inflammation And Anti-Cancer Activity
2355. Protective Effect Of Dexmedetomidine Against Perioperative Inflammation And On Pulmonary Function In Patients Undergoing Radical Resection Of Lung Cancer
2356. Protective Role Of Selenium And Adiponectin Deficiency In Chronic Inflammation Induced Colon Cancer.
2357. Protein S: A Multifunctional Anticoagulant Vitamin K-Dependent Protein At The Crossroads Of Coagulation, Inflammation, Angiogenesis, And Cancer
2358. Proteoglycan Neofunctions: Regulation Of Inflammation And Autophagy In Cancer Biology
2359. Proteomic Analysis Of Stage I Endometrial Cancer Tissue: Identification Of Proteins Associated With Oxidative Processes And Inflammation
2360. Proteomic Profiling Of Lymphocytes In Autoimmunity, Inflammation And Cancer
2361. P-Selectin Cell Adhesion Molecule In Inflammation, Thrombosis, Cancer Growth And Metastasis
2362. P-Selectin Mediates Adhesion Of Leukocytes, Platelets, And Cancer Cells In Inflammation, Thrombosis, And Cancer Growth And Metastasis
2363. Pstiing: A ‘Systems’ Approach Towards Integrating Signalling Pathways, Interaction And Transcriptional Regulatory Networks In Inflammation And Cancer
2364. Psychosocial Stress And Inflammation In Cancer
2365. Ptpn2 Regulates Inflammasome Activation And Controls Onset Of Intestinal Inflammation And Colon Cancer
2366. Ptx3 As A Paradigm For The Interplay Between Cellular And Humoral Innate Immunity In Inflammation And Cancer
2367. Ptx3 Is An Extrinsic Oncosuppressor Regulating Complement-Dependent Inflammation In Cancer
2368. Pulmonary Hypertension Begets Pulmonary Hypertension: Mutually Reinforcing Roles For Haemodynamics, Inflammation, And Cancer-Like Phenotypes
2369. Pulmonary Inflammation And Rat Lung Cancer Implications For Dust Exposure Limits
2370. Pulmonary Oxidative Stress, Inflammation And Cancer: Respirable Particulate Matter, Fibrous Dusts And Ozone As Major Causes Of Lung Carcinogenesis Through Reactive …
2371. Punica Granatum (Pomegranate) And Its Potential For Prevention And Treatment Of Inflammation And Cancer
2372. Putative Protein Biomarkers In Human Breast And Prostate Cancer Tissues And Implication Of Endometase/Matrilysin-2 In Inflammation And Apoptosis
2373. Pyridine (Phip) Induces Gene Expression Changes In Jak/Stat And Mapk Pathways Related To Inflammation, Diabetes And Cancer
2374. Quantification Of Global Lung Inflammation Using Volumetric 18F-Fdg Pet/Ct Parameters In Locally Advanced Non-Small-Cell Lung Cancer Patients Treated With …
2375. Quantitative Proteomics Identifies Steap4 As A Critical Regulator Of Mitochondrial Dysfunction Linking Inflammation And Colon Cancer
2376. Race, Inflammation, And Prostate Cancer: A Comparison Of African Americans And Caucasians.
2377. Racial Differences In The Relationship Between Clinical Prostatitis, Presence Of Inflammation In Benign Prostate And Subsequent Risk Of Prostate Cancer
2378. Radiation, Inflammation And The Immune Response In Cancer
2379. Radiation, Inflammation, And Immune Responses In Cancer
2380. Radiolabelled Lymphokines And Growth Factors For In Vivo Imaging Of Inflammation, Infection And Cancer
2381. Radiotherapy-Induced Changes In The Systemic Immune And Inflammation Parameters Of Head And Neck Cancer Patients
2382. Rage (Receptor For Advanced Glycation Endproducts), Rage Ligands, And Their Role In Cancer And Inflammation
2383. Rage And Its Ligands: Molecular Interplay Between Glycation, Inflammation, And Hallmarks Of Cancer—A Review
2384. Ralb Signaling: A Bridge Between Inflammation And Cancer
2385. Randomized Clinical Trial Of Medical Qigong On Quality Of Life, Fatigue, Side Effects, Mood, Status, And Inflammation Of Cancer Patients
2386. Randomized Clinical Trial: The Impact Of Medical Qigong (Traditional Chinese Medicine) On Fatigue, Quality Of Life, Side Effects, Mood Status And Inflammation Of Cancer …
2387. Rapid Analysis Of Effects Of Environmental Toxicants On Tumorigenesis And Inflammation Using A Transgenic Zebrafish Model For Liver Cancer
2388. Ratio (Nlr), Platelet-To-Lymphocyte Ratio (Plr), And Mean Platelet Volume (Mpv) As Biomarkers Of Systemic Inflammation In The Diagnosis Of Colorectal Cancer
2389. Ratio Of Free-To-Total Prostate Specific Antigen In Serum Cannot Distinguish Patients With Prostate Cancer From Those With Chronic Inflammation Of The Prostate
2390. Re: Low Cd38 Identifies Progenitor-Like Inflammation-Associated Luminal Cells That Can Initiate Human Prostate Cancer And Predict Poor Outcome
2391. Re: Possible Role Of Ovarian Epithelial Inflammation In Ovarian Cancer
2392. Re: Prostatic Inflammation Enhances Basal-To-Luminal Differentiation And Accelerates Initiation Of Prostate Cancer With A Basal Cell Origin
2393. Reactive Oxygen Species Are Involved In The Development Of Gastric Cancer And Gastric Cancer-Related Depression Through Abl1-Mediated Inflammation Signaling …
2394. Reactive Oxygen Species: A Link Between Chronic Inflammation And Cancer
2395. Rebamipide-Induced Downregulation Of Phospholipase D Inhibits Inflammation And Proliferation In Gastric Cancer Cells
2396. Recent Advances In Adam17 Research: A Promising Target For Cancer And Inflammation
2397. Recent Advances In Bioactive Components In Grape And Wine (Ⅲ)——Cancer, Inflammation, Neurodegenerative Diseases And Other Diseases Prenventing Effects
2398. Recent Advances In The Structure-Based And Ligand-Based Design Of Ikkβ Inhibitors As Anti-Inflammation And Anti-Cancer Agents
2399. Recent Data Concerning Heparanase: Focus On Fibrosis, Inflammation And Cancer
2400. Recent Insights Into Nf‐Κ B Signalling Pathways And The Link Between Inflammation And Prostate Cancer
2401. Receptor Proximal Kinases In Nf-Κb Signaling As Potential Therapeutic Targets In Cancer And Inflammation
2402. Red Meat And Inflammation And A1C In Breast Cancer Women (P05-038-19)
2403. Redox Genes; Learning From Genetically Modified Animals Guest Editor: Junichi Fujii Novel Roles Of Peroxiredoxins In Inflammation, Cancer And Innate Immunity
2404. Reg Proteins And Their Roles In Inflammation And Cancer Of The Human Digestive System
2405. Registered Report: Intestinal Inflammation Targets Cancer-Inducing Activity Of The Microbiota
2406. Regulating The Regulators: Overcoming Regulatory T Cell Suppression In Cancer And Identifying Inhibitors Of Inflammation Using Rna Interference
2407. Regulation And Function Of Nuclear Iκbα In Inflammation And Cancer
2408. Regulation Of Apoptosis Of Myeloid Immune Cells: Implication For Cancer Therapy And Inflammation
2409. Regulation Of Collagen-Rich Matrix Remodeling In Wound Healing, Inflammation And Cancer
2410. Regulation Of Drug Metabolizing Enzymes And Transporters In Infection, Inflammation, And Cancer
2411. Regulation Of Ferritin Synthesis In Inflammation And Cancer.
2412. Regulation Of Gene Expression And M2 Macrophage Polarization As New Potential Omega-3 Polyunsaturated Fatty Acid Targets In Colon Inflammation And Cancer
2413. Regulation Of Inflammation By The Nf‐Κb Pathway In Ovarian Cancer Stem Cells
2414. Regulation Of Inflammation In Cancer By Eicosanoids
2415. Regulation Of Inflammation In The Adipose Tissue In Cancer Cachexia: Effect Of Exercise
2416. Regulation Of Inflammation-And Angiogenesis-Related Gene Expression In Breast Cancer Cells And Co-Cultured Macrophages
2417. Regulation Of The Human C-Reactive Protein Gene, A Major Marker Of Inflammation And Cancer.
2418. Regulatory Effect Of Ccl26 On Cancer Related Genes During Inflammation
2419. Regulatory Mechanisms Of The Hb-Egf Autocrine Loop In Inflammation, Homeostasis, Development And Cancer
2420. Regulatory Role Of Chemerin In Lung Tumorigenesis And Cancer-Associated Inflammation
2421. Regulatory T, B Cells And Inflammation: Do They Play An Important Role In Lung Cancer?
2422. Relationship Between Body Composition Changes, Inflammation And Physical Functionality In Head And Neck Cancer Patients Undergoing Concurrent Chemo …
2423. Relationship Between Chronic Inflammation And Cancer: Interleukin-1Β Overexpression Induces Pancreatic Ductal Adenocarcinoma In Oncogenic Kras Mice
2424. Relationship Between Circulating Inflammation Proteins And Lung Cancer Diagnosis In The National Lung Screening Trial
2425. Relationship Between Inflammation And Cancer Progression: Recent Advances In Interleukin-6 Signaling And Its Blockage In Cancer Therapy
2426. Relationship Between The Insulin-Like Growth Factor-1 Axis, Weight Loss, An Inflammation-Based Score And Survival In Patients With Inoperable Non-Small Cell Lung Cancer
2427. Relationship Of General And Health-Related Anxiety And Worry To Markers Of Inflammation In Women With Advanced Cancer
2428. Relationship Of Nutritional Status And Inflammation With Survival In Patients With Advanced Cancer In Palliative Care
2429. Relationship Of Oxidative Stress, Inflammation, And The Risk Of Metabolic Syndrome In Patients With Oral Cancer
2430. Relevance Of Antioxid/Redox Genes; Learning From Genetically Modified Animals: Novel Roles Of Peroxiredoxins In Inflammation, Cancer And Innate Immunity
2431. Relevance Of Cancer Toxin Pathogenesis Theory With Transformation Of Inflammation To Carcinoma
2432. Remarks On Some Cases Of Inflammation Of The Breast Simulating Cancer
2433. Replication Study: Intestinal Inflammation Targets Cancer-Inducing Activity Of The Microbiota
2434. Reply To: Cancer Inflammation And Inflammatory Biomarkers: Can Neutrophil, Lymphocyte, And Platelet Counts Represent The Complexity Of The Immune System?
2435. Repression Of Let-7A Cluster Prevents Adhesion Of Colorectal Cancer Cells By Enforcing A Mesenchymal Phenotype In Presence Of Liver Inflammation
2436. Republished: Tracing Paks From Gi Inflammation To Cancer
2437. Research Advances In The Intervention Of Inflammation And Cancer By Active Ingredients Of Traditional Chinese Medicine
2438. Research Of The Role Of Traf 6 In Cancer Cachexia Skeletal Muscle Inflammation
2439. Research Showing More Links Between Infection/Inflammation & Cancer
2440. Research Shows More Links Between Infection/Inflammation And Cancer
2441. Resistance Exercise And Inflammation In Breast Cancer Patients Undergoing Adjuvant Radiation Therapy: Mediation Analysis From A Randomized, Controlled Intervention …
2442. Resistance Training Reduces Inflammation And Fatigue And Improves Physical Function In Older Breast Cancer Survivors
2443. Resistin As A Biomarker Linking Obesity And Inflammation To Cancer: Potential Clinical Perspectives
2444. Resolution Of Cancer-Promoting Inflammation: A New Approach For AntiCancer Therapy
2445. Resolution Of Gastric Cancer-Promoting Inflammation: A Novel Strategy For Anti-Cancer Therapy
2446. Resolution Of Inflammation For The Management Of Cancer
2447. Response Of Igg1 And Igg2 Subclasses To Helicobacter Pylori In Subjects With Chronic Inflammation Of The Gastric Mucosa, Atrophy And Gastric Cancer In A Country With …
2448. Response To Comment On ‘Tumour-Infiltrating Inflammation And Prognosis In Colorectal Cancer: Systematic Review And Meta-Analysis’
2449. Response: Re: Possible Role Of Ovarian Epithelial Inflammation In Ovarian Cancer
2450. Restoring Inflammatory Balance As A Potential Preventive Strategy For Inflammation Induced Cancer
2451. Resveratrol, Micrornas, Inflammation, And Cancer
2452. Retracted Article: Mouse Models Of Intestinal Inflammation And Cancer
2453. Retracted Article: Relationships Between Genetic Polymorphisms In Inflammation-Related Factor Gene And The Pathogenesis Of Nasopharyngeal Cancer
2454. Retraction Note To: Mouse Models Of Intestinal Inflammation And Cancer.
2455. Retrospective Study Of Systemic Immune-Inflammation Index In Muscle Invasive Bladder Cancer: Initial Results Of Single Centre
2456. Review PaperInflammation And Cancer – Double Face Of Toll-Like Receptors
2457. Rhogdi2 Suppresses Bladder Cancer Metastasis Via Reduction Of Inflammation In The Tumor Microenvironment
2458. Rig-I: A Double-Edged Sword Between Inflammation And Cancer
2459. Rigid Networks As A Potential Mechanism: Network Models, Novel Therapeutic Target Strategies, And The Contributions Of Hypoxia, Inflammation And Cellular Senescence
2460. Rip Kinases In Liver Cell Death, Inflammation And Cancer
2461. Risk Of Cancer Development In Ibd—Inflammation Vs Immunosuppression
2462. Risk Of Prostate Cancer Is Not Associated With Levels Of C‐Reactive Protein And Other Commonly Used Markers Of Inflammation
2463. Rna Regulons In Cancer And Inflammation
2464. Rnf20 Links Histone H2B Ubiquitylation With Inflammation And Inflammation-Associated Cancer
2465. Robust Early Inflammation Of The Peri-Pancreatic Visceral Adipose Tissue During Diet-Induced Obesity In The Krasg12D Model Of Pancreatic Cancer
2466. Role Of 1H-Mrsi And Dce-Mri In Identification Of Pattern Changes From Inflammation To Prostate Cancer
2467. Role Of Activation-Induced Cytidine Deaminase In Inflammation-Associated Cancer Development
2468. Role Of Aging, Inflammation, And Tissue Remodeling In Lung Cancer Progression
2469. Role Of Angiopoietin-Like 4 (Angptl4), A Member Of Matricellular Proteins: From Homeostasis To Inflammation And Cancer Metastasis
2470. Role Of Aurora Kinase A On Regulating Inflammation And Inducing Nf-Κb Pathway Activation In Gastric Cancer.
2471. Role Of Autophagy In Suppression Of Inflammation And Cancer
2472. Role Of B7-H4 In The Progression And Prognosis Of Cervical Inflammation To Cancer After Human Papilloma Virus Infection
2473. Role Of Bioactive Lipofishins In Prevention Of Inflammation And Colon Cancer
2474. Role Of Breast Cancer Resistance Protein In Obesity Associated Chronic Low Grade Inflammation
2475. Role Of Cancer Stem Cell-Associated Inflammation In Creating Pro-Inflammatory Tumorigenic Microenvironments
2476. Role Of Cancer-Related Inflammation In Esophageal Cancer
2477. Role Of Chemokines In Non-Small Cell Lung Cancer: Angiogenesis And Inflammation
2478. Role Of Complement In Cancer-Related Inflammation
2479. Role Of Epigenetics In Transformation Of Inflammation Into Colorectal Cancer
2480. Role Of Ets-2 Phosphorylation In Inflammation, Development And Cancer
2481. Role Of Helicobacter Pylori Infection And Chronic Inflammation In Gastric Cancer In The Cardia
2482. Role Of Ikappab Kinase Beta In Inflammation-Mediated Breast Cancer Development
2483. Role Of Inflammation And Eicosanoids In Breast Cancer
2484. Role Of Inflammation And Genes Associations With Prostate Cancer Risk.
2485. Role Of Inflammation And Inflammatory Mediators In Colorectal Cancer
2486. Role Of Inflammation And Insulin Resistance In Mouse Models Of Breast Cancer
2487. Role Of Inflammation And Oxidative Stress In Post‐Menopausal Oestrogen‐Dependent Breast Cancer
2488. Role Of Inflammation And Substrate Stiffness In Cancer Cell Transmigration
2489. Role Of Inflammation Associated With Interaction Between Osteopontin And Cd44 In A Case Of Pulmonary Tumor Thrombotic Microangiopathy Caused By Breast Cancer
2490. Role Of Inflammation Gene Polymorphisms On Pain Severity In Lung Cancer Patients
2491. Role Of Inflammation In Chemical-Induced Lung Cancer
2492. Role Of Inflammation In Obesity-Related Breast Cancer
2493. Role Of Inflammation In The Perioperative Management Of Urothelial Bladder Cancer With Squamous-Cell Features: Impact Of Neutrophil-To-Lymphocyte Ratio On Outcomes …
2494. Role Of Micrornas In Inflammation-Associated Liver Cancer
2495. Role Of Micrornas In The Immune System, Inflammation And Cancer
2496. Role Of Myeloid Derived Hematopoietic Cells In Inflammation And Immune Tolerance To Cancer
2497. Role Of Neurokinin-1 Receptor During The Transition Of Inflammation To Dysplasia In A Colitis-Associated Colon Cancer Model
2498. Role Of Nuclear Factor-Κb Pathway In Gastrointestinal Inflammation And Cancer
2499. Role Of Physical Exercise In The Regulation Of Epigenetic Mechanisms In Inflammation, Cancer, Neurodegenerative Diseases, And Aging Process
2500. Role Of Placenta Growth Factor In Cancer And Inflammation
2501. Role Of Platelets In Inflammation And Cancer: Novel Therapeutic Strategies
2502. Role Of Prostaglandin Receptor Ep2 In The Regulations Of Cancer Cell Proliferation, Invasion, And Inflammation
2503. Role Of Retinoic Acid-Metabolizing Cytochrome P450S, Cyp26, In Inflammation And Cancer
2504. Role Of Rsume In Inflammation And Cancer
2505. Role Of Se-Dependent Glutathione Peroxidases In Gastrointestinal Inflammation And Cancer
2506. Role Of Ship1 In Cancer And Mucosal Inflammation
2507. Role Of Sonic Hedgehog Signaling During Progression From Inflammation To Cancer In The Stomach
2508. Role Of Sparc In Inflammation And Cancer
2509. Role Of Sphingosine 1-Phosphate Receptors, Sphingosine Kinases And Sphingosine In Cancer And Inflammation
2510. Role Of Systemic And Bronchial Oxidative Stress And Inflammation In Lung Cancer Predisposition In Patients With Copd
2511. Role Of Systemic Inflammation Scores In Pulmonary Metastasectomy For Colorectal Cancer
2512. Role Of The Gut–Liver Axis In Liver Inflammation, Fibrosis, And Cancer: A Special Focus On The Gut Microbiota Relationship
2513. Role Of Trpv1 Channels In Mediating Chronic Pelvic Pain And The Role Of Inflammation In Prostate Cancer
2514. Role Of Tumour-Associated Macrophages In Cancer-Related Inflammation
2515. Role Of Zeb1 In Macrophages During Homeostasis, Inflammation And Cancer
2516. Roles For Inflammation And Regulatory T Cells In Colon Cancer
2517. Roles Of Inflammation In Cancer Initiation, Progression, And Metastasis
2518. Roles Of Keratinocyte Inflammation In Oral Cancer: Regulating The Prostaglandin E 2 , Interleukin-6 And Tnf-Α Production Of Oral Epithelial Cells By Areca …
2519. Roles Of Nf-Κb Signaling In The Regulation Of Mirnas Impacting On Inflammation In Cancer
2520. Roles Of Programmed Cell Death Protein 5 In Inflammation And Cancer
2521. Roles Of Tnf-Α And Il-6 In Regulating Bone Cancer Pain Via Trpa1 Signal Pathway And Beneficial Effects Of Inhibition Of Neuro-Inflammation And Trpa1
2522. Roles Of Toll-Like Receptors: From Inflammation To Lung Cancer Progression
2523. Runx3 At The Interface Of Immunity, Inflammation And Cancer
2524. Runx3 In Immunity, Inflammation And Cancer
2525. S-1 Combination Therapy (Fgs) As Salvage Chemotherapy In Patients With Gemcitabine-Refractory Advanced Pancreatic Cancer: Inflammation-Based Prognostic Score …
2526. S100A8 And S100A9 In Inflammation And Cancer
2527. S100A9 As A Pharmacological Target Molecule In Inflammation And Cancer
2528. S100A9, Inflammation, And Regulation Of Immune Suppression In Cancer
2529. S4 Chronic Inflammation And Bladder Cancer: How Hot Is The Link?
2530. Sag-Ups Regulates Malignant Transformation—From Chronic Inflammation To Pro-Tumorigenesis To Liver Cancer
2531. Salivary Agglutinin/Glycoprotein-340/Dmbt1: A Single Molecule With Variable Composition And With Different Functions In Infection, Inflammation And Cancer
2532. Salmonella Infection In Chronic Inflammation And Gastrointestinal Cancer
2533. Salvianolic Acid B Slows The Progression Of Breast Cancer Cell Growth Via Enhancement Of Apoptosis And Reduction Of Oxidative Stress, Inflammation, And …
2534. Saponins Regulate Intestinal Inflammation In Colon Cancer And Ibd
2535. Sarcopenia And Inflammation Are Independent Predictors Of Survival In Male Patients Newly Diagnosed With Small Cell Lung Cancer
2536. Science Writers And Editors On The Journal Press List: Paclitaxel Related To Increased Risk Of Lung Inflammation In Women Receiving Radiation For Breast Cancer
2537. Screening For Frailty Among Older Patients With Cancer Using Blood Biomarkers Of Inflammation
2538. Secondary Bile Acids And Short Chain Fatty Acids In The Colon: A Focus On Colonic Microbiome, Cell Proliferation, Inflammation, And Cancer
2539. Secreted Phospholipases A2 Are Intestinal Stem Cell Niche Factors With Distinct Roles In Homeostasis, Inflammation, And Cancer
2540. Secreted Pla2 Induces Proliferation In Astrocytoma Through The Egf Receptor: Another Inflammation–Cancer Link
2541. Selenium Unmasks Protective Iron Armor: A Possible Defense Against Cutaneous Inflammation And Cancer
2542. Self-Assembling Polymer Systems For Advanced Treatment Of Cancer And Inflammation
2543. Semaphorin Signaling In Cancer-Associated Inflammation
2544. Senescence-Associated Sin3B Promotes Inflammation And Pancreatic Cancer Progression
2545. Serum Autoantibodies In Chronic Prostate Inflammation In Prostate Cancer Patients
2546. Serum Biomarkers Of Inflammation For Diagnosis Of Prostate Cancer In Patients With Nonspecific Elevations Of Serum Prostate Specific Antigen Levels
2547. Serum Levels Of Rapid Turnover Proteins Are Decreased And Related To Systemic Inflammation In Patients With Ovarian Cancer
2548. Serum Levels Of Secreted Group Iia Phospholipase A2 In Benign Prostatic Hyperplasia And Prostate Cancer: A Biomarker For Inflammation Or Neoplasia?
2549. Serum Psa Level Correlates With The Needle Biopsy Extent Of Atrophy And Chronic Inflammation, But Not With High Grade Pin And Prostate Cancer
2550. Serum Pthrp Predicts Weight Loss In Cancer Patients Independent Of Hypercalcemia, Inflammation, And Tumor Burden
2551. Session 1: Sex Hormones And Aromatases In Chronic Inflammation And Cancer
2552. Session 27. Inflammation And Cancer
2553. Sex Steroid-Induced Dna Methylation Changes And Inflammation Response In Prostate Cancer
2554. Shh, Gi Mucins And Rate Of Proliferation In Response To Chronic Injury And Inflammation: Possible Origin Of Pancreatic Cancer?
2555. Sick And Tired: Mood, Fatigue, And Inflammation In Cancer
2556. Signal Transducer And Activator Of Transcription (Stats) Proteins In Cancer And Inflammation: Functions And Therapeutic Implication
2557. Signal Transducer And Activator Of Transcription 5 Signaling Causes Gigantism, Inflammation, And Premature Death But Protects Mice From Aggressive Liver Cancer
2558. Signal Transducer And Activator Of Transcription-3, Inflammation, And Cancer: How Intimate Is The Relationship?
2559. Signaling By The Matrix Proteoglycan Decorin Controls Inflammation And Cancer Through Pdcd4 And Microrna-21
2560. Signaling Molecules: The Pathogenic Role Of The Il-6/Stat-3 Trans Signaling Pathway In Intestinal Inflammation And In Colonic Cancer
2561. Signaling Pathways Bridging Microbial-Triggered Inflammation And Cancer
2562. Significance Of Advanced Lung Cancer Inflammation Index (Ali) In Untreated And Treated Stage Iv Non-Small Cell Lung Cancer (Nsclc): An Australian Cancer Centre …
2563. Significance Of Coexistent Granulomatous Inflammation And Lung Cancer
2564. Significance Of Heparanase In Cancer And Inflammation
2565. Significance Of Inflammation-Based Indices In The Prognosis Of Patients With Non-Metastatic Colorectal Cancer
2566. Significance Of Systemic Immune-Inflammation Index (Sii) And C-Reactive Protein-To-Albumin Ratio (Car) In Patients With Esophageal Cancer: A Meta-Analysis
2567. Significance Of The Inflammation-Based Glasgow Prognostic Score For Short-And Long-Term Outcomes After Curative Resection Of Gastric Cancer
2568. Significance Of The Inflammation-Based Prognostic Score In Recurrent Pancreatic Cancer
2569. Silencing Of Matrix Metalloproteinase Mmp9 Nurtures Tumor Microenvironment In Chronic Inflammation Driven Colon Cancer
2570. Similarities And Distinctions Of Cancer And Immune Metabolism In Inflammation And Tumors
2571. Simple Indices Of Inflammation As Predictors Of Death From Cancer Or Cardiovascular Disease In A Prospective Cohort After Two Decades Of Follow-Up
2572. Simultaneous Identification Of Differential Gene Expression And Connectivity In Inflammation, Adipogenesis And Cancer
2573. Sinomenine Hydrochloride Inhibits Breast Cancer Metastasis By Attenuating Inflammation-Related Epithelial-Mesenchymal Transition And Cancer Stemness
2574. Skin-Window-Induced Inflammation In Breast Cancer Patients: A Study Of Macrophage Migration
2575. Sleep Disturbance, Inflammation And Depression Risk In Cancer Survivors
2576. Smad4 Loss In Mice Causes Spontaneous Head And Neck Cancer With Increased Genomic Instability And Inflammation
2577. Smoking And Lung Cancer: The Role Of Inflammation
2578. Smoking, Inflammation And Small Cell Lung Cancer: Recent Developments
2579. Smoking—A Trigger For Chronic Inflammation And Cancer Development In The Pancreas
2580. Snx9 As A Novel Biomarker For Chronic Inflammation-Induced Immunosuppression: Implications For Cancer Therapy (112.16)
2581. Social Disparities In Biological Risk Factors Of Cancer In Young Adulthood: Obesity, Inflammation, And Socio-Behavioral Mechanisms
2582. Social Network Ties And Inflammation In Us Adults With Cancer
2583. Social Relationships, Inflammation Markers, And Breast Cancer Incidence In The Women’S Health Initiative
2584. Social Relationships, Inflammation, And Cancer Survival
2585. Social Support Predicts Inflammation, Pain, And Depressive Symptoms: Longitudinal Relationships Among Breast Cancer Survivors
2586. Socs, Inflammation, And Cancer
2587. Socs3 Induction By Pparγ Restrains Cancer-Promoting Inflammation
2588. Sorafenib Improves Alkylating Therapy By Blocking Induced Inflammation, Invasion And Angiogenesis In Breast Cancer Cells
2589. Sorafenib Treatment During Partial Hepatectomy Reduces Tumorgenesis In An Inflammation-Associated Liver Cancer Model
2590. Sp0005 Inflammation And Cancer: Friend Or Foe
2591. Sp0020 Adam17 As A Masterswitch In The Regulation Of Inflammation And Cancer
2592. Sp0085 Regulatory B10 Cells During Inflammation, Autoimmunity And Cancer
2593. Sp0127 Transition From Chronic Inflammation To Cancer: Immune Endocrine Synergies
2594. Sp0128 Common Epigenetic Biomarkers In Chronic Inflammation And Cancer
2595. Sparc Ameliorates Ovarian Cancer-Associated Inflammation
2596. Specific Antigen Level And Acute Inflammation On The Percentage Of Free Serum Prostate Specific Antigen Levels In Men Without Clinically Detectable Prostate Cancer
2597. Spect/Ct Alters Management By Revealing Hyperemia Of Inflammation As The Cause Of False-Positive I-131 Whole-Body Scans In Post-Thyroidectomy Thyroid Cancer …
2598. Spectroscopic Imaging (1H-Mrsi) And Dynamic Contrast-Enhanced Magnetic Resonance (Dce-Mri): Pattern Changes From Inflammation To Prostate Cancer
2599. Sphingosine 1-Phosphate Is A Missing Link Between Chronic Inflammation And Colon Cancer
2600. Sphingosine-1-Phosphate In Chronic Intestinal Inflammation And Cancer
2601. Sphingosine-1-Phosphate Links Persistent Stat3 Activation, Chronic Intestinal Inflammation, And Development Of Colitis-Associated Cancer
2602. Sphingosine-1-Phosphate Signaling In Inflammation And Cancer
2603. Sphingosine-1-Phosphate: Driver Of Nfκb And Stat3 Persistent Activation In Chronic Intestinal Inflammation And Colitis-Associated Cancer
2604. Spontaneous Regression Of Metastatic Pancreatic Cancer: A Role For Recurrent Inflammation
2605. Sporadic Colorectal Cancer: The Role Of Chronic Inflammation
2606. Squamous Trans-Differentiation Of Pancreatic Cancer Cells Promotes Stromal Inflammation
2607. Src As The Link Between Inflammation And Cancer
2608. Src Family Kinases, Hck And Fgr, Associate With Local Inflammation And Tumour Progression In Colorectal Cancer
2609. ß1, 6Glcnac-Branched N-Glycans Regulate Inflammation And Cancer
2610. Stabilized Epoxygenated Fatty Acids Regulate Inflammation, Pain, Angiogenesis And Cancer
2611. Staging And Surgical Management Of Pancreatic And Biliary Cancer And Inflammation
2612. Stat1 And Stat3 Transcription Factors In Inflammation-Associated Colon Cancer
2613. Stat3 Activation Of Mir-21 And Mir-181B-1 Via Pten And Cyld Are Part Of The Epigenetic Switch Linking Inflammation To Cancer
2614. Stat3 Acts Through Pre-Existing Nucleosome-Depleted Regions Bound By Fos During An Epigenetic Switch Linking Inflammation To Cancer
2615. Stat3 And Sphingosine-1-Phosphate In Inflammation-Associated Colorectal Cancer
2616. Stat3 And The Inflammation/Acute Phase Response In Involution And Breast Cancer
2617. Stat3 Downstream Gene Product Chitinase 3-Like 1 Is A Potential Biomarker Of Inflammation-Induced Lung Cancer In Multiple Mouse Lung Tumor Models And …
2618. Stat3 In The Systemic Inflammation Of Cancer Cachexia
2619. Stat3: Linking Inflammation To Epithelial Cancer-More Than A” Gut” Feeling?
2620. Stat3-Driven Cancer-Related Inflammation As A Key Therapeutic Target For Cancer Immunotherapy
2621. Stat3-Induced Wnt5A Signaling Loop In Embryonic Stem Cells, Adult Normal Tissues, Chronic Persistent Inflammation, Rheumatoid Arthritis And Cancer
2622. State Of The Art. Chronic Obstructive Pulmonary Disease, Inflammation, And Lung Cancer
2623. State Of The Science: Stress, Inflammation, And Cancer.
2624. Stats In Cancer Inflammation And Immunity: A Leading Role For Stat3
2625. Stellate Cells In Tissue Repair, Inflammation, And Cancer
2626. Sterile Inflammation Fuels Gastric Cancer
2627. ‘Sterile’Inflammation And Autophagy In Cancer Immunotherapy
2628. Stim1 And Stim2 Mediate Cancer-Induced Inflammation In T Cell Acute Lymphoblastic Leukemia
2629. Sting: Infection, Inflammation And Cancer
2630. Streptococcus Infantarius And Colonic Cancer: Identification And Purification Of Cell Wall Proteins Putatively Involved In Colorectal Inflammation And Carcinogenesis In …
2631. Stress Neuromediators Are Key Regulators Of The Intestinal Barrier: Link To Inflammation And Cancer
2632. Stress, Inflammation, Cancer And Dementia; Cddo And Curcumin As Therapeutic Agents
2633. Stress, Inflammation, Cancer, And Dementia: Curcumin And Cddo As Therapeutic Agents
2634. Stress-Adaptive Response In Ovarian Cancer Drug Resistance: Role Of Trap1 In Oxidative Metabolism-Driven Inflammation
2635. Stromal Induction Of Breast Cancer: Inflammation And Invasion
2636. Stromal Inflammation In Pancreatic Cancer: Mechanisms And Translational Applications
2637. Studies On 68Ga-Based Agents For Pet Imaging Of Cancer And Inflammation
2638. Studies On Redox-Proteins And Cytokines In Inflammation And Cancer
2639. Studies On Serum Ykl-40 As A Biomarker In Diseases With Inflammation, Tissue Remodelling, Fibroses And Cancer
2640. Studies On The Effects Of Plant And Food Constituents On Cyclooxygenase-2: Aspects In Inflammation And Cancer
2641. Studies On The Role Of Interleukin-6 In Prostate Cancer Development And In The Induction Of Chronic Prostatic Inflammation By Propionibacterium Acnes
2642. Study Examining The Relationship Between Performance Status And Systemic Inflammation Frameworks And Cytokine Profiles In Patients With Advanced Cancer
2643. Study Of The Effect Of Vitamin D And Omega-3 Fatty Acids Cosupplementation As Adjuvant Chemotherapy On Inflammation And Nutritional Status In Colorectal Cancer …
2644. Study Of The Feasibility Of Fdg-Pet/Ct Imaging To Quantify Radiation-Induced Lung Inflammation In Locally Advanced Non-Small Cell Lung Cancer Patients Receiving Proton …
2645. Study Of Tlr4 And Il-8 Gene Polymorphisms In H.Pylori-Induced Inflammation In Gastric Cancer In An Ethnic Kashmiri Population
2646. Study On Antitussive Effects Of Eprazinone Dihydrochloride On Radiation Induced Inflammation Of Upper Respiratory Tract Due To Postoperative Irradiation Of Breast Cancer
2647. Study On Level Of Inflammation Factors In Patients With Lung Cancer [J]
2648. Subclinical Inflammation And Endothelial Dysfunction In Patients With Chronic Pancreatitis And Newly Diagnosed Pancreatic Cancer
2649. Subclinical Prostatic Inflammation Attributable To Chlamydia Trachomatis In A Patient With Prostate Cancer.
2650. Sugar Intake, Inflammation, And Depression In Breast Cancer Patients
2651. Sun-338 Inflammation Promotes Aggressive Thyroid Cancer Progression In A Mouse Model
2652. Supplement Enriched With N-3 Polyunsaturated Fatty Acids On Markers Of Inflammation, Oxidative Stress And Metabolic Status Of Ear, Nose And Throat Cancer …
2653. Supplemental Information Low Cd38 Identifies Progenitor-Like Inflammation-Associated Luminal Cells That Can Initiate Human Prostate Cancer And Predict Poor Outcome
2654. Suppressing The Molecular Signaling Pathways Involved In Inflammation And Cancer In Breast Cancer Cell Lines Mda-Mb-231 And Mcf-7 By Mir-590
2655. Suppression Of Intestinal Inflammation And Inflammation-Driven Colon Cancer In Mice By Dietary Sphingomyelin: Importance Of Peroxisome Proliferator-Activated …
2656. Suppression Of Macrophages-Induced Inflammation Via Targeting Ras And Par-4 Signaling In Breast Cancer Cell Lines
2657. Suppressor Cells Are Increased And Correlated With Type 2 Immune Responses, Malnutrition, Inflammation, And Poor Prognosis In Patients With Breast Cancer
2658. Surgery For Triple-Negative Breast Cancer-Does The Type Of Anaesthesia Have An Influence On Oxidative Stress, Inflammation, Molecular Regulators, And Outcomes …
2659. Surgical And Not Analgesic Technique Affects Postoperative Inflammation Following Colorectal Cancer Surgery: A Prospective, Randomized Study
2660. Survival Analysis Of Patients With Stage Iv Gastric Cancer Following Palliative Surgery Based On Inflammation-Based Prognostic Score
2661. Sy05 Alcohol And Cancer Sy05-1 Carcinogenic Etheno Dna Adducts Generated During Inflammation And Cyp2E1 Induction In …
2662. Symposium: Inflammation; Changes In Gene Expression Contribute To Cancer Prevention By Cox Inhibitors
2663. Synthesis And Bioactivity Of Novel Histone Acetylation Inhibitors: Potential New Drugs For Treatment Of Cancer And Inflammation
2664. Synthesis And Biological Evaluation Of Anti Inflammation And Anti Cancer Compounds
2665. Synthesis Of A Series Of Substituted Thiazole Derivatives: New Cox‐2 Enzyme Inhibitors For Colon Cancer And Inflammation Treatment
2666. Synthesis Of Thioether‐Linked Analogues Of The 2, 3‐Sialyl‐Tf And Meca‐79 Antigens: Mucin‐Type Glycopeptides Associated With Cancer And Inflammation
2667. Synthesis, Characterization And Inhibitory Effects Of Crocetin Derivative Compounds In Cancer And Inflammation
2668. Systemic And Intestinal Chronic Inflammation, Diet And Cancer: An Unbreakable Bond
2669. Systemic And Local Inflammation In Colorectal Cancer
2670. Systemic Chronic Inflammation And Colorectal Cancer-An Unsolved Puzzle.
2671. Systemic Disease Or Periodontal Disease? Distinguishing Causes Of Gingival Inflammation: A Guide For Dental Practitioners. Part 2: Cancer Related, Infective, And Other …
2672. Systemic Immune Inflammation Index And Treatment Response In Patients With Metastatic Renal Cell Cancer.
2673. Systemic Immune-Inflammation Index (Sii) As Prognostic/Predictive Factor In Patients (Pts) With Metastatic Renal Cell Cancer (Mrcc) Treated With Sunitinib.
2674. Systemic Immune‐Inflammation Index (Sii) Is Useful To Predict Survival Outcomes In Patients With Surgically Resected Non‐Small Cell Lung Cancer
2675. Systemic Immune-Inflammation Index (Sii) Predicts Poor Survival In Pancreatic Cancer Patients Undergoing Resection
2676. Systemic Immune–Inflammation Index As A Useful Prognostic Indicator Predicts Survival In Patients With Advanced Gastric Cancer Treated With Neoadjuvant …
2677. Systemic Immune-Inflammation Index For Predicting Prognosis Of Colorectal Cancer
2678. Systemic Immune-Inflammation Index Is A Promising Noninvasive Marker To Predict Survival Of Lung Cancer: A Meta-Analysis
2679. Systemic Immune-Inflammation Index Predicting Chemoradiation Resistance And Poor Outcome In Patients With Stage Iii Non-Small Cell Lung Cancer
2680. Systemic Immune-Inflammation Index Predicts Prognosis In Patients With Epithelial Ovarian Cancer: A Retrospective Study
2681. Systemic Immune-Inflammation Index Predicts Prognosis Of Bladder Cancer Patients After Radical Cystectomy
2682. Systemic Immune-Inflammation Index Predicts Prognosis Of Patients With Advanced Pancreatic Cancer
2683. Systemic Immune-Inflammation Index Predicts Survival Of Patients After Curative Resection For Non-Small Cell Lung Cancer
2684. Systemic Immune-Inflammation Index Predicts The Clinical Outcome In Patients With Metastatic Renal Cell Cancer Treated With Sunitinib
2685. Systemic Immune-Inflammation Index To Predict The Clinical Outcome In Patients With Metastatic Renal Cell Cancer Treated With Sunitinib.
2686. Systemic Immune-Inflammation Index, Based On Platelet Counts And Neutrophil-Lymphocyte Ratio, Is Useful For Predicting Prognosis In Small Cell Lung Cancer
2687. Systemic Immune-Inflammation Index, Serum Albumin, And Fibrinogen Impact Prognosis In Castration-Resistant Prostate Cancer Patients Treated With First-Line Docetaxel
2688. Systemic Immune-Inflammation Index, Thymidine Phosphorylase And Survival Of Localized Gastric Cancer Patients After Curative Resection
2689. Systemic Inflammation After Radiation Predicts Locoregional Recurrence, Progression, And Mortality In Stage Ii-Iii Triple-Negative Breast Cancer
2690. Systemic Inflammation Among Breast Cancer Survivors: The Roles Of Goal Disengagement Capacities And Health‐Related Self‐Protection
2691. Systemic Inflammation And Experimental Cancer In A Murine Model
2692. Systemic Inflammation And Nutritional Status In Patients On Palliative Cancer Care: A Systematic Review Of Observational Studies
2693. Systemic Inflammation And Prediction Of Chemotherapy Outcomes In Patients Receiving Docetaxel For Advanced Cancer
2694. Systemic Inflammation And Survival Of Patients With Prostate Cancer: Evidence From The Glasgow Inflammation Outcome Study
2695. Systemic Inflammation And Symptom Severity In Patients With Advanced Cancer: A Prospective Study
2696. Systemic Inflammation As A Confounding Factor In Cancer Biomarker Discovery And Validation
2697. Systemic Inflammation Biomarkers Predict Survival In Patients Of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy-A Single …
2698. Systemic Inflammation Correlates With Increased Expression Of Skeletal Muscle Ubiquitin But Not Uncoupling Proteins In Cancer Cachexia
2699. Systemic Inflammation In Colorectal Cancer
2700. Systemic Inflammation In Colorectal Cancer: Underlying Factors, Effects, And Prognostic Significance
2701. Systemic Inflammation Increases Cancer Cell Adhesion To Hepatic Sinusoids By Neutrophil Mediated Mechanisms
2702. Systemic Inflammation Is Associated With The Density Of Immune Cells In The Tumor Microenvironment Of Gastric Cancer
2703. Systemic Inflammation Promotes Lung Metastasis Via E-Selectin Upregulation In Mouse Breast Cancer Model
2704. Systemic Inflammation Response Index (Siri), Cancer Stem Cells And Survival Of Localised Gastric Adenocarcinoma After Curative Resection
2705. Systemic Inflammation Score (Sis) To Predict The Effect Of The Postoperative Adjuvant Chemotherapy For Patients With Stage Iii Colorectal Cancer.
2706. Systemic Inflammation Score In Locally Advanced Rectal Cancer Patients Following Total Mesorectal Excision
2707. Systemic Inflammation Score Is A Prognostic Marker After Curative Resection In Gastric Cancer
2708. Systemic Inflammation Score: A Novel Risk Stratification Tool For Postoperative Outcomes After Video-Assisted Thoracoscopic Surgery Lobectomy For Early-Stage …
2709. Systemic Inflammation, As Measured By The Neutrophil/Lymphocyte Ratio, May Have Differential Prognostic Impact Before And During Treatment With Fluorouracil …
2710. Systemic Inflammation, Atrial Fibrillation, And Cancer
2711. Systemic Inflammation, Cardiorespiratory Fitness, And Quality Of Life In Patients With Advanced Non-Small Cell Lung Cancer
2712. Systemic Inflammation, Nutritional Status And Tumor Immune Microenvironment Determine Outcome In Resected Non-Small Cell Lung Cancer
2713. Systemic Inflammation, Nutritional Status And Tumor Immune Microenvironment Determine Outcome Of Resected Non-Small Cell Lung Cancer
2714. Systemic Inflammation-Immune Status Predicts Survival In Stage Iii-N2 Non-Small Cell Lung Cancer
2715. Systemic-Inflammation-Based Score Can Predict Prognosis In Metastatic Gastric Cancer Patients Before First-Line Chemotherapy
2716. Systems For Advanced Treatment Of Cancer And Inflammationr. Palao-Suay Systems For Advanced Treatment Of Cancer And Inflammation
2717. Tai Chi, Cellular Inflammation, And Transcriptome Dynamics In Breast Cancer Survivors With Insomnia: A Randomized Controlled Trial
2718. Talcum Powder, Chronic Pelvic Inflammation And Nsaids In Relation To Risk Of Epithelial Ovarian Cancer
2719. Tam Receptors, Phosphatidylserine, Inflammation, And Cancer
2720. Taming The Pi3K Team To Hold Inflammation And Cancer At Bay
2721. Targeted Deletion Of Mir‐139‐5P Activates Mapk, Nf‐Κb And Stat 3 Signaling And Promotes Intestinal Inflammation And Colorectal Cancer
2722. Targeted Imaging Of Colonic Tumors In Smad3−/− Mice Discriminates Cancer And Inflammation
2723. Targeting A Hallmark Of Cancer: Simultaneous Inflammation And Tumor Control For Palliative Care In Metastatic Cancer
2724. Targeting Activation-Induced Cytidine Deaminase Prevents Colon Cancer Development Despite Persistent Colonic Inflammation
2725. Targeting Cancer‐Related Inflammation In The Era Of Immunotherapy
2726. Targeting Cancer-Related Inflammation: Chinese Herbal Medicine Inhibits Epithelial-To-Mesenchymal Transition In Pancreatic Cancer
2727. Targeting Damp-Induced Inflammation To Prevent Breast Cancer Metastasis And Improve Anti-Tumor Immunity
2728. Targeting Er Stress Induced Apoptosis And Inflammation In Cancer
2729. Targeting Fcgamma Receptors: Potential Therapeutic Approaches In Inflammation, Autoimmune Disease And Cancer
2730. Targeting Il-17 For Cancer-Associated Inflammation And Immunity
2731. Targeting Inflammation And Polyamine Synthesis In Epithelial Ovarian Cancer: Pde10 And Odc1 Inhibition In C-Myc Amplified Disease
2732. Targeting Inflammation For Bladder Cancer Chemoprevention
2733. Targeting Inflammation For Prevention And Treatment Of Cancer By Tocotrienols: Food For Thought
2734. Targeting Inflammation In Cancer-Related-Fatigue: A Rationale For Mistletoe Therapy As Supportive Care In Colorectal Cancer Patients
2735. Targeting Inflammation In Ovarian Cancer Through Natural Antioxidants, Potential Therapeutic And Preventive Implications
2736. Targeting Inflammation In Pancreatic Cancer: Clinical Translation
2737. Targeting Inflammation To Prevent Breast Cancer Metastasis
2738. Targeting Nadph Oxidases For The Treatment Of Cancer And Inflammation
2739. Targeting Nampt For Therapeutic Intervention In Cancer And Inflammation: Structure‐Based Drug Design And Biological Screening
2740. Targeting Nrf2 In Inflammation And Cancer
2741. Targeting Polyamines And Inflammation For Cancer Prevention
2742. Targeting Selectins And Selectin Ligands In Inflammation And Cancer
2743. Targeting The Key Factors Of Inflammation In Cancer: Plant Intervention
2744. Targeting The Nuclear Receptor Hnf4Α As A Potential Therapy For Gut Inflammation And Cancer
2745. Targeting The Pparγ And Er Pathways Via Modulation Of Inflammation In The Tumor Microenvironment: A Novel Lung Cancer Prevention Strategy
2746. Targeting The Seven Cancer Hallmarks By Modulation Of Oxidative Stress-Induced Inflammation And Immune Activation: A Radical Therapeutic Approach
2747. Targeting The Sphingosine-1-Phosphate Axis In Cancer, Inflammation And Beyond
2748. Target-Oriented Mechanisms Of Novel Herbal Therapeutics In The Chemotherapy Of Gastrointestinal Cancer And Inflammation
2749. T-Cell Activation Promotes Tumorigenesis In Inflammation-Associated Cancer
2750. Tea And Epigallocatechin-3-Gallate On The Growth Of Probiotic Bacteria And Lps-Induced Inflammation In Differentiated Human Colon Cancer (Ht-29) Cells.
2751. Tea Catechins Reduce Viability And Cytokine-Induced Inflammation In Gastric Cancer (Ags) Cells
2752. Telomerase As A Potential Marker For Inflammation And Cancer Detection In Bronchial Washing: A Prospective Study
2753. Tgf [Beta] Signaling Enhances Wound Healing Inflammation In Post-Partum Breast Cancer
2754. Tgfβ And Cancer Metastasis: An Inflammation Link
2755. Tgf-Β At The Crossroads Between Inflammation, Suppression And Cancer
2756. Tgfβ Receptor Inhibitor Galunisertib Is Linked To Inflammation-And Remodeling-Related Proteins In Patients With Pancreatic Cancer
2757. Tgf-Β-Induced Epithelial-Mesenchymal Transition: A Link Between Cancer And Inflammation
2758. Th1 Cells In Cancer-Associated Inflammation
2759. Th9 Cell Differentiation, Transcriptional Control And Function In Inflammation, Autoimmune Diseases And Cancer
2760. Thalidomide Attenuates Mammary Cancer Associated-Inflammation, Angiogenesis And Tumor Growth In Mice
2761. The “Herald” Lesion Of The Bladder: A Lesion Which Portends The Approach Of Cancer Or Inflammation Fromoutside The Bladder
2762. The 2015 Espen Sir David Cuthbertson Lecture: Inflammation As The Driving Force Of Muscle Wasting In Cancer
2763. The A3 Adenosine Receptor: A Link Between Inflammation And Cancer
2764. The Advanced Lung Cancer Inflammation Index Is A Prognostic Marker In Patients Undergoing Curative-Intent Therapy For Lung Cancer
2765. The Advanced Lung Cancer Inflammation Index Is An Independent Prognostic Factor After Surgical Resection In Patients With Non-Small-Cell Lung Cancer
2766. The Adventures Of Sonic Hedgehog In Development And Repair. Ii. Sonic Hedgehog And Liver Development, Inflammation, And Cancer
2767. The Angiopoietin—Tie System: Common Signaling Pathways For Angiogenesis, Cancer, And Inflammation
2768. The Aryl Hydrocarbon Receptor Repressor–More Than A Simple Feedback Inhibitor Of Ahr Signaling: Clues For Its Role In Inflammation And Cancer
2769. The Association Between Diet-Associated Inflammation And Breast Cancer: Findings From An Iranian Case-Control Study
2770. The Association Between Inflammation And Colorectal Cancer
2771. The Azoxymethane Plus Dextran Sulfate Sodium-Induced Mouse Colon Cancer Model For The Study Of Dietary Chemoprevention Of Inflammation-Associated …
2772. The Cancer Microbiota: Emt And Inflammation As Shared Molecular Mechanisms Associated With Plasticity And Progression
2773. The Case For The Role Of Chronic Inflammation In The Development Of Prostate Cancer
2774. The Cgas–Cgamp–Sting Pathway Connects Dna Damage To Inflammation, Senescence, And Cancer
2775. The Changes Of Energy Interactions Between Nucleus Function And Mitochondria Functions Causing Transmutation Of Chronic Inflammation Into Cancer Metabolism
2776. The Characterisation Of Neutrophil Function In Patients Undergoing Colorectal Cancer Resection And The Impact Of Hmg-Coa Reductase Inhibitors On Host Inflammation
2777. The Chemistry Of Punica Granatum And Its Potential For Prevention And Treatment Of Inflammation And Cancer
2778. The Combination Of Histological Prostate Atrophy And Inflammation Is Associated With Lower Risk Of Prostate Cancer In Biopsy Specimens
2779. The Combination Of Systemic Inflammation-Based Marker Nlr And Circulating Regulatory T Cells Predicts The Prognosis Of Resectable Pancreatic Cancer Patients